WO2021220988A1 - Sample inspection device and sample inspection system - Google Patents

Sample inspection device and sample inspection system Download PDF

Info

Publication number
WO2021220988A1
WO2021220988A1 PCT/JP2021/016533 JP2021016533W WO2021220988A1 WO 2021220988 A1 WO2021220988 A1 WO 2021220988A1 JP 2021016533 W JP2021016533 W JP 2021016533W WO 2021220988 A1 WO2021220988 A1 WO 2021220988A1
Authority
WO
WIPO (PCT)
Prior art keywords
sample
inspection
sample testing
testing device
test
Prior art date
Application number
PCT/JP2021/016533
Other languages
French (fr)
Japanese (ja)
Inventor
功 縄田
基司 原頭
Original Assignee
キヤノンメディカルシステムズ株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by キヤノンメディカルシステムズ株式会社 filed Critical キヤノンメディカルシステムズ株式会社
Priority to CN202180002475.2A priority Critical patent/CN113892028A/en
Publication of WO2021220988A1 publication Critical patent/WO2021220988A1/en

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/84Systems specially adapted for particular applications
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/00584Control arrangements for automatic analysers

Definitions

  • a sample testing device that performs a test to detect the detection target contained in the sample is known.
  • the detection target is collected from, for example, a body fluid component such as a runny nose.
  • Detection targets include test substances such as adenovirus and influenza virus.
  • various tests can be performed by using a plurality of sample testing devices.
  • the sample test device is provided with an input / output device.
  • the input / output device performs various inputs, displays and prints test results. For example, when a plurality of inspections are performed separately by a plurality of devices, input and printing are performed for each device, which is inefficient. Therefore, if the sample testing device is centrally managed by the master and the slave, it is expected that the testing efficiency will be improved.
  • the sample inspection device includes an inspection unit, an input / output unit, a communication unit, and a control unit.
  • the inspection unit detects a detection target contained in the sample.
  • the input / output unit includes a display unit that displays information related to the inspection and an input unit that receives input of information related to the inspection.
  • the communication unit communicates with a sample inspection device of a slave having the inspection unit.
  • the control unit transmits control information used for controlling the sample testing device of the slave from the communication unit, and processes the detection result received from the sample testing device of the slave.
  • FIG. 1 is a diagram showing an example of a sample testing system to which the sample testing device according to the present embodiment is applied.
  • FIG. 2 is a diagram showing an example of the configuration of the biological reaction device shown in FIG.
  • FIG. 3 is a block diagram showing an example of the configuration of the sample testing device (master sample testing device) according to the present embodiment.
  • FIG. 4 is a block diagram showing an example of the configuration of the sample testing device (slave sample testing device) according to the present embodiment.
  • FIG. 5 is a flowchart showing a processing procedure by the sample test system in the present embodiment.
  • FIG. 6 is a flowchart showing a processing procedure by the sample test system in the present embodiment.
  • FIG. 7 is a flowchart showing a processing procedure by the sample test system in the present embodiment.
  • FIG. 1 is a diagram showing an example of a sample testing system to which the sample testing device according to the present embodiment is applied.
  • FIG. 2 is a diagram showing an example of the configuration of the biological reaction device shown in FIG
  • FIG. 8A is a diagram for explaining the processing by the sample test system in the present embodiment.
  • FIG. 8B is a diagram for explaining the processing by the sample test system in the present embodiment.
  • FIG. 8C is a diagram for explaining the processing by the sample test system in the present embodiment.
  • FIG. 8D is a diagram for explaining the processing by the sample test system in the present embodiment.
  • FIG. 8E is a diagram for explaining the processing by the sample test system in the present embodiment.
  • FIG. 8F is a diagram for explaining the processing by the sample test system in the present embodiment.
  • FIG. 8G is a diagram for explaining the processing by the sample test system in the present embodiment.
  • FIG. 9 is a flowchart showing a processing procedure by the sample test system in the modified example of the present embodiment.
  • FIG. 9 is a flowchart showing a processing procedure by the sample test system in the modified example of the present embodiment.
  • FIG. 10 is a flowchart showing a processing procedure by the sample test system in the modified example of the present embodiment.
  • FIG. 11 is a side sectional view showing a first structure which is an example of the structure of the indicator in the sample inspection device according to the present embodiment.
  • FIG. 12 is a side sectional view showing a second structure which is an example of the structure of the indicator in the sample inspection device according to the present embodiment.
  • FIG. 13 is a diagram for explaining an example of dimming of the indicator in the sample inspection device according to the present embodiment.
  • FIG. 1 is a diagram showing an example of a sample testing system 1 to which the sample testing device 10 according to the present embodiment is applied.
  • the sample testing system 1 includes a plurality of sample testing devices 10 and a biological reaction device 2.
  • the biological reaction device 2 is used to perform a test for detecting a detection target contained in a sample (for example, a body fluid component such as a runny nose). Details of the biological reaction device 2 will be described later.
  • the biological reaction device 2 is an example of a “device”.
  • the sample testing device 10 includes a cover 20, a main body 30, and an indicator 35.
  • the cover 20 is provided so as to be openable and closable with respect to the sample testing device 10.
  • the main body 30 is provided with a table for mounting the biological reaction device 2, and the cover 20 is provided to cover the table.
  • the biological reaction device 2 is attached to the base of the main body 30, and the base is covered with the cover 20.
  • the cover 20 may be provided to be detachably provided with respect to the sample test device 10.
  • the indicator 35 is provided on the front surface of the main body 30.
  • the indicator 35 will be described later.
  • the plurality of sample testing devices 10 are composed of, for example, sample testing devices 10A, 10B, and 10C.
  • the sample test device 10A is the master sample test device 10
  • the sample test devices 10B and 10C are slave sample test devices 10.
  • the sample test device 10A is communicably connected to the sample test devices 10B and 10C via a network.
  • the sample testing devices 10A, 10B, and 10C are connected to, for example, an in-hospital LAN (Local Area Network) installed in a hospital or the like to transmit and receive information.
  • an in-hospital LAN Local Area Network
  • the sample test device 10A which is the master sample test device 10
  • the input / output device 40 Since the input / output device 40 has a display, a printer, and the like described later, the cost is high. Therefore, it is preferable that the sample test devices 10B and 10C, which are the slave sample test devices 10, are not provided with the input / output device 40 from the viewpoint of cost.
  • the input / output device 40 is an example of an “input / output unit”.
  • FIG. 2 is a diagram showing an example of the configuration of the biological reaction device 2 shown in FIG.
  • the biological reaction device 2 is mounted on a mounting table 4 which is a table of the main body 30, and has a housing 21, a transparent substrate 22, an optical waveguide 23, and a protective member 24.
  • a part of the lower surface of the housing 21 is open, and a chip in which the optical waveguide 23 and the protective member 24 are formed by thin film technology is fitted on the transparent substrate 22 in the opening.
  • a part of the protective member 24 is open (open end 24a).
  • the reaction vessel 201 is formed by the housing 21, the optical waveguide 23, the protective member 24, and the like.
  • the biological reaction device 2 is configured to be capable of accommodating a sample solution containing a test object (test substance) inside the reaction container 201.
  • the housing 21 is made of, for example, resin or the like.
  • a first recess is formed on the lower surface of the housing 21.
  • a second recess forming the upper surface and the side surface of the reaction vessel 201 is formed on a part of the upper surface of the first recess.
  • a protective member 24, an optical waveguide 23, and a transparent substrate 22 are arranged in the first recess in this order from the top.
  • a hole 21a for introducing a sample solution, a reagent, or the like is formed in the reaction vessel 201 inside the housing 21 so as to penetrate upward near one end of the upper surface of the second recess, and near the other end.
  • a hole 21b is formed so as to penetrate the housing 21 upward and allow air to escape from the reaction vessel 201.
  • a plurality of holes 21a and 21b may be formed.
  • the transparent substrate 22 is formed of, for example, resin or optical glass.
  • the transparent substrate 22 allows light incident from the light source 311 provided in the main body 30 to pass through the optical waveguide 23. Further, the transparent substrate 22 allows the light incident from the optical waveguide 23 to pass through the photodetector 312 provided in the main body 30.
  • the optical waveguide 23 is formed of a material that allows light to pass through, such as resin or optical glass.
  • resin for example, a phenol resin, an epoxy resin, an acrylic resin or the like can be used.
  • the optical waveguide 23 serves as an optical path for light incident from the transparent substrate 22 and emitted to the transparent substrate 22. That is, the optical waveguide 23 fulfills the same role and function as the core (core material) in the optical fiber.
  • the protective member 24 and the transparent substrate 22 are formed of a material having a refractive index different from that of the optical waveguide 23, totally reflect light at the interface with the optical waveguide 23, and confine the light in the optical waveguide 23. It functions as a clad. Further, the protective member 24 and the transparent substrate 22 physically protect the optical waveguide 23.
  • the optical waveguide 23 propagates the light incident from the main body 30 through the transparent substrate 22.
  • light affected by the concentration of the test substance contained in the reaction vessel 201, that is, the reaction state is propagated.
  • a grating 23a is arranged on the protective member 24 side near the light incident on the optical waveguide 23.
  • the grating 23a diffracts the incident light L1 incident on the optical waveguide 23 at a predetermined angle.
  • the light diffracted in the grating 23a is incident on the interface between the optical waveguide 23 and the surface composed of the transparent substrate 22, the protective member 24, or the mixture 202 at an angle equal to or less than the complementary angle of the critical angle.
  • the incident light L1 propagates (waveguides) while being repeatedly reflected in the optical waveguide 23 at the interface of the optical waveguide 23.
  • a grating 23b is arranged on the protective member 24 side near the light emitted from the optical waveguide 23.
  • the grating 23b diffracts the light optical waveguided by the optical waveguide 23 at a predetermined angle.
  • the light diffracted by the grating 23b is emitted from the optical waveguide 23 to the outside at a predetermined angle.
  • the protective member 24 has an opening at the position of the second recess of the housing 21.
  • the protective member 24 is arranged in close contact with the upper surface of the optical waveguide 23.
  • the protective member 24 is arranged in close contact with the upper surface of the optical waveguide 23 to form a plane protective layer.
  • the protective member 24 has an opening end 24a for exposing the main surface (for example, the upper surface) of the optical waveguide 23.
  • the opening end 24a is a vertical surface that forms an opening inside the protective member 24.
  • the upper surface of the optical waveguide 23 is exposed by the open end 24a.
  • the upper surface of the reaction vessel 201 is composed of the upper surface of the second recess of the housing 21, the side surface is composed of the side surface of the second recess of the housing 21 and the open end 24a of the protective member 24, and the lower surface is the optical waveguide 23. It is composed of the upper surface of.
  • the reaction vessel 201 contains the sample solution and the reagent, and reacts the test substance contained in the sample solution with the reagent.
  • a plurality of first antibodies 211 are immobilized on the lower surface of the surface forming the reaction vessel 201, that is, the upper surface of the optical waveguide 23.
  • the first antibody 211 is a substance that specifically reacts with the antigen 212 contained in the test substance by an antigen-antibody reaction.
  • the first antibody 211 is fixed to the upper surface of the optical waveguide 23 by, for example, a hydrophobic interaction or a chemical bond that occurs with the upper surface of the optical waveguide 23.
  • the reaction vessel 201 is, for example, empty in advance. At the time of measuring the test substance, for example, the mixed solution 202 of the sample solution and the reagent is injected into the reaction vessel 201 from the outside through the hole 21a.
  • the sample solution contains a test substance containing the antigen 212.
  • the reagent includes reagent component 213.
  • the reagent component 213 includes, for example, a second antibody 214 that specifically reacts with the antigen 212 by an antigen-antibody reaction, and magnetic particles 215 to which the second antibody 214 is bound. At least a part of the magnetic particles 215 is formed of a magnetic material such as magnetite. In the magnetic particles 215, for example, the surface of particles formed from a magnetic material is coated with a polymer material.
  • the magnetic particles 215 may be configured to cover the surface of the particles made of a polymer material with a magnetic material. Further, the magnetic particles 215 may be replaced with any magnetic particles 215 as long as they are dispersible in the mixed liquid
  • the antigen 212 contained in the test substance in the sample solution and the reagent contained in the reagent are injected into the reaction vessel 201.
  • Ingredients 213 are housed.
  • the mixed solution 202 is injected into the reaction vessel 201, the air in the reaction vessel 201 is discharged to the outside through the holes 21b.
  • the reagent component 213 moves in a dispersible manner in the mixed solution 202 filled in the reaction vessel 201.
  • the magnetic particles 215 are selected so that the gravity applied to the magnetic particles 215 is larger than the buoyancy in the mixture 202 applied in the direction opposite to the gravity.
  • the magnetic particles 215 to which the second antibody 214 is bound are fixed near the upper surface of the optical waveguide 23 by binding the second antibody 214 to the first antibody 211 via the antigen 212.
  • the second antibody 214 may be the same as or different from the first antibody 211.
  • the first antibody 211 fixed on the upper surface of the optical waveguide 23 reacts with the antigen 212 contained in the test substance, so that the magnetic particles 215 to which the second antibody 214 is bound are formed in the optical waveguide 23. It is fixed near the top surface.
  • the light guided through the optical waveguide 23 is scattered and absorbed by the magnetic particles 215 fixed in the vicinity of the upper surface of the optical waveguide 23.
  • the light guided through the optical waveguide 23 is attenuated and emitted from the optical waveguide 23. That is, the incident light L1 is attenuated according to the amount of the antigen 212 that binds the first antibody 211 and the second antibody 214 immobilized on the magnetic particles 215. In other words, the incident light L1 is attenuated according to the amount of antigen 212 contained in the reaction vessel 201.
  • a region separated by a distance L in the vertical upward direction from the surface of the optical waveguide 23, that is, a region near the surface of the optical waveguide 23 is defined as a sensing area 205.
  • the sensing area 205 is an area where evanescent light can be generated.
  • the first antibody 211 immobilized on the upper surface of the optical waveguide 23 is immobilized on the magnetic particles 215 contained in the reagent component 213 via the antigen 212 contained in the test substance in the sample solution. 2 Binds to antibody 214.
  • the magnetic particles 215 to which the second antibody 214 is bound are held in the vicinity of the upper surface of the optical waveguide 23.
  • the first antibody 211, the second antibody 214, and the antigen 212 are very small as compared with the magnetic particles 215.
  • the first antibody 211, the antigen 212, the second antibody 214, and the magnetic particles 215 are shown as having the same size.
  • the second antibody 214 immobilized on the magnetic particles 215 binds to the first antibody 211 immobilized on the upper surface of the optical waveguide 23 via the antigen 212.
  • the magnetic particles 215 to which the second antibody 214 is bound remain in the sensing area 205.
  • the magnetic particles 215 remaining in the sensing area 205 scatter and absorb the evanescent light, and attenuate the evanescent light. .. Scattering and absorption of evanescent light in the sensing area 205 affects the light propagating in the optical waveguide 23.
  • the evanescent light is attenuated in the sensing area 205
  • the light optical waveguided in the optical waveguide 23 is also attenuated. Therefore, when the evanescent light is strongly scattered and absorbed in the sensing area 205, the intensity of the light propagating in the optical waveguide 23 decreases. In other words, the greater the amount of magnetic particles 215 that remain in the sensing area 205, the lower the intensity of the light output from the optical waveguide 23.
  • the magnetic particles 215 remaining in the sensing area 205 include the first antibody 211 immobilized on the upper surface of the optical waveguide 23 via the antigen 212 to be measured and the second antibody 214 immobilized on the magnetic particles 215. Is not limited to the combination of. Therefore, in order to measure the accurate concentration of the antigen 212 contained in the test substance, the magnetic particles 215 to which the second antibody 214 that is not involved in the measurement, that is, that is not bound to the antigen 212, is bound is measured in the sensing area 205. You need to stay away from it. As a specific method, for example, there is a method of moving the magnetic particles 215 in which the second antibody 214 is not bound to the antigen 212 by the proximity action by a magnetic field.
  • the magnetic particles 215 finally staying in the sensing area 205 are bound to the first antibody 211 fixed on the upper surface of the optical waveguide 23 via the antigen 212 and the second antibody 214. Therefore, the value of the intensity of the light emitted from the biological reaction device 2 and the time-series change in the intensity correspond to the amount and concentration of the magnetic particles 215 remaining in the sensing area 205.
  • the biological reaction device 2 may have a configuration capable of simultaneously measuring the same test substance on a plurality of channels in parallel for the same measurement item. At this time, the biological reaction device 2 has, for example, an independent optical waveguide for each channel.
  • FIG. 3 is a block diagram showing an example of the configuration of the sample testing device 10A according to the present embodiment.
  • the input / output device 40 is mounted on the upper surface of the sample test device 10A, and includes an output device 41 and an input device 42.
  • the output device 41 has a display 411 and a printer 412.
  • the front surface of the input / output device 40 of the sample test device 10A is inclined so that the user can easily see the display 411.
  • Display 411 displays various information.
  • the display 411 displays various images generated by the processing circuit 34 described later, and displays a GUI (Graphical User Interface) for accepting various operations from the user.
  • the display 411 is a liquid crystal display, an OLED (Organic Light Emitting Diode) display, a CRT (Cathode Ray Tube) display, or the like.
  • the display 411 follows the control of the processing circuit 34 described later, for example, various operation screens, information indicating the light intensity of the emitted light L2 supplied from the photodetector 312 described later, time-series data of information indicating the light intensity, and , Display information about inspection.
  • Information about the test includes, for example, the test result of the test.
  • the test result is, for example, the amount (concentration, weight, number, etc.) or presence / absence of the antigen 212.
  • the display 411 is an example of a “display unit”.
  • the printer 412 has various operation screens displayed on the display 411, for example, information indicating the light intensity of the emitted light L2 supplied from the photodetector 312 described later, and information indicating the light intensity. Print out the time-series data of the above and the test results of the test substance.
  • the printer 412 is an example of a "printing unit".
  • the input device 42 is realized by, for example, a trackball, a switch, a button, a mouse, a keyboard, a touch pad that performs an input operation by touching an operation surface, a touch panel display in which a display screen and a touch pad are integrated, and the like.
  • the input device 42 outputs an operation input signal corresponding to the user's operation to the processing circuit 34 described later.
  • the input interface circuit is not limited to the one provided with physical operating parts such as a mouse and a keyboard.
  • an electric signal processing circuit that receives an electric signal corresponding to an input operation from an external input device provided separately from the device and outputs this electric signal to a processing circuit 34 described later is also an example of an input interface circuit. included.
  • the input device 42 is an example of an “input unit”.
  • the main body 30 has a detection unit 31 as shown in FIG.
  • the detection unit 31 includes a light source 311 and a photodetector 312, and a reader 313.
  • the light source 311 is, for example, a diode such as an LED (Light Emitting Diode) or a lamp such as a xenon lamp.
  • the light source 311 is arranged at a position where light can be incident in the optical waveguide 23 toward the grating 23a shown in FIG.
  • the light source 311 incidents the incident light L1 into the optical waveguide 23 via the transparent substrate 22 of the biological reaction device 2.
  • the photodetector 312 outputs an electric signal based on the reaction state in the reaction vessel 201 containing the mixed liquid 202. Specifically, the photodetector 312 detects the emitted light L2 emitted to the outside of the optical waveguide 23, and generates an electric signal indicating the intensity of the detected emitted light L2, that is, digital data regarding the light detection intensity. .. The digital data regarding the light detection intensity generated by the photodetector 312 is supplied to the processing circuit 34 described later.
  • the detection unit 31 may have a configuration capable of simultaneously measuring the same test substance on a plurality of channels in parallel for the same measurement item. At this time, the detection unit 31 may have a light source and a photodetector for each channel, for example, or may share the light source and the photodetector.
  • the detection unit 31 has a detector that detects the opening / closing of the cover 20 with respect to the main body 30.
  • the detector detects that the cover 20 has been opened from the main body 30, it outputs information indicating that the cover 20 has been opened to the processing circuit 34, and the cover 20 is closed by the main body 30.
  • information indicating that the cover 20 has been closed is output to the processing circuit 34.
  • the reading device 313 reads the type of the detection target from the identifier provided in the biological reaction device 2, and outputs the reading information indicating the type of the biological reaction device 2 to the processing circuit 34.
  • an identifier that identifies the type of the biological reaction device 2 is provided on the back surface of the biological reaction device 2.
  • the type of biological reaction device 2 is a biological reaction device 2 for virus A test or a biological reaction device for virus B test. 2 and so on.
  • a QR code (registered trademark) 2a that identifies the type of the biological reaction device 2 is printed on the back surface of the biological reaction device 2.
  • the reading device 313 reads the type of the biological reaction device 2 from the QR code (registered trademark) 2a printed on the back surface of the biological reaction device 2. , The reading information indicating the type of the biological reaction device 2 is output to the processing circuit 34.
  • the types of detection targets are color-coded, and green and blue are assigned to the biological reaction devices 2 for virus A and virus B inspection, respectively.
  • the biological reaction device 2 for virus A test and the package of the reagent to react with the biological reaction device 2 are color-coded in green.
  • the biological reaction device 2 for virus B inspection, the package of the reagent to react with the biological reaction device 2, and the like are color-coded in blue.
  • the QR code (registered trademark) 2a is used as an identifier for identifying the type of the biological reaction device 2, but the present invention is not limited to this, and for example, a barcode or the like may be used.
  • the main body 30 further includes a magnetic field generator 32, a storage circuit 33, and a processing circuit 34.
  • the magnetic field generator 32 is mediated by the reaction in the reaction vessel 201 shown in FIG. 2, that is, the antigen 212 of the second antibody 214 fixed to the magnetic particles 215 and the first antibody 211 fixed to the upper surface of the optical waveguide 23. Generates energy that promotes binding.
  • the magnetic field generator 32 has an upper magnetic field generator 32a and a lower magnetic field generator 32b, as shown in FIG. Further, the magnetic field generator 32 has a drive circuit (not shown). The magnetic field generator 32 applies a magnetic field to the reaction vessel 201 under the control of the processing circuit 34.
  • the lower magnetic field generator 32b is composed of, for example, a permanent magnet and an electromagnet.
  • the lower magnetic field generator 32b is provided below the biological reaction device 2. Specifically, the lower magnetic field generator 32b is provided below the mounting table 4 on which the biological reaction device 2 is mounted. For example, the timing at which the application of the lower magnetic field is started and the timing at which the application of the lower magnetic field is stopped are predetermined.
  • the lower magnetic field generator 32b uniformly generates a vertically downward magnetic field, which is energy for promoting the reaction in the reaction vessel 201, in the horizontal direction. Due to the generated vertical downward magnetic field, the magnetic particles 215 to which the second antibody 214 is bound are lowered by receiving the vertical downward force. At this time, the lower magnetic field generator 32b brings the magnetic particles 215 to which the second antibody 214 is bound closer to the optical waveguide 23 by generating a magnetic field of a predetermined strength.
  • the upper magnetic field generator 32a is composed of, for example, a permanent magnet and an electromagnet.
  • the upper magnetic field generator 32a is provided above the biological reaction device 2 as shown in FIG.
  • the timing at which the application of the upper magnetic field is started and the timing at which the application of the upper magnetic field is stopped are predetermined.
  • the timing for starting the application of the upper magnetic field is set to the time when a predetermined time has elapsed from the timing when the application of the lower magnetic field is stopped.
  • the upper magnetic field generator 32a uniformly generates a vertically upward magnetic field in the reaction vessel 201 in the horizontal direction. Due to the generated vertical upward magnetic field, the magnetic particles 215 to which the second antibody 214 is bound rise by receiving a vertically upward force.
  • the upper magnetic field generator 32a selectively moves the magnetic particles 215 to which the second antibody 214 is bound away from the sensing area 205 by generating a magnetic field having a predetermined strength. That is, in the upper magnetic field generator 32a, by adjusting the strength of the generated magnetic field, the first antibody 211 fixed on the upper surface of the optical waveguide 23 and the second antibody 214 that binds via the antigen 212 are bound. It is possible to keep only the magnetic particles 215 in the sensing area 205.
  • the storage circuit 33 has a recording medium that can be read by a processor, such as a magnetic or optical recording medium or a semiconductor memory.
  • the storage circuit 33 stores a program executed in the circuit of the sample test device 10A.
  • a part or all of the program and data in the storage medium of the storage circuit 33 may be configured to be downloaded via an electronic network.
  • the storage circuit 33 stores information indicating the light intensity of the emitted light L2 supplied from the photodetector 312, time-series data of information indicating the light intensity, inspection results of the test substance to be measured, and the like.
  • the storage circuit 33 stores a time schedule for measuring the target test substance.
  • the time schedule is, for example, the timing at which the application of the lower magnetic field generated by the lower magnetic field generator 32b is started, the timing at which the application of the lower magnetic field is stopped, the timing at which the application of the upper magnetic field is started, and the measurement are performed. It's timing. These timings are obtained in advance empirically and experimentally.
  • the processing circuit 34 is, for example, a processor that controls each constituent circuit of the sample testing device 10A.
  • the processing circuit 34 functions as the center of the sample testing device 10A.
  • the processing circuit 34 calls each operation program from the storage circuit 33 and executes the called program to realize the control function 341, the communication function 342, and the measurement function 343.
  • the control function 341 is an example of a "control unit”.
  • the communication function 342 is an example of a "communication unit”.
  • the measurement function 343 is an example of an “inspection unit”.
  • the measurement function 343 performs an inspection for detecting a detection target contained in a sample by using a biological reaction device 2, a light source 311, a photodetector 312, and a magnetic field generator 32.
  • the measurement function 343 and the light source 311 are controlled to generate light under predetermined conditions.
  • the processing circuit 34 continuously or intermittently generates the incident light L1 from the light source 311 from the start of the measurement to the end of the measurement.
  • the measurement function 343 controls the magnetic field generator 32 according to the time schedule stored in the storage circuit 33, and switches the application state of energy for promoting the reaction in the reaction vessel 201 of the biological reaction device 2. Specifically, as described above, the timing for starting the application of the lower magnetic field, the timing for stopping the application of the lower magnetic field, the timing for starting the application of the upper magnetic field, and the timing for stopping the application of the upper magnetic field are predetermined. Therefore, the timing for starting the application of the upper magnetic field is set to the time when a predetermined time has elapsed from the timing when the application of the lower magnetic field is stopped.
  • the measurement function 343 reads a time schedule from the storage circuit 33, controls the magnetic field generator 32 based on the read time schedule, and generates a magnetic field in the magnetic field generator 32.
  • the measurement function 343 derives a test result regarding the amount (for example, antigen concentration, etc.) or presence / absence of the test substance from the optical signal supplied from the photodetector 312.
  • the timing for deriving the inspection result is predetermined, and is set to a time when a predetermined time has elapsed from the timing when the application of the upper magnetic field is started.
  • the measurement function 343 reads the time schedule from the storage circuit 33, and derives the inspection result from the optical signal supplied from the photodetector 312 based on the read time schedule.
  • the measurement function 343 determines whether or not the sample solution is likely to be positive or negative when a predetermined time elapses from the timing at which the application of the upper magnetic field is started, and the determination result is the test result. Derived as. Specifically, the measurement function 343 compares the intensity of the optical signal acquired when a predetermined time elapses from the timing of starting the application of the upper magnetic field with, for example, the threshold value stored in the storage circuit 33. By doing so, the judgment is made. Here, when the intensity of the acquired optical signal is equal to or less than the threshold value, the measurement function 343 determines that there is a high possibility of being positive as the measurement result of the test substance, and derives the determination result as the test result. On the other hand, when the intensity of the acquired optical signal is greater than the threshold value, the measurement function 343 determines that there is a high possibility of being negative as the measurement result of the test substance, and derives the determination result as the test result.
  • the control function 341 outputs the inspection result to the output device 41.
  • the control function 341 controls the display 411 and the printer 412 as the output device 41, and presents information on the inspection to the user.
  • the control function 341 presents the inspection result regarding the amount or presence / absence of the test substance to the user by displaying it on the display 411 or printing it with a printer.
  • control function 341 controls the sample inspection device 10A and the sample inspection devices 10B and 10C, which are its own devices. The control of the control function 341 will be described later.
  • the communication function 342 communicates with the sample testing devices 10B and 10C.
  • FIG. 4 is a block diagram showing an example of the configuration of the sample testing devices 10B and 10C according to the present embodiment.
  • sample test devices 10B and 10C are not provided with the input / output device 40 from the viewpoint of cost.
  • the measurement function 343 uses the biological reaction device 2, the light source 311, the photodetector 312, and the magnetic field generator 32 to perform an inspection for detecting the detection target contained in the sample.
  • the communication function 342 communicates with the sample test device 10A.
  • the control function 341 operates under the control of the sample testing device 10A. The control of the control function 341 will be described later.
  • processor used in the above description is, for example, a CPU (Central Processing Unit), a GPU (Graphics Processing Unit), an integrated circuit for a specific application (Application Specific Integrated Circuit: ASIC)), a programmable logic device (for example, a simple one). It means a circuit such as a programmable logic device (Simple Programmable Logic Device: SPLD), a composite programmable logic device (Complex Programmable Logic Device: CPLD), and a field programmable gate array (Field Programmable Gate Array: FPGA).
  • SPLD Simple Programmable Logic Device
  • CPLD Complex Programmable Logic Device
  • FPGA Field Programmable Gate Array
  • the processor realizes the function by reading and executing the program stored in the storage circuit 60.
  • each processor of the present embodiment is not limited to the case where each processor is configured as a single circuit, and a plurality of independent circuits may be combined to form one processor to realize its function. good. Further, the plurality of components in FIGS. 3 and 4 may be integrated into one processor to realize the function.
  • the sample test system includes a plurality of sample test devices 10 composed of a master sample test device 10 and a slave sample test device 10, for example, the user can use the master sample test device 10. By operating only one unit, it is possible to operate a plurality of sample testing devices to perform various tests at the same time, and it is possible to improve the testing efficiency. Further, since the slave sample test device 10 is not provided with the input / output device 40 from the viewpoint of cost, it is possible to inexpensively configure a sample test system capable of performing a plurality of tests at the same time. However, since the input / output device 40 is not provided in the slave sample test device 10, the following problems arise in the above sample test system.
  • the input / output device 40 is not provided in the slave sample test device 10, there arises a problem that it is not possible to know what test is planned.
  • the user uses a sample test device different from the sample test device 10B due to a mistake or the like.
  • the user may attach the biological reaction device 2 for virus B testing to the sample testing device 10C.
  • the user may attach the biological reaction device 2 for virus A testing to the sample testing device 10B.
  • the test may be redone and the test efficiency may decrease. ..
  • the input / output device 40 is not provided in the slave sample inspection device 10, there arises a problem that it is not possible to know what is being inspected. Specifically, when the virus B is tested by the sample test device 10B, which is the slave sample test device 10, the sample test device 10B has the cover 20 closed at the time of the test, so that the virus B test is performed. It is not possible to confirm the color-coded blue color on the biological reaction device 2 for the virus. In this situation, the user confirms what test item is currently being tested by visually recognizing the screen displayed on the display 411 of the sample test device 10A, which is the master sample test device 10. can do.
  • an indicator 35 is provided in the main body 30 of the sample testing devices 10A to 10C in FIGS. 1, 3 and 4 in order to improve the testing efficiency.
  • the indicator 35 has a light emitting unit capable of emitting different colors. Examples of the color that the indicator 35 can emit light include green and blue.
  • the light emitting portion of the indicator 35 is formed so that the user can easily see it.
  • the light emitting portion of the indicator 35 is formed in a convex shape so as to protrude from the front surface of the main body portion 30.
  • the sample test device 10 includes a measurement function 343, an input / output device 40, a communication function 342, and a control function 341 in the master sample test device 10.
  • the measurement function 343 detects a detection target included in the sample.
  • the input / output device 40 includes a display 411 that displays information related to inspection, and an input device 42 that receives input of information related to inspection.
  • the communication function 342 communicates with the slave sample inspection device 10.
  • the slave sample inspection device 10 has a measurement function 343.
  • the control function 341 causes the communication function 342 to transmit control information used for controlling the slave sample inspection device 10.
  • the master sample test device 10 and the slave sample test device 10 further include an indicator 35, and the control function 341 of the master sample test device 10 carries out the test by transmitting control information from the communication function 342.
  • the indicator 35 of the sample test device 10 selected as the device to perform the test is controlled so as to emit light in a color corresponding to the type of the detection target of the test.
  • the control function 341 processes the detection result received from the slave sample inspection device 10.
  • 5 to 7 are flowcharts showing the procedure of processing by the sample test system 1 in the present embodiment.
  • 8A to 8G are diagrams for explaining the processing by the sample test system 1 in the present embodiment.
  • step S100 of FIG. 5 the control function 341 of the sample test device 10A, which is the master sample test device 10, receives a test order from, for example, a HIS (Hospital Information System) server, and is scheduled to be ordered based on the test order. After displaying the list of inspections, the selection of inspection items is accepted as the detection target. For example, as shown in FIG. 8A, the control function 341 displays a screen for accepting the selection of the inspection item on the display 411, and the control function 341 accepts the selection of the inspection item to be performed via the input device 42.
  • HIS Hospital Information System
  • the control function 341 recognizes the operating status of the sample testing devices 10A, 10B, and 10C, and includes an area 110 for accepting selection of test items and an area 120 for displaying the operating status of the sample testing device 10A.
  • the area 130 for displaying the operating state of the sample testing device 10B and the area 130 for displaying the operating state of the sample testing device 10C are overlapped and displayed on the display 411.
  • the areas 110, 120, 130, and 140 include tabs having different display positions, and the tabs of the areas 110, 120, 130, and 140 are used to identify the areas 110, 120, 130, and 140, respectively. "Item", "1", "2", "3" are written.
  • the control function 341 displays the entire area 110 and only the tabs of the areas 120, 130, and 140 on the display 411.
  • the inspection item columns 111, 112, 113 that accept the selection of the inspection item are displayed in the area 110.
  • the inspection item columns 111, 112, and 113 are displayed for each line, and the inspection item is selected by selecting the displayed line.
  • the test item column 111 the test item "virus A”, the ID “111111” of the patient as a sample, the name “YYYY”, and the usage status "3" are displayed.
  • the usage state "3" in the test item column 111 means that the sample test device 10C is testing the patient with the ID "111111” and the name "YYYY” for "virus A”. means.
  • the sample test device 10C is a sample test device that is performing the test, and the test item column 111 cannot be selected by the user.
  • test item column 112 the test item "virus A”, the patient ID “123456” as a sample, the name “XXXX”, and the usage status "standby” are displayed.
  • the usage state "standby" in the test item column 112 means that the test for "virus A” has not been performed on the patient with the ID "123456” and the name "XXXX”.
  • test item column 113 the test item “virus B”, the ID "123456" of the patient as a sample, the name "XXXX", and the usage state "standby” are displayed.
  • the usage state "standby" in the test item column 113 means that the test for "virus B" has not been performed on the patient with the ID "123456" and the name "XXXX".
  • the sample test devices 10A and 10B are sample test devices that have not been tested, and the test item columns 112 and 113 are in a state that can be selected by the user.
  • the control function 341 accepts the selection of the inspection items "virus A” and "virus B” as detection targets.
  • the control function 341 accepts selection of inspection items "virus A” and "virus B" as detection targets.
  • step S101 of FIG. 5 the control function 341 of the sample testing device 10A assigns a test item to each sample testing device as a selected detection target.
  • control function 341 selects a sample testing device that can be tested from the sample testing devices 10A, 10B, and 10C. For example, the control function 341 selects the sample testing devices 10A and 10B to which the instruction described later for causing the indicator 35 to emit light is not sent. Then, the control function 341 assigns the test items “virus A” and “virus B” selected in step S100 to the sample test devices 10A and 10B, respectively.
  • control function 341 displays a list of testable sample test devices from the sample test devices 10A, 10B, and 10C, and then accepts the selection of the testable sample test device via the input device 42. ..
  • the control function 341 accepts selection of testable sample testing devices 10A and 10B by operating the input device 42. Then, the control function 341 assigns the test items “virus A” and “virus B” selected in step S100 to the sample test devices 10A and 10B, respectively.
  • step S102 of FIG. 5 the test item "virus A” is inspected by the sample inspection device 10A, and the inspection item “virus B” is inspected by the sample inspection device 10B.
  • step S110 of FIG. 6 the control function 341 of the sample test device 10A lights the indicator 35 of the sample test device 10A in green color-coded according to the test item “virus A”.
  • control function 341 of the sample test device 10A controls the indicator 35 of the sample test device 10A so that it lights up in green before the test of the test item "virus A" is performed.
  • the control function 341 of the sample testing device 10A is green and lights the indicator 35 of the sample testing device 10A.
  • control function 341 of the sample test device 10A controls the indicator 35 of the sample test device 10A so as to light up in a color indicating the test item "virus A”, but the present invention is not limited to this.
  • the control function 341 of the sample test device 10A displays the test item "virus A" as a character string, so that the indicator 35 of the sample test device 10A is displayed. May be controlled.
  • step S111 of FIG. 6 the control function 341 of the sample test device 10A displays the guide information for opening the cover 20 on the display 411 as the guide information of the test performed by the sample test device 10A.
  • the tab of the area 120 displayed on the display 411 of the sample testing device 10A is shown in green.
  • the control function 341 causes the display 411 to display the entire area 120 and only the tabs of the areas 110, 130, and 140.
  • columns 121, 122, 123, 124 are displayed in the area 120.
  • the inspection item "virus A” is displayed in column 121.
  • the ID "123456" and the name "XXXX” of the patient as a sample are displayed.
  • the message "Please open the cover of the device in which the lamp is lit" is displayed as guide information for opening the cover 20 of the sample testing device 10A.
  • the guide information of the column 123 is displayed as an illustration.
  • step S112 of FIG. 6 when the detection unit 31 of the sample inspection device 10A detects that the cover 20 has been opened from the main body 30, it outputs information indicating that the cover 20 has been opened.
  • step S113 of FIG. 6 the control function 341 of the sample test device 10A uses the biological reaction device 2 as guide information for the test performed by the sample test device 10A according to the information indicating that the cover 20 has been opened.
  • the guide information for mounting is displayed on the display 411.
  • the column 123 provides guide information for mounting the biological reaction device 2 on the sample test device 10A.
  • the message "Please install the inspection cartridge.” Is displayed.
  • the guide information of the column 123 is displayed as an illustration.
  • step S114 of FIG. 6 the reading device 313 of the sample testing device 10A confirms the type of the biological reaction device 2 mounted on the sample testing device 10A.
  • the reading device 313 is a type of the biological reaction device 2 from the QR code (registered trademark) 2a printed on the back surface of the biological reaction device 2 when the biological reaction device 2 is attached to the sample testing device 10A. Is read, and reading information indicating the type of the biological reaction device 2 is output. At this time, the control function 341 of the sample inspection device 10A acquires the reading information output from the reading device 313.
  • QR code registered trademark
  • step S115 of FIG. 6 the control function 341 of the sample test device 10A collates the test item “virus A” assigned to the sample test device 10A with the type of the biological reaction device 2 represented by the acquired read information, and the living body.
  • the display 411 displays the collation result indicating whether or not the type of the reaction device 2 is the device used for the inspection item “virus A”.
  • the type of the biological reaction device 2 represented by the read information is not the biological reaction device 2 for testing the test item "virus A" assigned to the sample test device 10A. That is, when the biological reaction device 2 for virus A test is not correctly attached to the sample test device 10A (step S115; No in FIG. 6), the control function 341 of the sample test device 10A is attached to the sample test device 10A. The user is notified by, for example, a pop-up screen that the type of the biological reaction device 2 is wrong. After that, the process of step S113 is performed again.
  • the type of the biological reaction device 2 represented by the read information is the biological reaction device 2 for testing the test item "virus A" assigned to the sample test device 10A. That is, when the biological reaction device 2 for virus A test is correctly attached to the sample test device 10A (step S115; Yes in FIG. 6), the process of step S116 is performed.
  • step S116 of FIG. 6 the control function 341 of the sample test device 10A displays the guide information prompting the liquid delivery to the biological reaction device 2 on the display 411 as the guide information of the test performed by the sample test device 10A.
  • the column 123 contains the sample solution and the reagent from the hole 21a of the biological reaction device 2 to the reaction vessel 201.
  • the message "Please send the solution to the inspection cartridge” is displayed.
  • the guide information of the column 123 is displayed as an illustration.
  • step S117 of FIG. 6 the control function 341 of the sample testing device 10A displays the guide information prompting the liquid to be sent to the biological reaction device 2 on the display 411, and when a predetermined time has elapsed, the sample testing device 10A As the guide information for the inspection carried out by the above, the guide information for closing the cover 20 is displayed on the display 411.
  • the column 123 contains, for example, the message “Close the cover” as guide information for closing the cover 20. Please. The inspection will start. ”Is displayed.
  • the guide information of the column 123 is displayed as an illustration.
  • step S118 of FIG. 6 when the detection unit 31 of the sample inspection device 10A detects that the cover 20 is closed in the main body 30, it outputs information indicating that the cover 20 is closed.
  • step S119 of FIG. 6 the measurement function 343 of the sample test device 10A starts the test performed by the sample test device 10A according to the information indicating that the cover 20 is closed.
  • the control function 341 of the sample test device 10A blinks the indicator 35 of the sample test device 10A in green color-coded according to the test item “virus A”.
  • control function 341 of the sample test device 10A controls the indicator 35 of the sample test device 10A so as to blink in green during the test of the test item "virus A". In this way, the control function 341 of the sample test device 10A controls the indicator 35 of the sample test device 10A so as to emit light in different light emission modes before and during the test.
  • step S119 of FIG. 6 the control function 341 of the sample inspection device 10A monitors whether or not the inspection of the measurement function 343 is completed.
  • step S119 If the inspection of the measurement function 343 is not completed (step S119; No in FIG. 6), the process of step S119 is performed again.
  • step S119 when the test of the measurement function 343 is completed (step S119; Yes in FIG. 6), the measurement function 343 of the sample test device 10A stores the test result of the test item “virus A” in the storage circuit 33, and steps S120. Is processed.
  • step S120 of FIG. 6 the control function 341 of the sample test device 10A turns off the indicator 35 of the sample test device 10A.
  • step S121 of FIG. 6 the control function 341 of the sample test device 10A causes the output device 41 to output the test result of the test item “virus A” carried out by the measurement function 343.
  • the control function 341 controls the display 411 and the printer 412 as the output device 41, and presents the inspection result to the user.
  • the control function 341 presents the inspection result to the user by displaying it on the display 411 or printing it with a printer.
  • the control function 341 of the sample test device 10A causes the communication function 342 to transmit control information used for controlling the sample test device 10B, which is a slave sample test device, and receives the control information from the sample test device 10B as follows. Process the detection result.
  • step S130 of FIG. 7 the control function 341 of the sample test device 10A instructs the sample test device 10B to light the indicator 35 in blue color-coded for the test item “virus B”.
  • control function 341 of the sample test device 10A controls the indicator 35 of the sample test device 10B so that it lights up in blue before the test of the test item "virus B" is performed.
  • the control function 341 of the sample test device 10A gives a lighting instruction for lighting the indicator 35 in blue corresponding to the test item "virus B" as a control signal via the communication function 342 of the sample test device 10B.
  • the control signal or the lighting instruction is an example of "control information”.
  • control function 341 of the sample test device 10A controls the indicator 35 of the sample test device 10B so as to light up in a color indicating the test item "virus B", but the present invention is not limited to this.
  • the control function 341 of the sample test device 10A displays the test item "virus B" as a character string, so that the indicator 35 of the sample test device 10B is displayed. May be controlled.
  • step S131 of FIG. 7 the control function 341 of the sample test device 10B sets the indicator 35 of the sample test device 10B in a color representing the test item “virus B” in response to the lighting instruction transmitted from the sample test device 10A. Turn it on.
  • step S132 of FIG. 7 the control function 341 of the sample test device 10A displays the guide information for opening the cover 20 on the display 411 as the guide information of the test performed by the sample test device 10B.
  • the tab of the area 130 displayed on the display 411 of the sample testing device 10A is shown in blue.
  • the control function 341 causes the display 411 to display the entire area 130 and only the tabs of the areas 110, 120, and 140.
  • columns 131, 132, 133, 134 are displayed in the area 130.
  • the inspection item "virus B” is displayed in the column 131.
  • the ID "123456" and the name "XXXX” of the patient as a sample are displayed.
  • the message "Please open the cover of the device in which the lamp is lit” is displayed as guide information for opening the cover 20 of the sample testing device 10B.
  • the guide information of column 133 is displayed as an illustration.
  • step S132 the communication function 342 of the sample test device 10A transmits a notification indicating that the guide information for opening the cover 20 is displayed on the display 411 to the sample test device 10B.
  • step S133 of FIG. 7 when the detection unit 31 of the sample test device 10B detects that the cover 20 has been opened from the main body 30 of the sample test device 10B, the cover 20 of the sample test device 10B is opened.
  • the notification in step S132 is an example of "control information".
  • the communication function 342 of the sample test device 10B transmits information indicating that the cover 20 of the sample test device 10B has been opened to the sample test device 10A as a reply to the notification in step S132.
  • step S134 of FIG. 7 the control function 341 of the sample test device 10A serves as guide information for the test performed by the sample test device 10B according to the information indicating that the cover 20 of the sample test device 10B has been opened.
  • Guide information for mounting the biological reaction device 2 on the sample test device 10B is displayed on the display 411.
  • column 133 contains, for example, the message "test cartridge” as guide information for mounting the biological reaction device 2 on the sample test device 10B. Please install. ”Is displayed.
  • column 134 the guide information of column 133 is displayed as an illustration.
  • step S134 the communication function 342 of the sample test device 10A transmits to the sample test device 10B a notification indicating that the guide information for mounting the biological reaction device 2 on the sample test device 10B is displayed on the display 411. do.
  • step S135 of FIG. 7 the reading device 313 of the sample testing device 10B confirms the type of the biological reaction device 2 mounted on the sample testing device 10B.
  • the reading device 313 of the sample testing device 10B is a living body from the QR code (registered trademark) 2a printed on the back surface of the biological reaction device 2 when the biological reaction device 2 is attached to the sample testing device 10B.
  • the type of the reaction device 2 is read, and the reading information indicating the type of the biological reaction device 2 is output.
  • the notification in step S134 is an example of "control information".
  • the communication function 342 of the sample testing device 10B transmits the reading information output from the reading device 313 of the sample testing device 10B to the sample testing device 10A as a reply to the notification in step S134.
  • the control function 341 of the sample testing device 10A acquires the reading information output from the sample testing device 10B.
  • step S136 of FIG. 7 the control function 341 of the sample test device 10A collates the test item “virus B” assigned to the sample test device 10B with the type of the biological reaction device 2 represented by the acquired read information, and the living body.
  • the display 411 displays a collation result indicating whether or not the type of the reaction device 2 is the device used for the inspection item “virus B”.
  • the type of the biological reaction device 2 represented by the read information is not the biological reaction device 2 for testing the test item "virus B" assigned to the sample test device 10B. That is, when the biological reaction device 2 for virus B test is not correctly attached to the sample test device 10B (step S136; No in FIG. 7), the control function 341 of the sample test device 10A is the main body of the sample test device 10B. The user is notified by, for example, a pop-up screen that the type of the biological reaction device 2 attached to the 30 is wrong. After that, the process of step S134 is performed again.
  • the type of the biological reaction device 2 represented by the read information is the biological reaction device 2 for testing the test item "virus B" assigned to the sample testing device 10B. That is, when the biological reaction device 2 for virus B test is correctly attached to the sample test device 10B (step S136; Yes in FIG. 7), the process of step S137 is performed.
  • step S137 of FIG. 7 the control function 341 of the sample test device 10A guides the liquid to be sent to the biological reaction device 2 mounted on the sample test device 10B as guide information for the test performed by the sample test device 10B.
  • the information is displayed on the display 411.
  • the mixed solution 202 of the sample solution and the reagent is injected into the reaction vessel 201 through the hole 21a of the biological reaction device 2 in the column 133.
  • the message "Please send the liquid to the inspection cartridge” is displayed as the guide information prompting the user.
  • the guide information of column 133 is displayed as an illustration.
  • step S137 the communication function 342 of the sample test device 10A sends a notification indicating that the guide information prompting the liquid to be sent to the biological reaction device 2 mounted on the sample test device 10B is displayed on the display 411 for the sample test. It is transmitted to the device 10B.
  • step S138 of FIG. 7 a predetermined time has elapsed since the control function 341 of the sample test device 10A displays the guide information prompting the liquid delivery to the biological reaction device 2 mounted on the sample test device 10B on the display 411. At that time, as the guide information for the test performed by the sample test device 10B, the guide information for closing the cover 20 of the sample test device 10B is displayed on the display 411.
  • column 133 contains, for example, the message "Please close the cover” as guide information for closing the cover 20 of the sample testing device 10B. The inspection will start. ”Is displayed.
  • the guide information of column 133 is displayed as an illustration.
  • step S138 the communication function 342 of the sample test device 10A transmits a notification indicating that the guide information for closing the cover 20 of the sample test device 10B is displayed on the display 411 to the sample test device 10B.
  • step S139 of FIG. 7 when the detection unit 31 of the sample test device 10B detects that the cover 20 is closed in the main body 30 of the sample test device 10B, the cover 20 of the sample test device 10B is closed.
  • the notifications in steps S137 and S138 are examples of "control information".
  • the communication function 342 of the sample test device 10B transmits information indicating that the cover 20 of the sample test device 10B has been opened to the sample test device 10A as a reply to the notifications in steps S137 and S138.
  • step S140 of FIG. 7 the control function 341 of the sample test device 10A blinks the indicator 35 of the sample test device 10B in blue color-coded according to the test item “virus B”.
  • control function 341 of the sample test device 10A controls the indicator 35 of the sample test device 10B so as to blink in blue during the test of the test item "virus B".
  • the control function 341 of the sample test device 10A controls the indicator 35 of the sample test device 10B so as to emit light in different light emission modes before and during the test.
  • the control function 341 of the sample test device 10A gives a blinking instruction for blinking the indicator 35 in blue corresponding to the test item "virus B" as a control signal via the communication function 342 of the sample test device 10B.
  • the control signal or the blinking instruction is an example of "control information”.
  • step S141 of FIG. 7 the control function 341 of the sample test device 10B sets the indicator 35 of the sample test device 10B in a color representing the test item “virus B” in response to the blinking instruction transmitted from the sample test device 10A. Make it blink.
  • the measurement function 343 of the sample test device 10B starts the test performed by the sample test device 10B in response to the blinking instruction.
  • step S142 of FIG. 7 the control function 341 of the sample inspection device 10B monitors whether or not the inspection of the measurement function 343 is completed.
  • step S142 If the inspection of the measurement function 343 is not completed (step S142; No in FIG. 7), the process of step S119 is performed again.
  • step S142 when the inspection of the measurement function 343 is completed (step S142; Yes in FIG. 7), the process of step S143 is performed.
  • step S143 of FIG. 7 the communication function 342 of the sample test device 10B transmits information for reporting that the test performed by the sample test device 10B has been completed to the sample test device 10A.
  • step S144 of FIG. 7 the control function 341 of the sample test device 10A turns off the indicator 35 of the sample test device 10B in response to the information for reporting that the test performed by the sample test device 10B has been completed. ..
  • control function 341 of the sample test device 10A transmits, as a control signal, a turn-off instruction for turning off the indicator 35 to the sample test device 10B via the communication function 342.
  • control signal or the extinguishing instruction is an example of "control information”.
  • step S145 of FIG. 7 the control function 341 of the sample test device 10B turns off the indicator 35 of the sample test device 10B in response to the turn-off instruction transmitted from the sample test device 10A.
  • step S146 of FIG. 7 the communication function 342 of the sample test device 10B transmits the test result of the test item “virus B” carried out by the sample test device 10B to the sample test device 10A in response to the turn-off instruction.
  • the measurement function 343 of the sample test device 10A stores the test result of the test item “virus B” in the storage circuit 33.
  • step S147 of FIG. 7 the control function 341 of the sample test device 10A causes the output device 41 to output the test result of the test item “virus B” carried out by the sample test device 10B.
  • the control function 341 controls the display 411 and the printer 412 as the output device 41, and presents the inspection result to the user.
  • the control function 341 presents the inspection result to the user by displaying it on the display 411 or printing it with a printer.
  • the measurement function 343 detects the detection target included in the sample.
  • the input / output device 40 includes a display 411 that displays information related to inspection, a printer 412 that prints inspection results of inspection, and an input device 42 that receives input of information related to inspection.
  • the communication function 342 communicates with the slave sample inspection device 10.
  • the slave sample test device 10 has the measurement function 343, but the slave sample test device 10 is not provided with the input / output device 40.
  • the control function 341 causes the communication function 342 to transmit control information used for controlling the slave sample inspection device 10.
  • the master sample test device 10 and the slave sample test device 10 further include an indicator 35, and the control function 341 of the master sample test device 10 carries out the test by transmitting control information from the communication function 342.
  • the indicator 35 of the sample test device 10 selected as the device to perform the test is controlled so as to emit light in a color corresponding to the type of the detection target of the test.
  • the control function 341 processes the detection result received from the slave sample inspection device 10.
  • the slave sample inspection device 10 is not provided with the input / output device 40 has been described, but the slave sample inspection device 10 may be provided with the input / output device 40, or , An input / output device different from the input / output device 40 of the master sample test device 10 may be provided.
  • the slave sample test device 10 may be provided with a printer 412 for printing the test results of the test.
  • the test efficiency can be improved by controlling the slave sample test device 10 by the master sample test device 10.
  • the user can grasp what test is planned. Specifically, when the virus B is tested by the sample test device 10B, which is the slave sample test device 10, the sample test device 10B causes the indicator 35 to emit light in blue corresponding to the test item "virus B". ing. Therefore, the user can attach the biological reaction device 2 for virus B testing to the sample testing device 10B by visually recognizing the blue light emitted from the indicator 35 of the sample testing device 10B. As a result, in the present embodiment, the risk of the user using a sample testing device different from the sample testing device 10B due to a mistake or the like is reduced. As described above, in the sample test system of the present embodiment, the user can correctly attach the biological reaction device 2 to the sample test device 10, so that the test efficiency is improved.
  • the user can grasp what is being inspected. Specifically, when the virus B is tested by the sample test device 10B, which is the slave sample test device 10, the cover 20 of the sample test device 10B is closed at the time of the test, but the sample test device 10B Is blue according to the inspection item "virus B" and causes the indicator 35 to emit light. Therefore, when the user is performing another work, even if he / she does not approach the sample test device 10A displayed on the screen, the sample test device can determine what test item is currently being tested. It can be confirmed at a glance by the light emission of the indicator 35 of 10B. As described above, in the sample test system of the present embodiment, it is possible to confirm what test item is currently being tested without interrupting the work performed by the user, so that the test efficiency is improved. improves.
  • test efficiency can be improved even with the sample test device 10 alone.
  • the master sample test device 10 uses the biological reaction device 2 to perform a test for detecting a detection target contained in the sample, a measurement function 343, an indicator 35 capable of emitting different colors, and a control function 341.
  • the control function 341 is a color according to the type of the detection target, and is a color-coded color for the biological reaction device 2 and a color-coded color for the reagent package to react with the biological reaction device 2.
  • the indicator 35 is controlled so as to emit light in the same color. For example, when the virus A is inspected by the sample inspection apparatus 10, the control function 341 is green according to the inspection item "virus A" and is color-coded into the biological reaction device 2 for the virus A inspection.
  • the indicator 35 is made to emit light in the same green color as the color and the color-coded color in the package of the reagent to react with the biological reaction device 2 for virus A test. Therefore, the user can attach the biological reaction device 2 for virus A test to the sample test device 10 by visually recognizing the green light emitted from the indicator 35 of the sample test device 10. As described above, in the sample test system of the present embodiment, the user can correctly attach the biological reaction device 2 to the sample test device 10, so that the test efficiency is improved.
  • the sample testing device 10A which is the master sample testing device 10
  • the processing when a test order is received from the HIS server but the embodiment is not limited to this.
  • the processing performed without receiving the inspection order will be described.
  • the biological reaction device 2 is attached to the sample test device 10 that can be tested among the plurality of sample test devices 10 and is selected by the user. ..
  • the sample test device 10A which is the master sample test device 10, accepts the test by the selected sample test device 10.
  • 9 and 10 are flowcharts showing the procedure of processing by the sample test system 1 in the modified example of this embodiment.
  • step S200 is executed instead of step S115 of FIG.
  • steps S111, S112, and S114 are executed.
  • step S114 when the biological reaction device 2 is attached to the sample test device 10A, the reading device 313 transfers the biological reaction device 2 from the QR code (registered trademark) 2a printed on the back surface of the biological reaction device 2. The type is read, and the reading information indicating the type of the biological reaction device 2 is output.
  • the control function 341 of the sample inspection device 10A acquires the reading information output from the reading device 313. After that, the process of step S200 is performed.
  • step S200 of FIG. 9 the control function 341 accepts the inspection of the detection target from the type of the biological reaction device 2 represented by the acquired read information.
  • the type of biological reaction device 2 represented by the read information is a biological reaction device 2 for testing virus A.
  • the control function 341 accepts the inspection of the inspection item "virus A" as the detection target based on the type of the biological reaction device 2 represented by the read information. After that, the process of step S110 is performed.
  • step S110 the control function 341 controls the indicator 35 of the sample inspection device 10A so that it lights up in green before the inspection of the inspection item “virus A” is performed. After that, steps S116 to S122 are executed.
  • step S210 is executed instead of step S136 in FIG. 7.
  • steps S132 to S135 are executed.
  • the reading device 313 of the sample testing device 10B starts with the QR code (registered trademark) 2a printed on the back surface of the biological reaction device 2 when the biological reaction device 2 is attached to the sample testing device 10B.
  • the type of the biological reaction device 2 is read, and the reading information indicating the type of the biological reaction device 2 is output.
  • the communication function 342 of the sample testing device 10B transmits the reading information output from the reading device 313 of the sample testing device 10B to the sample testing device 10A as a reply to the notification in step S134.
  • the control function 341 of the sample testing device 10A acquires the reading information output from the sample testing device 10B. After that, the process of step S210 is performed.
  • step S210 of FIG. 10 the control function 341 accepts the inspection of the detection target from the type of the biological reaction device 2 represented by the acquired read information.
  • the type of biological reaction device 2 represented by the read information is the biological reaction device 2 for virus B inspection.
  • the control function 341 accepts the inspection of the inspection item "virus B" as the detection target based on the type of the biological reaction device 2 represented by the read information.
  • step S130 the control function 341 of the sample test device 10A controls the indicator 35 of the sample test device 10B so that it lights up in blue before the test of the test item “virus B” is performed.
  • the control function 341 of the sample test device 10A gives a lighting instruction for lighting the indicator 35 in blue corresponding to the test item "virus B" as a control signal via the communication function 342 of the sample test device 10B. Send to.
  • step S131 the control function 341 of the sample test device 10B sets the indicator 35 of the sample test device 10B in a color representing the test item “virus B” in response to the lighting instruction transmitted from the sample test device 10A. Turn it on. After that, steps S137 to S147 are executed.
  • the sample testing device 10 in addition to the above-mentioned effects, the case where the biological reaction device 2 is attached to the sample testing device 10 selected by the user is used as a trigger. It is possible to accept the inspection by the selected sample inspection apparatus 10.
  • FIG. 11 is a side sectional view showing a first structure which is an example of the structure of the indicator 35 in the sample inspection device 10 according to the present embodiment.
  • the indicator 35 includes a substrate 351 and a multi-color LED (Light Emitting Diode) 352 provided on the substrate 351 and a case 353 that covers the multi-color LED 352.
  • a multi-color LED Light Emitting Diode
  • the substrate 351 is provided on the front surface of the main body 30 of the sample inspection device 10.
  • the multicolor LED 352 is a light emitting unit provided on the substrate 351 and capable of emitting a plurality of colors.
  • the multicolor LED 352 emits an arbitrary color by mixing red (R), green (G), and blue (B), which are the three primary colors of light.
  • three color LEDs of red (R), green (G), and blue (B) are arranged in close proximity in order to emit an arbitrary color.
  • the following cases can be considered when emitting a low-brightness color such as brown or gray.
  • a low-brightness color such as brown or gray.
  • the multi-color LED 352 has a structure in which LEDs of three colors are arranged close to each other, the light may not be uniformly mixed.
  • the case 353 has a light mixing member 353a and a light shielding member 353b.
  • the light mixing member 353a has a dome shape and mixes a plurality of colors emitted by the multicolor LED 352.
  • a white translucent resin is used as the light mixing member 353a.
  • the light-shielding member 353b is provided on the light mixing member 353a and blocks light from the outside.
  • a black light-shielding paint is used as the light-shielding member 353b.
  • an opening 353c is formed which penetrates the light-shielding member 353b and exposes the light mixing member 353a.
  • a plurality of colors emitted by the multicolor LED 352 are mixed by the light mixing member 353a while being reflected by the dome-shaped inner wall of the light mixing member 353a.
  • the portion (exposed portion) where the opening 353c is formed is thin, so that the light in which the colors are uniformly mixed by the light mixing member 353a is emitted from the opening 353c.
  • the light in which the colors are uniformly mixed by the light mixing member 353a is emitted from the opening 353c.
  • the light shielding member 353b blocks the light incident on the multi-color LED 352 from the outside, the user can distinguish whether or not the LED is emitting light. That is, when the LED does not emit light, it looks dark to the user.
  • the light in which the colors are uniformly mixed by the light mixing member 353a is emitted from the opening 353c formed at the top of the dome-shaped case 353, so that the emitted light is emitted.
  • the range of is small. Therefore, in order to improve the visibility, it is necessary to enlarge the exit port for emitting the light in which the colors are uniformly mixed by the light mixing member 353a. Therefore, in the example shown in FIG. 12, the exit port is enlarged to improve visibility.
  • FIG. 12 is a side sectional view showing a second structure which is an example of the structure of the indicator 35 in the sample inspection device 10 according to the present embodiment.
  • the indicator 35 includes a substrate 351 and a multi-color LED 352 provided on the substrate 351 and a case 354 that covers the multi-color LED 352. That is, in the example shown in FIG. 12, the indicator 35 includes a case 354 instead of the case 353 in the example shown in FIG.
  • the case 354 has a light mixing member 354a, a light shielding member 354b, and a dimming member 354c.
  • the light-shielding member 354b is provided on the side surface of the case 354 to block light from the outside.
  • the light-shielding member 354b is, for example, a case in which a black light-shielding paint is used.
  • the light mixing member 354a is provided at a position facing the multicolor LED 352 of the light shielding member 354b, and mixes a plurality of colors emitted by the multicolor LED 352.
  • a white translucent film is used as the light mixing member 354a.
  • the dimming member 354c is a member that covers the light-shielding member 354b and the light mixing member 354a, and the light in which the colors are uniformly mixed by the light mixing member 354a is emitted from the dimming member 354c.
  • a dimming film such as an ND (Neutral Density) filter is used.
  • the light-shielding member 354b and the dimming member 354c are provided to improve the visibility of low-brightness colors.
  • a plurality of colors emitted by the multicolor LED 352 are mixed by being reflected between the light mixing member 354a and the substrate 351.
  • a plurality of colors emitted by the multicolor LED 352 are mixed by being reflected inside the light mixing member 354a.
  • the light mixing member 354a is not shielded from light and the dimming member 354c is provided on the light mixing member 354a, the light in which the colors are uniformly mixed by the light mixing member 354a is reduced. It is emitted from the optical member 354c.
  • the light in which the colors are uniformly mixed by the light mixing member 354a is emitted from the dimming member 354c.
  • the light shielding member 354b blocks the light incident on the multi-color LED 352 from the outside, the user can distinguish whether or not the LED is emitting light. That is, when the LED does not emit light, it looks dark to the user.
  • the exit port for emitting the light in which the colors are uniformly mixed by the light mixing member 354a can be made larger than that in the example shown in FIG. 11, so that the visibility is improved.
  • the dimming member 354c on the light mixing member 354a, the visibility of low-brightness colors can be improved.
  • FIG. 13 is a diagram for explaining an example of dimming of the indicator 35 in the sample inspection device 10 according to the present embodiment.
  • the control function 341 of the sample test device 10A accepts the request and receives the request.
  • the screen 360 as shown in FIG. 13 is displayed on the display 411.
  • "LED1", “LED2", and “LED3" on the screen 360 are set by the user as colors for lighting the indicator 35.
  • "LED1" and “LED2" are set by the user as color-coded colors for the inspection items "virus A” and "virus B", respectively.
  • the brightness of the red (R), green (G), and blue (B) LEDs (light sources), which are the three primary colors of light, is displayed in the multicolor LEDs 352 of the sample inspection devices 10A, 10B, and 10C.
  • Each has an adjusting unit 361 to 363 for adjusting and a setting button 364.
  • Each of the adjusting units 361 to 363 includes a button for the user to adjust the color value using the input device 42, and the larger the set color value, the brighter the light source of the color.
  • “0” is displayed as the initial value of the color value.
  • the setting button 364 by setting the red (R), green (G), and blue (B) values to the maximum values by operating the adjustment units 361 to 363, the indicator 35 The light emitted from is white.
  • the user sets the value of red (R) to the maximum value, sets the values of green (G) and blue (B) to the minimum value by operating the adjustment units 361 to 363, and presses the setting button 364.
  • the light emitted from the indicator 35 turns red.
  • the user sets the green (G) value to the maximum value and the red (R) and blue (B) values to the minimum value by operating the adjustment units 361 to 363, and sets the setting button 364.
  • the light emitted from the indicator 35 turns green.
  • the user sets the blue (B) value to the maximum value and the red (R) and green (G) values to the minimum value by operating the adjustment units 361 to 363, and sets the setting button 364.
  • the light emitted from the indicator 35 becomes blue.
  • the user sets the values of red (R), green (G), and blue (B) to arbitrary values by operating the adjustment units 361 to 363, and operates the setting button 364.
  • the control function 341 of the sample test device 10A can emit a low-brightness color such as brown or gray as the light emitted from the indicator 35.
  • the dimming of the indicator 35 is performed, for example, at the time of shipment immediately before the sample test device 10 is shipped, or at the time of installation when the sample test device 10 is installed in a hospital or the like.
  • the user sets blue as the color-coded color for the inspection item "virus B”
  • the user sets the value of blue (B) to the maximum value by operating the adjustment units 361 to 363, and red (R), Set the green (G) value to the minimum value and operate the setting button 364.
  • the control function 341 of the sample inspection device 10A identifies the information representing the color set on the screen 360 by the user, the information representing the inspection item, and the type of the biological reaction device 2 used for the inspection of the inspection item.
  • the information representing the QR code (registered trademark) 2a to be used is associated with the information and stored in the storage circuit 33 of the sample testing device 10A.
  • the control function 341 of the sample inspection device 10A receives the inspection item "virus A” or “virus B” when the inspection item "virus A” or “virus B” is selected by the user when the inspection order is received from the HIS server.
  • the indicators 35 of the sample testing devices 10A and 10B which are testable sample testing devices, are lit in green and blue, respectively, as the colors coded into "virus A” and "virus B” on the screen 360. ..
  • the control function 341 of the sample test device 10A obtains the type of the bioreaction device 2 from the QR code (registered trademark) 2a of the bioreaction device 2 attached to the sample test device 10A.
  • the reading device 313 receives the inspection of the inspection item "virus A” from the type of the read biological reaction device 2, the user displays the inspection item "virus A” on the screen 360 as a color-coded color.
  • the indicator 35 of the sample testing device 10A which is a testable sample testing device, is turned on in the set green color.
  • the control function 341 of the sample test device 10A is set by the user on the screen 360 as a color-coded color for the received test item.
  • the indicator 35 can be turned on with the specified color.
  • the inspection efficiency can be improved.

Abstract

A sample inspection device (10A) according to an embodiment includes an inspection unit (343), an input/output unit (40), a communication unit (342), and a control unit (341). The inspection unit detects a detection target included in a sample. The input/output unit includes a display unit (411) that displays information related to the inspection, and an input unit (42) that receives an input of the information related to the inspection. The communication unit carries out communication with slave sample inspection devices (10B, 10C) that include the inspection unit. The control unit causes control information used in control of the slave sample inspection devices to be sent from the communication unit and also processes detection results received from the slave sample inspection devices.

Description

検体検査装置、及び、検体検査システムSpecimen testing device and sample testing system
 本明細書及び図面に開示の実施形態は、検体検査装置、及び、検体検査システムに関する。 The embodiments disclosed in this specification and drawings relate to a sample testing device and a sample testing system.
 検体に含まれる検出対象を検出する検査を行う検体検査装置が知られている。検出対象は、例えば、鼻水などの体液成分等から採取される。検出対象としては、アデノウイルスやインフルエンザウイルスなどの被検物質が挙げられる。例えば、複数の検体検査装置を用いることにより、様々な検査を行うことができる。検体検査装置には入出力装置が設けられ、例えば、入出力装置により、各種入力が行われたり、検査結果の表示及び印刷が行われたりする。例えば、複数の検査を複数の装置で分けて行う場合、装置毎に入力や印刷などが行われるため、効率が悪い。そこで、検体検査装置をマスターとスレーブとで集中管理するようにした場合、検査効率のアップが期待される。 A sample testing device that performs a test to detect the detection target contained in the sample is known. The detection target is collected from, for example, a body fluid component such as a runny nose. Detection targets include test substances such as adenovirus and influenza virus. For example, various tests can be performed by using a plurality of sample testing devices. The sample test device is provided with an input / output device. For example, the input / output device performs various inputs, displays and prints test results. For example, when a plurality of inspections are performed separately by a plurality of devices, input and printing are performed for each device, which is inefficient. Therefore, if the sample testing device is centrally managed by the master and the slave, it is expected that the testing efficiency will be improved.
特表2014-532871号公報Special Table 2014-532871 特表2011-503617号公報Japanese Patent Publication No. 2011-503617 特表2015-519544号公報Japanese Patent Application Laid-Open No. 2015-591544
 本明細書及び図面に開示の実施形態が解決しようとする課題の一つは、検査効率の向上を図ることである。ただし、本明細書及び図面に開示の実施形態により解決される課題は上記課題に限られない。後述する実施形態に示す各構成による各効果に対応する課題を他の課題として位置づけることもできる。 One of the problems to be solved by the embodiment disclosed in the present specification and drawings is to improve the inspection efficiency. However, the problems solved by the embodiments disclosed in the present specification and the drawings are not limited to the above problems. It is also possible to position the problem corresponding to each effect of each configuration shown in the embodiment described later as another problem.
 実施形態に係る検体検査装置は、検査部と、入出力部と、通信部と、制御部とを備える。前記検査部は、検体に含まれる検出対象を検出する。前記入出力部は、検査に関する情報を表示する表示部、及び、前記検査に関する情報の入力を受け付ける入力部を有する。前記通信部は、前記検査部を有するスレーブの検体検査装置と通信を行う。前記制御部は、前記スレーブの検体検査装置の制御に用いられる制御情報を前記通信部から送信させ、かつ、前記スレーブの検体検査装置から受信した検出結果を処理する。 The sample inspection device according to the embodiment includes an inspection unit, an input / output unit, a communication unit, and a control unit. The inspection unit detects a detection target contained in the sample. The input / output unit includes a display unit that displays information related to the inspection and an input unit that receives input of information related to the inspection. The communication unit communicates with a sample inspection device of a slave having the inspection unit. The control unit transmits control information used for controlling the sample testing device of the slave from the communication unit, and processes the detection result received from the sample testing device of the slave.
図1は、本実施形態に係る検体検査装置が適用される検体検査システムの一例を示す図である。FIG. 1 is a diagram showing an example of a sample testing system to which the sample testing device according to the present embodiment is applied. 図2は、図1に示す生体反応デバイスの構成の一例を示す図である。FIG. 2 is a diagram showing an example of the configuration of the biological reaction device shown in FIG. 図3は、本実施形態に係る検体検査装置(マスターの検体検査装置)の構成の一例を示すブロック図である。FIG. 3 is a block diagram showing an example of the configuration of the sample testing device (master sample testing device) according to the present embodiment. 図4は、本実施形態に係る検体検査装置(スレーブの検体検査装置)の構成の一例を示すブロック図である。FIG. 4 is a block diagram showing an example of the configuration of the sample testing device (slave sample testing device) according to the present embodiment. 図5は、本実施形態における検体検査システムによる処理の手順を示すフローチャートである。FIG. 5 is a flowchart showing a processing procedure by the sample test system in the present embodiment. 図6は、本実施形態における検体検査システムによる処理の手順を示すフローチャートである。FIG. 6 is a flowchart showing a processing procedure by the sample test system in the present embodiment. 図7は、本実施形態における検体検査システムによる処理の手順を示すフローチャートである。FIG. 7 is a flowchart showing a processing procedure by the sample test system in the present embodiment. 図8Aは、本実施形態における検体検査システムによる処理を説明するための図である。FIG. 8A is a diagram for explaining the processing by the sample test system in the present embodiment. 図8Bは、本実施形態における検体検査システムによる処理を説明するための図である。FIG. 8B is a diagram for explaining the processing by the sample test system in the present embodiment. 図8Cは、本実施形態における検体検査システムによる処理を説明するための図である。FIG. 8C is a diagram for explaining the processing by the sample test system in the present embodiment. 図8Dは、本実施形態における検体検査システムによる処理を説明するための図である。FIG. 8D is a diagram for explaining the processing by the sample test system in the present embodiment. 図8Eは、本実施形態における検体検査システムによる処理を説明するための図である。FIG. 8E is a diagram for explaining the processing by the sample test system in the present embodiment. 図8Fは、本実施形態における検体検査システムによる処理を説明するための図である。FIG. 8F is a diagram for explaining the processing by the sample test system in the present embodiment. 図8Gは、本実施形態における検体検査システムによる処理を説明するための図である。FIG. 8G is a diagram for explaining the processing by the sample test system in the present embodiment. 図9は、本実施形態の変形例における検体検査システムによる処理の手順を示すフローチャートである。FIG. 9 is a flowchart showing a processing procedure by the sample test system in the modified example of the present embodiment. 図10は、本実施形態の変形例における検体検査システムによる処理の手順を示すフローチャートである。FIG. 10 is a flowchart showing a processing procedure by the sample test system in the modified example of the present embodiment. 図11は、本実施形態に係る検体検査装置におけるインジケータの構造の一例である第1の構造を示す側断面図である。FIG. 11 is a side sectional view showing a first structure which is an example of the structure of the indicator in the sample inspection device according to the present embodiment. 図12は、本実施形態に係る検体検査装置におけるインジケータの構造の一例である第2の構造を示す側断面図である。FIG. 12 is a side sectional view showing a second structure which is an example of the structure of the indicator in the sample inspection device according to the present embodiment. 図13は、本実施形態に係る検体検査装置におけるインジケータの調光の一例を説明するための図である。FIG. 13 is a diagram for explaining an example of dimming of the indicator in the sample inspection device according to the present embodiment.
 以下、添付図面を参照して、検体検査装置、及び、検体検査システムの実施形態を詳細に説明する。なお、実施形態は、以下の実施形態に限られるものではない。また、一つの実施形態に記載した内容は、原則として他の実施形態にも同様に適用される。 Hereinafter, embodiments of the sample testing device and the sample testing system will be described in detail with reference to the attached drawings. The embodiment is not limited to the following embodiments. In principle, the contents described in one embodiment are similarly applied to other embodiments.
 図1は、本実施形態に係る検体検査装置10が適用される検体検査システム1の一例を示す図である。図1に示すように、検体検査システム1は、複数の検体検査装置10、及び、生体反応デバイス2を備える。 FIG. 1 is a diagram showing an example of a sample testing system 1 to which the sample testing device 10 according to the present embodiment is applied. As shown in FIG. 1, the sample testing system 1 includes a plurality of sample testing devices 10 and a biological reaction device 2.
 生体反応デバイス2は、検体(例えば、鼻水などの体液成分等)に含まれる検出対象を検出する検査を行うために用いられる。生体反応デバイス2の詳細については後述する。生体反応デバイス2は、「デバイス」の一例である。 The biological reaction device 2 is used to perform a test for detecting a detection target contained in a sample (for example, a body fluid component such as a runny nose). Details of the biological reaction device 2 will be described later. The biological reaction device 2 is an example of a “device”.
 図1に示すように、検体検査装置10は、カバー20、本体部30、及び、インジケータ35を備える。 As shown in FIG. 1, the sample testing device 10 includes a cover 20, a main body 30, and an indicator 35.
 カバー20は、検体検査装置10に対して開閉可能に設けられる。具体的には、本体部30には、生体反応デバイス2を装着するための台が設けられ、カバー20は、当該台を覆うために設けられる。例えば、検出対象を検出する検査を行うときに、本体部30の台に生体反応デバイス2が装着され、台は、カバー20により覆われる。ここで、カバー20は、検体検査装置10に対して開閉可能に設けられる場合を例にしているが、検体検査装置10に対して着脱可能に設けられてもよい。 The cover 20 is provided so as to be openable and closable with respect to the sample testing device 10. Specifically, the main body 30 is provided with a table for mounting the biological reaction device 2, and the cover 20 is provided to cover the table. For example, when performing an inspection to detect a detection target, the biological reaction device 2 is attached to the base of the main body 30, and the base is covered with the cover 20. Here, the case where the cover 20 is provided to be openable and closable with respect to the sample test device 10 is taken as an example, but the cover 20 may be provided to be detachably provided with respect to the sample test device 10.
 インジケータ35は、本体部30の前面に設けられている。インジケータ35については後述する。 The indicator 35 is provided on the front surface of the main body 30. The indicator 35 will be described later.
 図1において、複数の検体検査装置10は、例えば、検体検査装置10A、10B、10Cにより構成される。検体検査装置10A、10B、10Cのうち、検体検査装置10Aは、マスターの検体検査装置10であり、検体検査装置10B、10Cは、スレーブの検体検査装置10である。検体検査装置10Aは、ネットワークを介して、検体検査装置10B、10Cと通信可能に接続される。検体検査装置10A、10B、10Cは、例えば、病院等に設置された院内LAN(Local Area Network)に接続され、情報を送受信する。例えば、検体検査装置10B、10Cは、追加購入により、検体検査装置10Aが設置された検査室に設置されたものとする。 In FIG. 1, the plurality of sample testing devices 10 are composed of, for example, sample testing devices 10A, 10B, and 10C. Of the sample test devices 10A, 10B, and 10C, the sample test device 10A is the master sample test device 10, and the sample test devices 10B and 10C are slave sample test devices 10. The sample test device 10A is communicably connected to the sample test devices 10B and 10C via a network. The sample testing devices 10A, 10B, and 10C are connected to, for example, an in-hospital LAN (Local Area Network) installed in a hospital or the like to transmit and receive information. For example, it is assumed that the sample testing devices 10B and 10C are installed in the laboratory in which the sample testing device 10A is installed by additional purchase.
 ここで、図1に示すように、マスターの検体検査装置10である検体検査装置10Aには、入出力装置40が設けられている。入出力装置40は、後述のディスプレイやプリンタなどを有するため、コストとしては高価なものである。このため、スレーブの検体検査装置10である検体検査装置10B、10Cには、コスト面から入出力装置40を設けない方が好適である。入出力装置40は、「入出力部」の一例である。 Here, as shown in FIG. 1, the sample test device 10A, which is the master sample test device 10, is provided with the input / output device 40. Since the input / output device 40 has a display, a printer, and the like described later, the cost is high. Therefore, it is preferable that the sample test devices 10B and 10C, which are the slave sample test devices 10, are not provided with the input / output device 40 from the viewpoint of cost. The input / output device 40 is an example of an “input / output unit”.
 次に、検体検査装置10の本体部30の台に装着される生体反応デバイス2について説明する。図2は、図1に示す生体反応デバイス2の構成の一例を示す図である。 Next, the biological reaction device 2 mounted on the base of the main body 30 of the sample testing device 10 will be described. FIG. 2 is a diagram showing an example of the configuration of the biological reaction device 2 shown in FIG.
 生体反応デバイス2は、図2に示すように、本体部30の台である載置台4に載置され、筐体21、透明基板22、光導波路23及び保護部材24を有する。筐体21の下面の一部は開口しており、その開口部内には、透明基板22上に、光導波路23及び保護部材24を薄膜技術で形成したチップが嵌め込まれる。保護部材24の一部は開口されている(開口端24a)。また、筐体21、光導波路23及び保護部材24等によって反応容器201が形成される。なお、生体反応デバイス2は、その内部、すなわち反応容器201に、被検対象(被検物質)を含む試料溶液を収容可能に構成される。 As shown in FIG. 2, the biological reaction device 2 is mounted on a mounting table 4 which is a table of the main body 30, and has a housing 21, a transparent substrate 22, an optical waveguide 23, and a protective member 24. A part of the lower surface of the housing 21 is open, and a chip in which the optical waveguide 23 and the protective member 24 are formed by thin film technology is fitted on the transparent substrate 22 in the opening. A part of the protective member 24 is open (open end 24a). Further, the reaction vessel 201 is formed by the housing 21, the optical waveguide 23, the protective member 24, and the like. The biological reaction device 2 is configured to be capable of accommodating a sample solution containing a test object (test substance) inside the reaction container 201.
 筐体21は、例えば樹脂等で形成される。筐体21の下面には第1の凹部が形成されている。第1の凹部の上面の一部には反応容器201の上面及び側面を構成する第2の凹部が形成されている。そして、第1の凹部には上から順に保護部材24、光導波路23及び透明基板22が配置されている。また、第2の凹部の上面の一端部近傍に筐体21を上方に貫通してその内部の反応容器201に試料溶液及び試薬等を導入するための孔21aが形成され、他端部近傍に筐体21を上方に貫通して反応容器201から空気を逃がすための孔21bが形成されている。なお、孔21a及び孔21bは、それぞれ複数形成されてもよい。 The housing 21 is made of, for example, resin or the like. A first recess is formed on the lower surface of the housing 21. A second recess forming the upper surface and the side surface of the reaction vessel 201 is formed on a part of the upper surface of the first recess. A protective member 24, an optical waveguide 23, and a transparent substrate 22 are arranged in the first recess in this order from the top. Further, a hole 21a for introducing a sample solution, a reagent, or the like is formed in the reaction vessel 201 inside the housing 21 so as to penetrate upward near one end of the upper surface of the second recess, and near the other end. A hole 21b is formed so as to penetrate the housing 21 upward and allow air to escape from the reaction vessel 201. A plurality of holes 21a and 21b may be formed.
 透明基板22は、例えば樹脂又は光学ガラス等で形成される。透明基板22は、本体部30に設けられる光源311から入射された光を光導波路23へ通過させる。また、透明基板22は、光導波路23から入射された光を本体部30に設けられる光検出器312へ通過させる。 The transparent substrate 22 is formed of, for example, resin or optical glass. The transparent substrate 22 allows light incident from the light source 311 provided in the main body 30 to pass through the optical waveguide 23. Further, the transparent substrate 22 allows the light incident from the optical waveguide 23 to pass through the photodetector 312 provided in the main body 30.
 光導波路23は、光が透過する材料、例えば樹脂又は光学ガラス等により形成される。樹脂としては、例えば、フェノール樹脂、エポキシ樹脂及びアクリル樹脂等を用いることができる。光導波路23は、透明基板22から入射して透明基板22へと出射する光の光路となる。すなわち、光導波路23は、光ファイバーにおけるコア(心材)同様の役割機能を果たす。そして、保護部材24及び透明基板22は、光導波路23の素材とは異なった屈折率の素材で形成され、光導波路23との境界面で光を全反射させ、光を光導波路23内に閉じ込めるクラッドとしての機能役割を果たす。また、保護部材24及び透明基板22は、光導波路23を物理的に保護する。 The optical waveguide 23 is formed of a material that allows light to pass through, such as resin or optical glass. As the resin, for example, a phenol resin, an epoxy resin, an acrylic resin or the like can be used. The optical waveguide 23 serves as an optical path for light incident from the transparent substrate 22 and emitted to the transparent substrate 22. That is, the optical waveguide 23 fulfills the same role and function as the core (core material) in the optical fiber. The protective member 24 and the transparent substrate 22 are formed of a material having a refractive index different from that of the optical waveguide 23, totally reflect light at the interface with the optical waveguide 23, and confine the light in the optical waveguide 23. It functions as a clad. Further, the protective member 24 and the transparent substrate 22 physically protect the optical waveguide 23.
 光導波路23は、本体部30から透明基板22を介して入射された光を伝播させる。光導波路23では、反応容器201に収容された被検物質の濃度、すなわち反応状態により影響を受けた光が伝播される。 The optical waveguide 23 propagates the light incident from the main body 30 through the transparent substrate 22. In the optical waveguide 23, light affected by the concentration of the test substance contained in the reaction vessel 201, that is, the reaction state is propagated.
 また、光導波路23に光が入射する付近の保護部材24側にはグレーティング23aが配置される。グレーティング23aは、光導波路23に入射される入射光L1を所定の角度で回折させる。グレーティング23aにおいて回折された光は、光導波路23と、透明基板22、保護部材24、又は混合液202により構成される面との界面に対し、臨界角の補角以下の角度で入射する。これにより、入射光L1は、光導波路23の界面において光導波路23内で繰り返し反射しながら伝播(導波)する。 Further, a grating 23a is arranged on the protective member 24 side near the light incident on the optical waveguide 23. The grating 23a diffracts the incident light L1 incident on the optical waveguide 23 at a predetermined angle. The light diffracted in the grating 23a is incident on the interface between the optical waveguide 23 and the surface composed of the transparent substrate 22, the protective member 24, or the mixture 202 at an angle equal to or less than the complementary angle of the critical angle. As a result, the incident light L1 propagates (waveguides) while being repeatedly reflected in the optical waveguide 23 at the interface of the optical waveguide 23.
 光導波路23から光が出射する付近の保護部材24側にはグレーティング23bが配置される。グレーティング23bは、光導波路23により光導波された光を所定の角度で回折させる。グレーティング23bにおいて回折された光は、光導波路23から外部へ所定角度を有して出射される。 A grating 23b is arranged on the protective member 24 side near the light emitted from the optical waveguide 23. The grating 23b diffracts the light optical waveguided by the optical waveguide 23 at a predetermined angle. The light diffracted by the grating 23b is emitted from the optical waveguide 23 to the outside at a predetermined angle.
 保護部材24は、筐体21の第2の凹部の位置に開口を有する。保護部材24は、光導波路23の上面に密着して配置されている。保護部材24は、光導波路23の上面に密着して配置されることで、平面保護層を構成する。また、保護部材24は、図2に示すように、光導波路23の主面(例えば上面)を露出させるための開口端24aを有する。開口端24aは、保護部材24の内側の開口を形成する鉛直面である。この開口端24aにより、光導波路23の上面が露出される。 The protective member 24 has an opening at the position of the second recess of the housing 21. The protective member 24 is arranged in close contact with the upper surface of the optical waveguide 23. The protective member 24 is arranged in close contact with the upper surface of the optical waveguide 23 to form a plane protective layer. Further, as shown in FIG. 2, the protective member 24 has an opening end 24a for exposing the main surface (for example, the upper surface) of the optical waveguide 23. The opening end 24a is a vertical surface that forms an opening inside the protective member 24. The upper surface of the optical waveguide 23 is exposed by the open end 24a.
 反応容器201は、上面が筐体21の第2の凹部の上面により構成され、側面が筐体21の第2の凹部の側面及び保護部材24の開口端24aにより構成され、下面が光導波路23の上面により構成される。 The upper surface of the reaction vessel 201 is composed of the upper surface of the second recess of the housing 21, the side surface is composed of the side surface of the second recess of the housing 21 and the open end 24a of the protective member 24, and the lower surface is the optical waveguide 23. It is composed of the upper surface of.
 反応容器201は、試料溶液及び試薬を収容し、試料溶液に含まれる被検物質と試薬とを反応させる。反応容器201を形成する面のうちの下面、すなわち光導波路23の上面には、複数の第1抗体211が固定される。第1抗体211は、被検物質に含まれる抗原212と抗原抗体反応により特異的に反応する物質である。第1抗体211は、例えば光導波路23の上面との間に生じる疎水性相互作用又は化学結合等により、光導波路23の上面に固定される。 The reaction vessel 201 contains the sample solution and the reagent, and reacts the test substance contained in the sample solution with the reagent. A plurality of first antibodies 211 are immobilized on the lower surface of the surface forming the reaction vessel 201, that is, the upper surface of the optical waveguide 23. The first antibody 211 is a substance that specifically reacts with the antigen 212 contained in the test substance by an antigen-antibody reaction. The first antibody 211 is fixed to the upper surface of the optical waveguide 23 by, for example, a hydrophobic interaction or a chemical bond that occurs with the upper surface of the optical waveguide 23.
 反応容器201は、例えば、予め空の状態となっている。被検物質の測定時においては、例えば孔21aを介して、外部から反応容器201へ、試料溶液と試薬との混合液202が注入される。試料溶液には、抗原212を含む被検物質が含まれる。試薬には、試薬成分213が含まれる。試薬成分213には、例えば抗原212と抗原抗体反応により特異的に反応する第2抗体214と、第2抗体214が結合された磁性粒子215とが含まれる。磁性粒子215は、少なくとも一部がマグネタイト等の磁性体材料で形成されている。磁性粒子215は、例えば、磁性体材料から形成された粒子の表面が高分子材料で被覆されている。なお、磁性粒子215は、高分子材料で構成された粒子の表面を磁性体材料で被覆するように構成されてもよい。また、磁性粒子215は、混合液202において分散可能に構成されたものであればどのようなもので代替してもよい。 The reaction vessel 201 is, for example, empty in advance. At the time of measuring the test substance, for example, the mixed solution 202 of the sample solution and the reagent is injected into the reaction vessel 201 from the outside through the hole 21a. The sample solution contains a test substance containing the antigen 212. The reagent includes reagent component 213. The reagent component 213 includes, for example, a second antibody 214 that specifically reacts with the antigen 212 by an antigen-antibody reaction, and magnetic particles 215 to which the second antibody 214 is bound. At least a part of the magnetic particles 215 is formed of a magnetic material such as magnetite. In the magnetic particles 215, for example, the surface of particles formed from a magnetic material is coated with a polymer material. The magnetic particles 215 may be configured to cover the surface of the particles made of a polymer material with a magnetic material. Further, the magnetic particles 215 may be replaced with any magnetic particles 215 as long as they are dispersible in the mixed liquid 202.
 混合液202を注入することで、反応容器201には、光導波路23の上面に固定された第1抗体211に加えて、試料溶液中の被検物質に含まれる抗原212及び試薬に含まれる試薬成分213が収容される。反応容器201に混合液202が注入されると、反応容器201内の空気は、孔21bから外部へ排出される。 By injecting the mixed solution 202, in addition to the first antibody 211 fixed on the upper surface of the optical waveguide 23, the antigen 212 contained in the test substance in the sample solution and the reagent contained in the reagent are injected into the reaction vessel 201. Ingredients 213 are housed. When the mixed solution 202 is injected into the reaction vessel 201, the air in the reaction vessel 201 is discharged to the outside through the holes 21b.
 試薬成分213は、反応容器201に満たされた混合液202中を分散可能に移動する。このとき、磁性粒子215は、磁性粒子215に掛かる重力が、この重力と逆向きに掛かる混合液202中における浮力よりも大きくなるように選ばれる。第2抗体214が結合された磁性粒子215は、第2抗体214が、抗原212を介して第1抗体211と結合することで、光導波路23の上面近傍に固定される。なお、第2抗体214は、第1抗体211と同じものであっても、異なるものであってもよい。 The reagent component 213 moves in a dispersible manner in the mixed solution 202 filled in the reaction vessel 201. At this time, the magnetic particles 215 are selected so that the gravity applied to the magnetic particles 215 is larger than the buoyancy in the mixture 202 applied in the direction opposite to the gravity. The magnetic particles 215 to which the second antibody 214 is bound are fixed near the upper surface of the optical waveguide 23 by binding the second antibody 214 to the first antibody 211 via the antigen 212. The second antibody 214 may be the same as or different from the first antibody 211.
 生体反応デバイス2では、光導波路23の上面に固定された第1抗体211と被検物質に含まれる抗原212が反応することにより、第2抗体214が結合された磁性粒子215が光導波路23の上面近傍に固定される。光導波路23を導波する光は、光導波路23の上面近傍に固定される磁性粒子215により散乱及び吸収等される。この結果、光導波路23を導波する光は、減衰されて光導波路23から出射されることになる。すなわち、入射光L1は、第1抗体211と、磁性粒子215に固定化される第2抗体214とを結びつける抗原212の量に応じて減衰される。換言すると、入射光L1は、反応容器201内に収容された抗原212の量に応じて減衰される。 In the biological reaction device 2, the first antibody 211 fixed on the upper surface of the optical waveguide 23 reacts with the antigen 212 contained in the test substance, so that the magnetic particles 215 to which the second antibody 214 is bound are formed in the optical waveguide 23. It is fixed near the top surface. The light guided through the optical waveguide 23 is scattered and absorbed by the magnetic particles 215 fixed in the vicinity of the upper surface of the optical waveguide 23. As a result, the light guided through the optical waveguide 23 is attenuated and emitted from the optical waveguide 23. That is, the incident light L1 is attenuated according to the amount of the antigen 212 that binds the first antibody 211 and the second antibody 214 immobilized on the magnetic particles 215. In other words, the incident light L1 is attenuated according to the amount of antigen 212 contained in the reaction vessel 201.
 以下、反応容器201において、光導波路23の表面から鉛直上方向に距離Lだけ離れた領域、すなわち光導波路23の表面近傍に至る領域をセンシングエリア205と定義する。 Hereinafter, in the reaction vessel 201, a region separated by a distance L in the vertical upward direction from the surface of the optical waveguide 23, that is, a region near the surface of the optical waveguide 23 is defined as a sensing area 205.
 光が光導波路23内を伝播する場合、光導波路23の上面において近接場光(以下、エバネッセント光と記載する)が発生する。センシングエリア205は、エバネッセント光が発生し得る領域である。センシングエリア205において、光導波路23の上面に固定された第1抗体211は、試料溶液中の被検物質に含まれる抗原212を介し、試薬成分213に含まれる磁性粒子215に固定化された第2抗体214と結合する。これにより、光導波路23の上面の近傍に第2抗体214が結合された磁性粒子215が保持される。 When light propagates in the optical waveguide 23, near-field light (hereinafter referred to as evanescent light) is generated on the upper surface of the optical waveguide 23. The sensing area 205 is an area where evanescent light can be generated. In the sensing area 205, the first antibody 211 immobilized on the upper surface of the optical waveguide 23 is immobilized on the magnetic particles 215 contained in the reagent component 213 via the antigen 212 contained in the test substance in the sample solution. 2 Binds to antibody 214. As a result, the magnetic particles 215 to which the second antibody 214 is bound are held in the vicinity of the upper surface of the optical waveguide 23.
 次に、反応容器201内において起こる抗原抗体反応等によって光導波路23を伝播する光が受ける影響ついて説明する。なお、第1抗体211、第2抗体214及び抗原212は、磁性粒子215と比較して、ごく小さい。図2では、結合反応を模式的に示すため、第1抗体211、抗原212、第2抗体214及び磁性粒子215を同様な大きさとして図示する。 Next, the influence of the light propagating on the optical waveguide 23 due to the antigen-antibody reaction or the like occurring in the reaction vessel 201 will be described. The first antibody 211, the second antibody 214, and the antigen 212 are very small as compared with the magnetic particles 215. In FIG. 2, in order to schematically show the binding reaction, the first antibody 211, the antigen 212, the second antibody 214, and the magnetic particles 215 are shown as having the same size.
 磁性粒子215がセンシングエリア205内に進入すると、磁性粒子215に固定化される第2抗体214は、抗原212を介して光導波路23の上面に固定された第1抗体211と結合する。これにより、第2抗体214が結合された磁性粒子215は、センシングエリア205に留まる。磁性粒子215がセンシングエリア205に留まった状態で光導波路23の上面においてエバネッセント光が発生すると、センシングエリア205に留まっている磁性粒子215がこのエバネッセント光を散乱及び吸収等し、エバネッセント光を減衰させる。このセンシングエリア205におけるエバネッセント光の散乱及び吸収等は、光導波路23内を伝播する光に対して影響を及ぼす。すなわち、センシングエリア205においてエバネッセント光が減衰されることにより、光導波路23内を光導波する光も減衰される。したがって、センシングエリア205においてエバネッセント光が強く散乱及び吸収等されると、光導波路23内を伝播する光の強度が低下する。換言すると、センシングエリア205内に留まる磁性粒子215の量が多いほど、光導波路23から出力される光の強度が低下する。 When the magnetic particles 215 enter the sensing area 205, the second antibody 214 immobilized on the magnetic particles 215 binds to the first antibody 211 immobilized on the upper surface of the optical waveguide 23 via the antigen 212. As a result, the magnetic particles 215 to which the second antibody 214 is bound remain in the sensing area 205. When evanescent light is generated on the upper surface of the optical waveguide 23 while the magnetic particles 215 remain in the sensing area 205, the magnetic particles 215 remaining in the sensing area 205 scatter and absorb the evanescent light, and attenuate the evanescent light. .. Scattering and absorption of evanescent light in the sensing area 205 affects the light propagating in the optical waveguide 23. That is, as the evanescent light is attenuated in the sensing area 205, the light optical waveguided in the optical waveguide 23 is also attenuated. Therefore, when the evanescent light is strongly scattered and absorbed in the sensing area 205, the intensity of the light propagating in the optical waveguide 23 decreases. In other words, the greater the amount of magnetic particles 215 that remain in the sensing area 205, the lower the intensity of the light output from the optical waveguide 23.
 ただし、センシングエリア205内に留まる磁性粒子215は、測定対象である抗原212を介して光導波路23の上面に固定された第1抗体211と、磁性粒子215に固定化される第2抗体214とが結合したものに限られない。このため、被検物質に含まれる抗原212の正確な濃度を測定するためには、測定に関与しない、すなわち抗原212と結合していない第2抗体214が結合された磁性粒子215をセンシングエリア205から遠ざける必要がある。具体的な方法としては、例えば磁場による近接作用により、第2抗体214が抗原212と結合していない磁性粒子215を移動させる方法がある。 However, the magnetic particles 215 remaining in the sensing area 205 include the first antibody 211 immobilized on the upper surface of the optical waveguide 23 via the antigen 212 to be measured and the second antibody 214 immobilized on the magnetic particles 215. Is not limited to the combination of. Therefore, in order to measure the accurate concentration of the antigen 212 contained in the test substance, the magnetic particles 215 to which the second antibody 214 that is not involved in the measurement, that is, that is not bound to the antigen 212, is bound is measured in the sensing area 205. You need to stay away from it. As a specific method, for example, there is a method of moving the magnetic particles 215 in which the second antibody 214 is not bound to the antigen 212 by the proximity action by a magnetic field.
 これにより、最終的にセンシングエリア205に留まる磁性粒子215は、抗原212を介して光導波路23の上面に固定された第1抗体211と、第2抗体214とが結合されているものとなる。このため、生体反応デバイス2から出射される光の強度の値及び強度の時系列変化は、センシングエリア205に留まる磁性粒子215の量及び濃度等に対応する。 As a result, the magnetic particles 215 finally staying in the sensing area 205 are bound to the first antibody 211 fixed on the upper surface of the optical waveguide 23 via the antigen 212 and the second antibody 214. Therefore, the value of the intensity of the light emitted from the biological reaction device 2 and the time-series change in the intensity correspond to the amount and concentration of the magnetic particles 215 remaining in the sensing area 205.
 なお、生体反応デバイス2は、同一の測定項目について、同一の被検物質を複数チャンネルで同時に並行測定可能な構成であってもよい。このとき、生体反応デバイス2は、例えばチャンネル毎に独立した光導波路を有する。 The biological reaction device 2 may have a configuration capable of simultaneously measuring the same test substance on a plurality of channels in parallel for the same measurement item. At this time, the biological reaction device 2 has, for example, an independent optical waveguide for each channel.
 次に、マスターの検体検査装置10である検体検査装置10Aについて説明する。図3は、本実施形態に係る検体検査装置10Aの構成の一例を示すブロック図である。 Next, the sample testing device 10A, which is the master sample testing device 10, will be described. FIG. 3 is a block diagram showing an example of the configuration of the sample testing device 10A according to the present embodiment.
 まず、検体検査装置10Aの入出力装置40の構成について説明する。入出力装置40は、検体検査装置10Aの上面に搭載され、出力装置41、及び、入力装置42を備える。 First, the configuration of the input / output device 40 of the sample test device 10A will be described. The input / output device 40 is mounted on the upper surface of the sample test device 10A, and includes an output device 41 and an input device 42.
 出力装置41は、ディスプレイ411、及び、プリンタ412を有する。例えば、図1において、ユーザがディスプレイ411を視認しやすいように、検体検査装置10Aの入出力装置40の前面は傾斜している。 The output device 41 has a display 411 and a printer 412. For example, in FIG. 1, the front surface of the input / output device 40 of the sample test device 10A is inclined so that the user can easily see the display 411.
 ディスプレイ411は、各種の情報を表示する。例えば、ディスプレイ411は、後述の処理回路34によって生成された各種の画像を表示したり、ユーザから各種の操作を受け付けるためのGUI(Graphical User Interface)を表示したりする。例えば、ディスプレイ411は、液晶ディスプレイ、OLED(Organic Light Emitting Diode)ディスプレイやCRT(Cathode Ray Tube)ディスプレイ等である。ディスプレイ411は、後述の処理回路34の制御に従い、例えば、各種操作画面、後述の光検出器312から供給された出射光L2の光強度を示す情報、光強度を示す情報の時系列データ、及び、検査に関する情報等を表示する。検査に関する情報は、例えば、検査の検査結果を含む。検査結果は、例えば抗原212の量(濃度、重量、個数等)又は有無である。ディスプレイ411は、「表示部」の一例である。 Display 411 displays various information. For example, the display 411 displays various images generated by the processing circuit 34 described later, and displays a GUI (Graphical User Interface) for accepting various operations from the user. For example, the display 411 is a liquid crystal display, an OLED (Organic Light Emitting Diode) display, a CRT (Cathode Ray Tube) display, or the like. The display 411 follows the control of the processing circuit 34 described later, for example, various operation screens, information indicating the light intensity of the emitted light L2 supplied from the photodetector 312 described later, time-series data of information indicating the light intensity, and , Display information about inspection. Information about the test includes, for example, the test result of the test. The test result is, for example, the amount (concentration, weight, number, etc.) or presence / absence of the antigen 212. The display 411 is an example of a “display unit”.
 プリンタ412は、後述の処理回路34の制御の下、例えばディスプレイ411に表示される各種操作画面、後述の光検出器312から供給された出射光L2の光強度を示す情報、光強度を示す情報の時系列データ、及び被検物質の検査結果等を印刷する。プリンタ412は、「印刷部」の一例である。 Under the control of the processing circuit 34 described later, the printer 412 has various operation screens displayed on the display 411, for example, information indicating the light intensity of the emitted light L2 supplied from the photodetector 312 described later, and information indicating the light intensity. Print out the time-series data of the above and the test results of the test substance. The printer 412 is an example of a "printing unit".
 入力装置42は、例えばトラックボール、スイッチ、ボタン、マウス、キーボード、操作面へ触れることで入力操作を行うタッチパッド、及び表示画面とタッチパッドとが一体化されたタッチパネルディスプレイ等によって実現される。入力装置42は、ユーザの操作に対応した操作入力信号を後述の処理回路34に出力する。なお、本実施形態において入力インタフェース回路はマウス、キーボードなどの物理的な操作部品を備えるものだけに限られない。例えば、装置とは別体に設けられた外部の入力機器から入力操作に対応する電気信号を受け取り、この電気信号を後述の処理回路34へ出力する電気信号の処理回路も入力インタフェース回路の例に含まれる。入力装置42は、「入力部」の一例である。 The input device 42 is realized by, for example, a trackball, a switch, a button, a mouse, a keyboard, a touch pad that performs an input operation by touching an operation surface, a touch panel display in which a display screen and a touch pad are integrated, and the like. The input device 42 outputs an operation input signal corresponding to the user's operation to the processing circuit 34 described later. In this embodiment, the input interface circuit is not limited to the one provided with physical operating parts such as a mouse and a keyboard. For example, an electric signal processing circuit that receives an electric signal corresponding to an input operation from an external input device provided separately from the device and outputs this electric signal to a processing circuit 34 described later is also an example of an input interface circuit. included. The input device 42 is an example of an “input unit”.
 次に、検体検査装置10Aの本体部30の構成について説明する。 Next, the configuration of the main body 30 of the sample testing device 10A will be described.
 本体部30は、図3に示すように、検知ユニット31を有する。検知ユニット31は、光源311、光検出器312、及び、読取装置313を有する。 The main body 30 has a detection unit 31 as shown in FIG. The detection unit 31 includes a light source 311 and a photodetector 312, and a reader 313.
 光源311は、例えば、LED(Light Emitting Diode)等のダイオードやキセノンランプ等のランプである。光源311は、図2に示すグレーティング23aに向けて光導波路23内に光を入射可能な位置に配置される。光源311は、入射光L1を、生体反応デバイス2の透明基板22を介して光導波路23内に入射する。 The light source 311 is, for example, a diode such as an LED (Light Emitting Diode) or a lamp such as a xenon lamp. The light source 311 is arranged at a position where light can be incident in the optical waveguide 23 toward the grating 23a shown in FIG. The light source 311 incidents the incident light L1 into the optical waveguide 23 via the transparent substrate 22 of the biological reaction device 2.
 光検出器312は、混合液202が収容されている反応容器201内の反応状態に基づいた電気信号を出力する。具体的には、光検出器312は、光導波路23の外へ出射される出射光L2を検出し、検出された出射光L2の強度を示す電気信号、すなわち光検出強度に関するデジタルデータを生成する。光検出器312により生成された光検出強度に関するデジタルデータは後述の処理回路34に供給される。 The photodetector 312 outputs an electric signal based on the reaction state in the reaction vessel 201 containing the mixed liquid 202. Specifically, the photodetector 312 detects the emitted light L2 emitted to the outside of the optical waveguide 23, and generates an electric signal indicating the intensity of the detected emitted light L2, that is, digital data regarding the light detection intensity. .. The digital data regarding the light detection intensity generated by the photodetector 312 is supplied to the processing circuit 34 described later.
 なお、検知ユニット31は、同一の測定項目について、同一の被検物質を複数チャンネルで同時に並行測定可能な構成であってもよい。このとき、検知ユニット31は、例えばチャンネル毎に光源及び光検出器を有するとしてもよいし、光源及び光検出器を共有することもできる。 The detection unit 31 may have a configuration capable of simultaneously measuring the same test substance on a plurality of channels in parallel for the same measurement item. At this time, the detection unit 31 may have a light source and a photodetector for each channel, for example, or may share the light source and the photodetector.
 また、検知ユニット31は、本体部30に対するカバー20の開閉を検出する検出器を有する。当該検出器は、本体部30からカバー20が開けられたことを検出したときに、カバー20が開けられたことを表す情報を処理回路34に出力し、本体部30にカバー20が閉じられたことを検出したときに、カバー20が閉じられたことを表す情報を処理回路34に出力する。 Further, the detection unit 31 has a detector that detects the opening / closing of the cover 20 with respect to the main body 30. When the detector detects that the cover 20 has been opened from the main body 30, it outputs information indicating that the cover 20 has been opened to the processing circuit 34, and the cover 20 is closed by the main body 30. When this is detected, information indicating that the cover 20 has been closed is output to the processing circuit 34.
 読取装置313は、生体反応デバイス2に設けられた識別子から検出対象の種類を読み取り、生体反応デバイス2の種類を表す読取情報を処理回路34に出力する。具体的には、生体反応デバイス2の裏面には、生体反応デバイス2の種類を識別する識別子が設けられている。例えば、ウイルスAやウイルスBなどの抗原212を含む被検物質を検出対象とした場合、生体反応デバイス2の種類は、ウイルスA検査用の生体反応デバイス2や、ウイルスB検査用の生体反応デバイス2などである。例えば、生体反応デバイス2の裏面には、生体反応デバイス2の種類を識別するQRコード(登録商標)2aが印刷されている。読取装置313は、本体部30の装着台4に生体反応デバイス2が装着されたときに、生体反応デバイス2の裏面に印刷されたQRコード(登録商標)2aから生体反応デバイス2の種類を読み取り、当該生体反応デバイス2の種類を表す読取情報を処理回路34に出力する。 The reading device 313 reads the type of the detection target from the identifier provided in the biological reaction device 2, and outputs the reading information indicating the type of the biological reaction device 2 to the processing circuit 34. Specifically, an identifier that identifies the type of the biological reaction device 2 is provided on the back surface of the biological reaction device 2. For example, when a test substance containing an antigen 212 such as virus A or virus B is targeted for detection, the type of biological reaction device 2 is a biological reaction device 2 for virus A test or a biological reaction device for virus B test. 2 and so on. For example, a QR code (registered trademark) 2a that identifies the type of the biological reaction device 2 is printed on the back surface of the biological reaction device 2. When the biological reaction device 2 is mounted on the mounting base 4 of the main body 30, the reading device 313 reads the type of the biological reaction device 2 from the QR code (registered trademark) 2a printed on the back surface of the biological reaction device 2. , The reading information indicating the type of the biological reaction device 2 is output to the processing circuit 34.
 例えば、検出対象の種類は色分けされ、ウイルスA、ウイルスBの検査用の生体反応デバイス2には、それぞれ、緑色、青色が割り当てられている。具体的には、ウイルスA検査用の生体反応デバイス2、及び、当該生体反応デバイス2に反応させる試薬のパッケージなどは、緑色で色分けされている。同様に、ウイルスB検査用の生体反応デバイス2、及び、当該生体反応デバイス2に反応させる試薬のパッケージなどは、青色で色分けされている。 For example, the types of detection targets are color-coded, and green and blue are assigned to the biological reaction devices 2 for virus A and virus B inspection, respectively. Specifically, the biological reaction device 2 for virus A test and the package of the reagent to react with the biological reaction device 2 are color-coded in green. Similarly, the biological reaction device 2 for virus B inspection, the package of the reagent to react with the biological reaction device 2, and the like are color-coded in blue.
 ここで、本実施形態では、生体反応デバイス2の種類を識別する識別子として、QRコード(登録商標)2aを用いているが、これに限定されず、例えば、バーコードなどを用いてもよい。 Here, in the present embodiment, the QR code (registered trademark) 2a is used as an identifier for identifying the type of the biological reaction device 2, but the present invention is not limited to this, and for example, a barcode or the like may be used.
 本体部30は、図3に示すように、更に、磁場発生器32、記憶回路33、及び、処理回路34を有する。 As shown in FIG. 3, the main body 30 further includes a magnetic field generator 32, a storage circuit 33, and a processing circuit 34.
 磁場発生器32は、図2に示す反応容器201内の反応、すなわち磁性粒子215に固定された第2抗体214と光導波路23の上面に固定された第1抗体211との抗原212を介した結合を促進させるエネルギーを発生する。具体的には、磁場発生器32は、図3に示すように、上磁場発生器32a及び下磁場発生器32bを有する。また、磁場発生器32は、図示しない駆動回路を有する。磁場発生器32は、処理回路34の制御の下、反応容器201に対して磁場を印加する。 The magnetic field generator 32 is mediated by the reaction in the reaction vessel 201 shown in FIG. 2, that is, the antigen 212 of the second antibody 214 fixed to the magnetic particles 215 and the first antibody 211 fixed to the upper surface of the optical waveguide 23. Generates energy that promotes binding. Specifically, the magnetic field generator 32 has an upper magnetic field generator 32a and a lower magnetic field generator 32b, as shown in FIG. Further, the magnetic field generator 32 has a drive circuit (not shown). The magnetic field generator 32 applies a magnetic field to the reaction vessel 201 under the control of the processing circuit 34.
 下磁場発生器32bは、例えば永久磁石及び電磁石等で構成される。下磁場発生器32bは、生体反応デバイス2の下方に設けられる。具体的には、下磁場発生器32bは、生体反応デバイス2を装着する装着台4の下方に設けられる。例えば、下磁場の印加を開始するタイミング、下磁場の印加を停止するタイミングは予め決められている。下磁場発生器32bは、反応容器201内の反応を促進させるエネルギーである鉛直下向きの磁場を水平方向に一様に発生させる。発生された鉛直下向きの磁場により、第2抗体214が結合された磁性粒子215は、鉛直下方向の力を受けて下降する。このとき、下磁場発生器32bは、所定の強さの磁場を発生させることで、第2抗体214が結合された磁性粒子215を光導波路23に近づける。 The lower magnetic field generator 32b is composed of, for example, a permanent magnet and an electromagnet. The lower magnetic field generator 32b is provided below the biological reaction device 2. Specifically, the lower magnetic field generator 32b is provided below the mounting table 4 on which the biological reaction device 2 is mounted. For example, the timing at which the application of the lower magnetic field is started and the timing at which the application of the lower magnetic field is stopped are predetermined. The lower magnetic field generator 32b uniformly generates a vertically downward magnetic field, which is energy for promoting the reaction in the reaction vessel 201, in the horizontal direction. Due to the generated vertical downward magnetic field, the magnetic particles 215 to which the second antibody 214 is bound are lowered by receiving the vertical downward force. At this time, the lower magnetic field generator 32b brings the magnetic particles 215 to which the second antibody 214 is bound closer to the optical waveguide 23 by generating a magnetic field of a predetermined strength.
 上磁場発生器32aは、例えば永久磁石及び電磁石等で構成される。上磁場発生器32aは、図2に示すように、生体反応デバイス2の上方に設けられる。例えば、上磁場の印加を開始するタイミング、上磁場の印加を停止するタイミングは予め決められている。例えば、上磁場の印加を開始するタイミングは、下磁場の印加を停止したタイミングから所定時間が経過した時間に設定されている。上磁場発生器32aは、反応容器201において鉛直上向きの磁場を水平方向に一様に発生させる。発生された鉛直上向きの磁場により、第2抗体214が結合された磁性粒子215は、鉛直上方向の力を受けて上昇する。このとき、上磁場発生器32aは、所定の強さの磁場を発生させることで、第2抗体214が結合された磁性粒子215を選択的にセンシングエリア205から遠ざける。すなわち、上磁場発生器32aは、発生させる磁場の強さを調整することで、光導波路23の上面に固定される、第1抗体211と抗原212を介して結合する第2抗体214が結合された磁性粒子215のみをセンシングエリア205に留めることが可能となる。 The upper magnetic field generator 32a is composed of, for example, a permanent magnet and an electromagnet. The upper magnetic field generator 32a is provided above the biological reaction device 2 as shown in FIG. For example, the timing at which the application of the upper magnetic field is started and the timing at which the application of the upper magnetic field is stopped are predetermined. For example, the timing for starting the application of the upper magnetic field is set to the time when a predetermined time has elapsed from the timing when the application of the lower magnetic field is stopped. The upper magnetic field generator 32a uniformly generates a vertically upward magnetic field in the reaction vessel 201 in the horizontal direction. Due to the generated vertical upward magnetic field, the magnetic particles 215 to which the second antibody 214 is bound rise by receiving a vertically upward force. At this time, the upper magnetic field generator 32a selectively moves the magnetic particles 215 to which the second antibody 214 is bound away from the sensing area 205 by generating a magnetic field having a predetermined strength. That is, in the upper magnetic field generator 32a, by adjusting the strength of the generated magnetic field, the first antibody 211 fixed on the upper surface of the optical waveguide 23 and the second antibody 214 that binds via the antigen 212 are bound. It is possible to keep only the magnetic particles 215 in the sensing area 205.
 記憶回路33は、磁気的若しくは光学的記録媒体又は半導体メモリ等の、プロセッサにより読み取り可能な記録媒体等を有する。記憶回路33は、検体検査装置10Aの回路で実行されるプログラムを記憶する。なお、記憶回路33の記憶媒体内のプログラム及びデータの一部又は全部は電子ネットワークを介してダウンロードされるように構成してもよい。 The storage circuit 33 has a recording medium that can be read by a processor, such as a magnetic or optical recording medium or a semiconductor memory. The storage circuit 33 stores a program executed in the circuit of the sample test device 10A. A part or all of the program and data in the storage medium of the storage circuit 33 may be configured to be downloaded via an electronic network.
 記憶回路33は、光検出器312から供給された出射光L2の光強度を示す情報、光強度を示す情報の時系列データ、及び測定対象となる被検物質の検査結果等を記憶する。 The storage circuit 33 stores information indicating the light intensity of the emitted light L2 supplied from the photodetector 312, time-series data of information indicating the light intensity, inspection results of the test substance to be measured, and the like.
 記憶回路33は、対象となる被検物質の測定を行うためのタイムスケジュールを記憶する。タイムスケジュールとは、例えば下磁場発生器32bにより発生される下磁場の印加が開始されるタイミング、下磁場の印加が停止されるタイミング、上磁場の印加が開始されるタイミング及び測定が実施されるタイミングである。これらのタイミングは、予め経験的、実験的に取得される。 The storage circuit 33 stores a time schedule for measuring the target test substance. The time schedule is, for example, the timing at which the application of the lower magnetic field generated by the lower magnetic field generator 32b is started, the timing at which the application of the lower magnetic field is stopped, the timing at which the application of the upper magnetic field is started, and the measurement are performed. It's timing. These timings are obtained in advance empirically and experimentally.
 処理回路34は、例えば検体検査装置10Aの各構成回路を制御するプロセッサである。処理回路34は、検体検査装置10Aの中枢として機能する。処理回路34は、記憶回路33から各動作プログラムを呼び出し、呼び出したプログラムを実行することで制御機能341、通信機能342、及び、測定機能343を実現する。制御機能341は、「制御部」の一例である。通信機能342は、「通信部」の一例である。測定機能343は、「検査部」の一例である。 The processing circuit 34 is, for example, a processor that controls each constituent circuit of the sample testing device 10A. The processing circuit 34 functions as the center of the sample testing device 10A. The processing circuit 34 calls each operation program from the storage circuit 33 and executes the called program to realize the control function 341, the communication function 342, and the measurement function 343. The control function 341 is an example of a "control unit". The communication function 342 is an example of a "communication unit". The measurement function 343 is an example of an “inspection unit”.
 測定機能343は、生体反応デバイス2、光源311、光検出器312、磁場発生器32を用いて、検体に含まれる検出対象を検出する検査を行う。 The measurement function 343 performs an inspection for detecting a detection target contained in a sample by using a biological reaction device 2, a light source 311, a photodetector 312, and a magnetic field generator 32.
 具体的には、測定機能343、光源311を制御し、所定の条件で光を発生させる。測定機能343では、処理回路34は、少なくとも測定開始から測定終了までの間、連続的又は間欠的に光源311から入射光L1を発生させる。 Specifically, the measurement function 343 and the light source 311 are controlled to generate light under predetermined conditions. In the measurement function 343, the processing circuit 34 continuously or intermittently generates the incident light L1 from the light source 311 from the start of the measurement to the end of the measurement.
 また、測定機能343は、記憶回路33に記憶されているタイムスケジュールに従って磁場発生器32を制御し、生体反応デバイス2の反応容器201内の反応を促進させるエネルギーの印加状態を切り替える。具体的には、上述のように、下磁場の印加を開始するタイミング、下磁場の印加を停止するタイミング、上磁場の印加を開始するタイミング、上磁場の印加を停止するタイミングは予め決められており、上磁場の印加を開始するタイミングは、下磁場の印加を停止したタイミングから所定時間が経過した時間に設定されている。測定機能343は、記憶回路33からタイムスケジュールを読出し、読み出したタイムスケジュールに基づいて磁場発生器32を制御し、磁場発生器32に磁場を発生させる。 Further, the measurement function 343 controls the magnetic field generator 32 according to the time schedule stored in the storage circuit 33, and switches the application state of energy for promoting the reaction in the reaction vessel 201 of the biological reaction device 2. Specifically, as described above, the timing for starting the application of the lower magnetic field, the timing for stopping the application of the lower magnetic field, the timing for starting the application of the upper magnetic field, and the timing for stopping the application of the upper magnetic field are predetermined. Therefore, the timing for starting the application of the upper magnetic field is set to the time when a predetermined time has elapsed from the timing when the application of the lower magnetic field is stopped. The measurement function 343 reads a time schedule from the storage circuit 33, controls the magnetic field generator 32 based on the read time schedule, and generates a magnetic field in the magnetic field generator 32.
 また、測定機能343は、光検出器312から供給された光信号から被検物質の量(例えば、抗原濃度等)又は有無に関する検査結果を導出する。例えば、検査結果を導出するタイミングは予め決められており、上磁場の印加を開始するタイミングから所定時間が経過した時間に設定されている。測定機能343は、記憶回路33からタイムスケジュールを読出し、読み出したタイムスケジュールに基づいて、光検出器312から供給された光信号から検査結果を導出する。 Further, the measurement function 343 derives a test result regarding the amount (for example, antigen concentration, etc.) or presence / absence of the test substance from the optical signal supplied from the photodetector 312. For example, the timing for deriving the inspection result is predetermined, and is set to a time when a predetermined time has elapsed from the timing when the application of the upper magnetic field is started. The measurement function 343 reads the time schedule from the storage circuit 33, and derives the inspection result from the optical signal supplied from the photodetector 312 based on the read time schedule.
 例えば、測定機能343は、上磁場の印加を開始するタイミングから所定時間が経過した時間に達したときに、試料溶液が陽性又は陰性の可能性が高いかどうかを判定し、判定結果を検査結果として導出する。具体的には、測定機能343は、上磁場の印加を開始するタイミングから所定時間が経過した時間に達したときに取得した光信号の強度と、例えば記憶回路33に記憶された閾値を比較することで、判定を行う。ここで、取得した光信号の強度が閾値以下であった場合、測定機能343は、被検物質の測定結果として陽性の可能性が高いと判定し、判定結果を検査結果として導出する。一方、取得した光信号の強度が閾値より大きい場合、測定機能343は、被検物質の測定結果として陰性の可能性が高いと判定し、判定結果を検査結果として導出する。 For example, the measurement function 343 determines whether or not the sample solution is likely to be positive or negative when a predetermined time elapses from the timing at which the application of the upper magnetic field is started, and the determination result is the test result. Derived as. Specifically, the measurement function 343 compares the intensity of the optical signal acquired when a predetermined time elapses from the timing of starting the application of the upper magnetic field with, for example, the threshold value stored in the storage circuit 33. By doing so, the judgment is made. Here, when the intensity of the acquired optical signal is equal to or less than the threshold value, the measurement function 343 determines that there is a high possibility of being positive as the measurement result of the test substance, and derives the determination result as the test result. On the other hand, when the intensity of the acquired optical signal is greater than the threshold value, the measurement function 343 determines that there is a high possibility of being negative as the measurement result of the test substance, and derives the determination result as the test result.
 制御機能341は、検査結果を出力装置41に出力させる。例えば、制御機能341は、出力装置41として、ディスプレイ411やプリンタ412を制御し、検査に関する情報をユーザに提示する。具体的には、制御機能341は、被検物質の量又は有無に関する検査結果をディスプレイ411に表示したり、プリンタで印刷したりすることにより、ユーザに提示する。 The control function 341 outputs the inspection result to the output device 41. For example, the control function 341 controls the display 411 and the printer 412 as the output device 41, and presents information on the inspection to the user. Specifically, the control function 341 presents the inspection result regarding the amount or presence / absence of the test substance to the user by displaying it on the display 411 or printing it with a printer.
 また、制御機能341は、自装置である検体検査装置10A、及び、検体検査装置10B、10Cを制御する。制御機能341の制御については後述する。 Further, the control function 341 controls the sample inspection device 10A and the sample inspection devices 10B and 10C, which are its own devices. The control of the control function 341 will be described later.
 通信機能342は、検体検査装置10B、10Cと通信を行う。 The communication function 342 communicates with the sample testing devices 10B and 10C.
 次に、スレーブの検体検査装置10である検体検査装置10B、10Cについて説明する。図4は、本実施形態に係る検体検査装置10B、10Cの構成の一例を示すブロック図である。 Next, the sample testing devices 10B and 10C, which are the slave sample testing devices 10, will be described. FIG. 4 is a block diagram showing an example of the configuration of the sample testing devices 10B and 10C according to the present embodiment.
 上述のように、検体検査装置10B、10Cには、コスト面から入出力装置40が設けられていない。 As described above, the sample test devices 10B and 10C are not provided with the input / output device 40 from the viewpoint of cost.
 なお、測定機能343は、生体反応デバイス2、光源311、光検出器312、磁場発生器32を用いて、検体に含まれる検出対象を検出する検査を行う。通信機能342は、検体検査装置10Aと通信を行う。制御機能341は、検体検査装置10Aからの制御により動作する。制御機能341の制御については後述する。 The measurement function 343 uses the biological reaction device 2, the light source 311, the photodetector 312, and the magnetic field generator 32 to perform an inspection for detecting the detection target contained in the sample. The communication function 342 communicates with the sample test device 10A. The control function 341 operates under the control of the sample testing device 10A. The control of the control function 341 will be described later.
 上記説明において用いた「プロセッサ」という文言は、例えば、CPU(Central Processing Unit)、GPU(Graphics Processing Unit)、特定用途向け集積回路(Application Specific Integrated Circuit:ASIC))、プログラマブル論理デバイス(例えば、単純プログラマブル論理デバイス(Simple Programmable Logic Device:SPLD)、複合プログラマブル論理デバイス(Complex Programmable Logic Device:CPLD)、及びフィールドプログラマブルゲートアレイ(Field Programmable Gate Array:FPGA))等の回路を意味する。プロセッサが例えばCPUである場合、プロセッサは記憶回路60に保存されたプログラムを読み出し実行することで機能を実現する。一方、プロセッサが例えばASICである場合、記憶回路60にプログラムを保存する代わりに、プロセッサの回路内にプログラムを直接組み込まれる。なお、本実施形態の各プロセッサは、プロセッサごとに単一の回路として構成される場合に限らず、複数の独立した回路を組み合わせて1つのプロセッサとして構成し、その機能を実現するようにしてもよい。さらに、図3、図4における複数の構成要素を1つのプロセッサへ統合してその機能を実現するようにしてもよい。 The word "processor" used in the above description is, for example, a CPU (Central Processing Unit), a GPU (Graphics Processing Unit), an integrated circuit for a specific application (Application Specific Integrated Circuit: ASIC)), a programmable logic device (for example, a simple one). It means a circuit such as a programmable logic device (Simple Programmable Logic Device: SPLD), a composite programmable logic device (Complex Programmable Logic Device: CPLD), and a field programmable gate array (Field Programmable Gate Array: FPGA). When the processor is, for example, a CPU, the processor realizes the function by reading and executing the program stored in the storage circuit 60. On the other hand, when the processor is, for example, an ASIC, the program is directly incorporated in the circuit of the processor instead of storing the program in the storage circuit 60. It should be noted that each processor of the present embodiment is not limited to the case where each processor is configured as a single circuit, and a plurality of independent circuits may be combined to form one processor to realize its function. good. Further, the plurality of components in FIGS. 3 and 4 may be integrated into one processor to realize the function.
 ここで、検体検査システムは、マスターの検体検査装置10とスレーブの検体検査装置10とで構成された複数の検体検査装置10を備えているため、例えば、ユーザは、マスターの検体検査装置10を1台のみ操作することで、複数の検体検査装置を操作して様々な検査を同時に行うことができ、検査効率を向上することができる。また、スレーブの検体検査装置10には、コスト面から入出力装置40が設けられていないので、同時に複数の検査が行える検体検査システムを安価に構成することができる。しかし、スレーブの検体検査装置10に入出力装置40が設けられていないことから、上記の検体検査システムでは、以下の課題が生じる。 Here, since the sample test system includes a plurality of sample test devices 10 composed of a master sample test device 10 and a slave sample test device 10, for example, the user can use the master sample test device 10. By operating only one unit, it is possible to operate a plurality of sample testing devices to perform various tests at the same time, and it is possible to improve the testing efficiency. Further, since the slave sample test device 10 is not provided with the input / output device 40 from the viewpoint of cost, it is possible to inexpensively configure a sample test system capable of performing a plurality of tests at the same time. However, since the input / output device 40 is not provided in the slave sample test device 10, the following problems arise in the above sample test system.
 例えば、スレーブの検体検査装置10に入出力装置40が設けられていないため、何の検査を予定しているのかが分からないという課題が生じる。具体的には、スレーブの検体検査装置10である検体検査装置10BによりウイルスBの検査が行われる場合、ユーザは、見間違えなどにより、検体検査装置10Bとは別の検体検査装置を使用してしまう可能性がある。例えば、ユーザは、ウイルスB検査用の生体反応デバイス2を検体検査装置10Cに装着してしまう可能性がある。例えば、ユーザは、ウイルスA検査用の生体反応デバイス2を検体検査装置10Bに装着してしまう可能性がある。このように、本実施形態における検体検査システムでは、検体検査装置10に装着された生体反応デバイス2の種類が間違えている場合、検査のやり直しなどが生じてしまい、検査効率が下がる可能性がある。 For example, since the input / output device 40 is not provided in the slave sample test device 10, there arises a problem that it is not possible to know what test is planned. Specifically, when the virus B is tested by the sample test device 10B, which is the slave sample test device 10, the user uses a sample test device different from the sample test device 10B due to a mistake or the like. There is a possibility that it will end up. For example, the user may attach the biological reaction device 2 for virus B testing to the sample testing device 10C. For example, the user may attach the biological reaction device 2 for virus A testing to the sample testing device 10B. As described above, in the sample test system of the present embodiment, if the type of the biological reaction device 2 mounted on the sample test device 10 is wrong, the test may be redone and the test efficiency may decrease. ..
 また、スレーブの検体検査装置10に入出力装置40が設けられていないため、何を検査しているのかが分からないという課題が生じる。具体的には、スレーブの検体検査装置10である検体検査装置10BによりウイルスBの検査が行われている場合、検体検査装置10Bでは、検査時においてカバー20が閉じられているため、ウイルスB検査用の生体反応デバイス2に色分けされた青色を確認することができない。この状況においては、ユーザは、マスターの検体検査装置10である検体検査装置10Aのディスプレイ411に表示された画面を視認することにより、現在、何の検査項目の検査が行われているのかを確認することができる。しかし、ユーザは、別の作業を行っている等の理由で、画面表示している検体検査装置10Aに近づくことができない場合、現在、何の検査項目の検査が行われているのかを、一目で確認することができない。ユーザが確認のために検体検査装置10Aに近づく場合、ユーザが行っている作業を中断することになり、検査効率が下がる可能性がある。 Further, since the input / output device 40 is not provided in the slave sample inspection device 10, there arises a problem that it is not possible to know what is being inspected. Specifically, when the virus B is tested by the sample test device 10B, which is the slave sample test device 10, the sample test device 10B has the cover 20 closed at the time of the test, so that the virus B test is performed. It is not possible to confirm the color-coded blue color on the biological reaction device 2 for the virus. In this situation, the user confirms what test item is currently being tested by visually recognizing the screen displayed on the display 411 of the sample test device 10A, which is the master sample test device 10. can do. However, if the user cannot approach the sample test device 10A displayed on the screen because he / she is performing another work or the like, he / she can see at a glance what test item is currently being tested. I can't confirm with. When the user approaches the sample testing device 10A for confirmation, the work performed by the user is interrupted, which may reduce the testing efficiency.
 そこで、本実施形態における検体検査システムでは、検査効率の向上を図るために、図1、図3及び図4において、検体検査装置10A~10Cの本体部30にインジケータ35を設けている。インジケータ35は、異なる色を発光可能な発光部を有する。インジケータ35が発光可能な色としては、例えば、緑色や青色が挙げられる。インジケータ35の発光部は、ユーザが視認しやすいように形成されている。例えば、インジケータ35の発光部は、本体部30の前面から突出するように、凸形状に形成されている。 Therefore, in the sample testing system of the present embodiment, an indicator 35 is provided in the main body 30 of the sample testing devices 10A to 10C in FIGS. 1, 3 and 4 in order to improve the testing efficiency. The indicator 35 has a light emitting unit capable of emitting different colors. Examples of the color that the indicator 35 can emit light include green and blue. The light emitting portion of the indicator 35 is formed so that the user can easily see it. For example, the light emitting portion of the indicator 35 is formed in a convex shape so as to protrude from the front surface of the main body portion 30.
 そして、本実施形態における検体検査システムでは、検査効率の向上を図ることができるように、以下の処理を行う。本実施形態に係る検体検査装置10は、マスターの検体検査装置10において、測定機能343と、入出力装置40と、通信機能342と、制御機能341とを備える。測定機能343は、検体に含まれる検出対象を検出する。入出力装置40は、検査に関する情報を表示するディスプレイ411、及び、検査に関する情報の入力を受け付ける入力装置42を有する。通信機能342は、スレーブの検体検査装置10と通信を行う。ここで、スレーブの検体検査装置10は、測定機能343を有する。制御機能341は、スレーブの検体検査装置10の制御に用いられる制御情報を通信機能342から送信させる。例えば、マスターの検体検査装置10及びスレーブの検体検査装置10は、インジケータ35を更に備え、マスターの検体検査装置10の制御機能341は、制御情報を通信機能342から送信させることにより、検査を実施する装置として選択された検体検査装置10のインジケータ35を、当該検査の検出対象の種類に応じた色で発光するように制御する。また、制御機能341は、スレーブの検体検査装置10から受信した検出結果を処理する。 Then, in the sample test system in this embodiment, the following processing is performed so that the test efficiency can be improved. The sample test device 10 according to the present embodiment includes a measurement function 343, an input / output device 40, a communication function 342, and a control function 341 in the master sample test device 10. The measurement function 343 detects a detection target included in the sample. The input / output device 40 includes a display 411 that displays information related to inspection, and an input device 42 that receives input of information related to inspection. The communication function 342 communicates with the slave sample inspection device 10. Here, the slave sample inspection device 10 has a measurement function 343. The control function 341 causes the communication function 342 to transmit control information used for controlling the slave sample inspection device 10. For example, the master sample test device 10 and the slave sample test device 10 further include an indicator 35, and the control function 341 of the master sample test device 10 carries out the test by transmitting control information from the communication function 342. The indicator 35 of the sample test device 10 selected as the device to perform the test is controlled so as to emit light in a color corresponding to the type of the detection target of the test. Further, the control function 341 processes the detection result received from the slave sample inspection device 10.
 図5~図7は、本実施形態における検体検査システム1による処理の手順を示すフローチャートである。図8A~図8Gは、本実施形態における検体検査システム1による処理を説明するための図である。 5 to 7 are flowcharts showing the procedure of processing by the sample test system 1 in the present embodiment. 8A to 8G are diagrams for explaining the processing by the sample test system 1 in the present embodiment.
 図5のステップS100では、マスターの検体検査装置10である検体検査装置10Aの制御機能341は、例えばHIS(Hospital Information System)サーバから検査オーダを受け付け、検査オーダに基づいて、オーダされた実施予定の検査の一覧を表示した上で、検出対象として検査項目の選択を受け付ける。例えば、図8Aに示すように、制御機能341は、検査項目の選択を受け付ける画面をディスプレイ411に表示し、制御機能341は、入力装置42を介して、実施される検査項目の選択を受け付ける。 In step S100 of FIG. 5, the control function 341 of the sample test device 10A, which is the master sample test device 10, receives a test order from, for example, a HIS (Hospital Information System) server, and is scheduled to be ordered based on the test order. After displaying the list of inspections, the selection of inspection items is accepted as the detection target. For example, as shown in FIG. 8A, the control function 341 displays a screen for accepting the selection of the inspection item on the display 411, and the control function 341 accepts the selection of the inspection item to be performed via the input device 42.
 具体的には、制御機能341は、検体検査装置10A、10B、10Cの稼働状況を認識しており、検査項目の選択を受け付ける領域110と、検体検査装置10Aの稼働状態を表示する領域120と、検体検査装置10Bの稼働状態を表示する領域130と、検体検査装置10Cの稼働状態を表示する領域130とを重ねてディスプレイ411に表示させる。例えば、領域110、120、130、140は、それぞれ表示の位置が異なるタブを含み、領域110、120、130、140のタブには、それぞれ、領域110、120、130、140を識別するための「項目」、「1」、「2」、「3」が表記されている。 Specifically, the control function 341 recognizes the operating status of the sample testing devices 10A, 10B, and 10C, and includes an area 110 for accepting selection of test items and an area 120 for displaying the operating status of the sample testing device 10A. The area 130 for displaying the operating state of the sample testing device 10B and the area 130 for displaying the operating state of the sample testing device 10C are overlapped and displayed on the display 411. For example, the areas 110, 120, 130, and 140 include tabs having different display positions, and the tabs of the areas 110, 120, 130, and 140 are used to identify the areas 110, 120, 130, and 140, respectively. "Item", "1", "2", "3" are written.
 まず、制御機能341は、領域110の全体と、領域120、130、140のタブのみとをディスプレイ411に表示させる。この場合、領域110には、検査項目の選択を受け付ける検査項目欄111、112、113が表示される。例えば、検査項目欄111、112、113は、行毎に表示されていて、表示されている行を選ぶことにより、検査項目が選択される。 First, the control function 341 displays the entire area 110 and only the tabs of the areas 120, 130, and 140 on the display 411. In this case, the inspection item columns 111, 112, 113 that accept the selection of the inspection item are displayed in the area 110. For example, the inspection item columns 111, 112, and 113 are displayed for each line, and the inspection item is selected by selecting the displayed line.
 検査項目欄111には、検査項目「ウイルスA」、検体である患者のID「111111」、氏名「YYYY」、使用状態「3」が表示される。ここで、検査項目欄111の使用状態「3」とは、検体検査装置10Cにより、ID「111111」、氏名「YYYY」の患者に対して、「ウイルスA」の検査が実施されていることを意味する。この場合、検体検査装置10Cは、検査を実施している検体検査装置であり、検査項目欄111は、ユーザにより選択できない状態となっている。 In the test item column 111, the test item "virus A", the ID "111111" of the patient as a sample, the name "YYYY", and the usage status "3" are displayed. Here, the usage state "3" in the test item column 111 means that the sample test device 10C is testing the patient with the ID "111111" and the name "YYYY" for "virus A". means. In this case, the sample test device 10C is a sample test device that is performing the test, and the test item column 111 cannot be selected by the user.
 検査項目欄112には、検査項目「ウイルスA」、検体である患者のID「123456」、氏名「XXXX」、使用状態「待機」が表示される。ここで、検査項目欄112の使用状態「待機」とは、ID「123456」、氏名「XXXX」の患者に対して、「ウイルスA」の検査が実施されていないことを意味する。また、検査項目欄113には、検査項目「ウイルスB」、検体である患者のID「123456」、氏名「XXXX」、使用状態「待機」が表示される。ここで、検査項目欄113の使用状態「待機」とは、ID「123456」、氏名「XXXX」の患者に対して、「ウイルスB」の検査が実施されていないことを意味する。この場合、検体検査装置10A、10Bは、検査を実施していない検体検査装置であり、検査項目欄112、113は、ユーザにより選択可能な状態となっている。 In the test item column 112, the test item "virus A", the patient ID "123456" as a sample, the name "XXXX", and the usage status "standby" are displayed. Here, the usage state "standby" in the test item column 112 means that the test for "virus A" has not been performed on the patient with the ID "123456" and the name "XXXX". Further, in the test item column 113, the test item "virus B", the ID "123456" of the patient as a sample, the name "XXXX", and the usage state "standby" are displayed. Here, the usage state "standby" in the test item column 113 means that the test for "virus B" has not been performed on the patient with the ID "123456" and the name "XXXX". In this case, the sample test devices 10A and 10B are sample test devices that have not been tested, and the test item columns 112 and 113 are in a state that can be selected by the user.
 ここで、ユーザにより検査項目欄112、113が選択された場合、制御機能341は、検出対象として検査項目「ウイルスA」、「ウイルスB」の選択を受け付ける。例えば、検査項目欄112、113に表示されている患者は、ID「123456」、氏名「XXXX」の患者であるため、ユーザにより検査項目欄112又は検査項目欄113が選択された場合、制御機能341は、検出対象として検査項目「ウイルスA」、「ウイルスB」の選択を受け付ける。 Here, when the inspection item fields 112 and 113 are selected by the user, the control function 341 accepts the selection of the inspection items "virus A" and "virus B" as detection targets. For example, since the patients displayed in the test item fields 112 and 113 are patients with the ID "123456" and the name "XXXX", when the test item field 112 or the test item field 113 is selected by the user, the control function 341 accepts selection of inspection items "virus A" and "virus B" as detection targets.
 図5のステップS101では、検体検査装置10Aの制御機能341は、選択された検出対象として検査項目を各検体検査装置に割り当てる。 In step S101 of FIG. 5, the control function 341 of the sample testing device 10A assigns a test item to each sample testing device as a selected detection target.
 具体的には、制御機能341は、検体検査装置10A、10B、10Cの中から、検査可能な検体検査装置を選択する。例えば、制御機能341は、インジケータ35を発光させる後述の指示が送られていない検体検査装置10A、10Bを選択する。そして、制御機能341は、ステップS100において選択を受け付けた検査項目「ウイルスA」、「ウイルスB」を、それぞれ、検体検査装置10A、10Bに割り当てる。 Specifically, the control function 341 selects a sample testing device that can be tested from the sample testing devices 10A, 10B, and 10C. For example, the control function 341 selects the sample testing devices 10A and 10B to which the instruction described later for causing the indicator 35 to emit light is not sent. Then, the control function 341 assigns the test items “virus A” and “virus B” selected in step S100 to the sample test devices 10A and 10B, respectively.
 又は、制御機能341は、検体検査装置10A、10B、10Cの中から、検査可能な検体検査装置の一覧を表示した上で、検査可能な検体検査装置の選択を、入力装置42を介して受け付ける。例えば、制御機能341は、入力装置42の操作により、検査可能な検体検査装置10A、10Bの選択を受け付ける。そして、制御機能341は、ステップS100において選択を受け付けた検査項目「ウイルスA」、「ウイルスB」を、それぞれ、検体検査装置10A、10Bに割り当てる。 Alternatively, the control function 341 displays a list of testable sample test devices from the sample test devices 10A, 10B, and 10C, and then accepts the selection of the testable sample test device via the input device 42. .. For example, the control function 341 accepts selection of testable sample testing devices 10A and 10B by operating the input device 42. Then, the control function 341 assigns the test items “virus A” and “virus B” selected in step S100 to the sample test devices 10A and 10B, respectively.
 図5のステップS102では、検体検査装置10Aによる検査項目「ウイルスA」の検査が実施され、検体検査装置10Bによる検査項目「ウイルスB」の検査が実施される。 In step S102 of FIG. 5, the test item "virus A" is inspected by the sample inspection device 10A, and the inspection item "virus B" is inspected by the sample inspection device 10B.
 まず、検体検査装置10Aによる検査項目「ウイルスA」の検査について説明する。 First, the inspection of the inspection item "virus A" by the sample inspection apparatus 10A will be described.
 図6のステップS110では、検体検査装置10Aの制御機能341は、検査項目「ウイルスA」に色分けされた緑色で、検体検査装置10Aのインジケータ35を点灯させる。 In step S110 of FIG. 6, the control function 341 of the sample test device 10A lights the indicator 35 of the sample test device 10A in green color-coded according to the test item “virus A”.
 具体的には、検体検査装置10Aの制御機能341は、検査項目「ウイルスA」の検査の実施前において、緑色で点灯するように、検体検査装置10Aのインジケータ35を制御する。例えば、図8Bに示すように、検体検査装置10Aの制御機能341は、緑色で、検体検査装置10Aのインジケータ35を点灯させる。 Specifically, the control function 341 of the sample test device 10A controls the indicator 35 of the sample test device 10A so that it lights up in green before the test of the test item "virus A" is performed. For example, as shown in FIG. 8B, the control function 341 of the sample testing device 10A is green and lights the indicator 35 of the sample testing device 10A.
 なお、検体検査装置10Aの制御機能341は、検査項目「ウイルスA」を表す色で点灯するように、検体検査装置10Aのインジケータ35を制御しているが、これに限定されない。例えば、インジケータ35が文字列を表示可能である発光部を有する場合、検体検査装置10Aの制御機能341は、検査項目「ウイルスA」を文字列で表示するように、検体検査装置10Aのインジケータ35を制御してもよい。 Note that the control function 341 of the sample test device 10A controls the indicator 35 of the sample test device 10A so as to light up in a color indicating the test item "virus A", but the present invention is not limited to this. For example, when the indicator 35 has a light emitting unit capable of displaying a character string, the control function 341 of the sample test device 10A displays the test item "virus A" as a character string, so that the indicator 35 of the sample test device 10A is displayed. May be controlled.
 図6のステップS111では、検体検査装置10Aの制御機能341は、検体検査装置10Aにより実施される検査のガイド情報として、カバー20を開けるためのガイド情報をディスプレイ411に表示させる。 In step S111 of FIG. 6, the control function 341 of the sample test device 10A displays the guide information for opening the cover 20 on the display 411 as the guide information of the test performed by the sample test device 10A.
 具体的には、図8Cに示すように、検体検査装置10Aのディスプレイ411に表示されている領域120のタブは、緑色で表記されている。ここで、ユーザは、検体検査装置10Aのインジケータ35に点灯している色と同色である緑色で表記された領域120のタブを選択したものとする。この場合、制御機能341は、領域120の全体と、領域110、130、140のタブのみとをディスプレイ411に表示させる。この場合、領域120には、欄121、122、123、124が表示される。欄121には、検査項目「ウイルスA」が表示される。欄122には、検体である患者のID「123456」、氏名「XXXX」が表示される。欄123には、検体検査装置10Aのカバー20を開けるためのガイド情報として、例えば、メッセージ「ランプが点灯している機器のカバーを開けてください。」が表示される。欄124には、欄123のガイド情報がイラストで表示される。 Specifically, as shown in FIG. 8C, the tab of the area 120 displayed on the display 411 of the sample testing device 10A is shown in green. Here, it is assumed that the user has selected the tab of the area 120 indicated in green, which is the same color as the color lit on the indicator 35 of the sample testing device 10A. In this case, the control function 341 causes the display 411 to display the entire area 120 and only the tabs of the areas 110, 130, and 140. In this case, columns 121, 122, 123, 124 are displayed in the area 120. The inspection item "virus A" is displayed in column 121. In column 122, the ID "123456" and the name "XXXX" of the patient as a sample are displayed. In the column 123, for example, the message "Please open the cover of the device in which the lamp is lit" is displayed as guide information for opening the cover 20 of the sample testing device 10A. In the column 124, the guide information of the column 123 is displayed as an illustration.
 図6のステップS112では、検体検査装置10Aの検知ユニット31は、本体部30からカバー20が開けられたことを検出したときに、カバー20が開けられたことを表す情報を出力する。 In step S112 of FIG. 6, when the detection unit 31 of the sample inspection device 10A detects that the cover 20 has been opened from the main body 30, it outputs information indicating that the cover 20 has been opened.
 図6のステップS113では、検体検査装置10Aの制御機能341は、カバー20が開けられたことを表す情報に応じて、検体検査装置10Aにより実施される検査のガイド情報として、生体反応デバイス2を装着させるためのガイド情報をディスプレイ411に表示させる。 In step S113 of FIG. 6, the control function 341 of the sample test device 10A uses the biological reaction device 2 as guide information for the test performed by the sample test device 10A according to the information indicating that the cover 20 has been opened. The guide information for mounting is displayed on the display 411.
 具体的には、図8Dに示すように、検体検査装置10Aのディスプレイ411に表示されている領域120において、欄123には、検体検査装置10Aに生体反応デバイス2を装着させるためのガイド情報として、例えば、メッセージ「検査カートリッジを取り付けてください。」が表示される。欄124には、欄123のガイド情報がイラストで表示される。 Specifically, as shown in FIG. 8D, in the area 120 displayed on the display 411 of the sample test device 10A, the column 123 provides guide information for mounting the biological reaction device 2 on the sample test device 10A. , For example, the message "Please install the inspection cartridge." Is displayed. In the column 124, the guide information of the column 123 is displayed as an illustration.
 図6のステップS114では、検体検査装置10Aの読取装置313は、検体検査装置10Aに装着された生体反応デバイス2の種類を確認する。 In step S114 of FIG. 6, the reading device 313 of the sample testing device 10A confirms the type of the biological reaction device 2 mounted on the sample testing device 10A.
 具体的には、読取装置313は、検体検査装置10Aに生体反応デバイス2が装着されたときに、生体反応デバイス2の裏面に印刷されたQRコード(登録商標)2aから生体反応デバイス2の種類を読み取り、当該生体反応デバイス2の種類を表す読取情報を出力する。このとき、検体検査装置10Aの制御機能341は、読取装置313から出力された読取情報を取得する。 Specifically, the reading device 313 is a type of the biological reaction device 2 from the QR code (registered trademark) 2a printed on the back surface of the biological reaction device 2 when the biological reaction device 2 is attached to the sample testing device 10A. Is read, and reading information indicating the type of the biological reaction device 2 is output. At this time, the control function 341 of the sample inspection device 10A acquires the reading information output from the reading device 313.
 図6のステップS115では、検体検査装置10Aの制御機能341は、検体検査装置10Aに割り当てた検査項目「ウイルスA」と、取得した読取情報が表す生体反応デバイス2の種類とを照合し、生体反応デバイス2の種類が検査項目「ウイルスA」に用いられるデバイスであるか否かを表す照合結果をディスプレイ411に表示させる。 In step S115 of FIG. 6, the control function 341 of the sample test device 10A collates the test item “virus A” assigned to the sample test device 10A with the type of the biological reaction device 2 represented by the acquired read information, and the living body. The display 411 displays the collation result indicating whether or not the type of the reaction device 2 is the device used for the inspection item “virus A”.
 例えば、読取情報が表す生体反応デバイス2の種類が、検体検査装置10Aに割り当てた検査項目「ウイルスA」の検査用の生体反応デバイス2ではないものとする。すなわち、ウイルスA検査用の生体反応デバイス2が検体検査装置10Aに正しく装着されていない場合(図6のステップS115;No)、検体検査装置10Aの制御機能341は、検体検査装置10Aに装着された生体反応デバイス2の種類が間違えていることを、例えば、ポップアップ画面などでユーザに通知する。その後、再度、ステップS113の処理が行われる。 For example, it is assumed that the type of the biological reaction device 2 represented by the read information is not the biological reaction device 2 for testing the test item "virus A" assigned to the sample test device 10A. That is, when the biological reaction device 2 for virus A test is not correctly attached to the sample test device 10A (step S115; No in FIG. 6), the control function 341 of the sample test device 10A is attached to the sample test device 10A. The user is notified by, for example, a pop-up screen that the type of the biological reaction device 2 is wrong. After that, the process of step S113 is performed again.
 例えば、読取情報が表す生体反応デバイス2の種類が、検体検査装置10Aに割り当てた検査項目「ウイルスA」の検査用の生体反応デバイス2であるものとする。すなわち、ウイルスA検査用の生体反応デバイス2が検体検査装置10Aに正しく装着されている場合(図6のステップS115;Yes)、ステップS116の処理が行われる。 For example, it is assumed that the type of the biological reaction device 2 represented by the read information is the biological reaction device 2 for testing the test item "virus A" assigned to the sample test device 10A. That is, when the biological reaction device 2 for virus A test is correctly attached to the sample test device 10A (step S115; Yes in FIG. 6), the process of step S116 is performed.
 図6のステップS116では、検体検査装置10Aの制御機能341は、検体検査装置10Aにより実施される検査のガイド情報として、生体反応デバイス2への送液を促すガイド情報をディスプレイ411に表示させる。 In step S116 of FIG. 6, the control function 341 of the sample test device 10A displays the guide information prompting the liquid delivery to the biological reaction device 2 on the display 411 as the guide information of the test performed by the sample test device 10A.
 具体的には、図8Eに示すように、検体検査装置10Aのディスプレイ411に表示されている領域120において、欄123には、生体反応デバイス2の孔21aから反応容器201に試料溶液と試薬との混合液202を注入するよう促すガイド情報として、例えば、メッセージ「検査カートリッジに送液してください。」が表示される。欄124には、欄123のガイド情報がイラストで表示される。 Specifically, as shown in FIG. 8E, in the region 120 displayed on the display 411 of the sample testing device 10A, the column 123 contains the sample solution and the reagent from the hole 21a of the biological reaction device 2 to the reaction vessel 201. As guide information prompting to inject the mixed solution 202 of the above, for example, the message "Please send the solution to the inspection cartridge" is displayed. In the column 124, the guide information of the column 123 is displayed as an illustration.
 図6のステップS117では、検体検査装置10Aの制御機能341は、生体反応デバイス2への送液を促すガイド情報をディスプレイ411に表示させてから、所定時間が経過したときに、検体検査装置10Aにより実施される検査のガイド情報として、カバー20を閉じるためのガイド情報をディスプレイ411に表示させる。 In step S117 of FIG. 6, the control function 341 of the sample testing device 10A displays the guide information prompting the liquid to be sent to the biological reaction device 2 on the display 411, and when a predetermined time has elapsed, the sample testing device 10A As the guide information for the inspection carried out by the above, the guide information for closing the cover 20 is displayed on the display 411.
 具体的には、図8Fに示すように、検体検査装置10Aのディスプレイ411に表示されている領域120において、欄123には、カバー20を閉じるためのガイド情報として、例えば、メッセージ「カバーを閉じてください。検査を開始します。」が表示される。欄124には、欄123のガイド情報がイラストで表示される。 Specifically, as shown in FIG. 8F, in the area 120 displayed on the display 411 of the sample test apparatus 10A, the column 123 contains, for example, the message “Close the cover” as guide information for closing the cover 20. Please. The inspection will start. ”Is displayed. In the column 124, the guide information of the column 123 is displayed as an illustration.
 図6のステップS118では、検体検査装置10Aの検知ユニット31は、本体部30にカバー20が閉じられたことを検出したときに、カバー20が閉じられたことを表す情報を出力する。 In step S118 of FIG. 6, when the detection unit 31 of the sample inspection device 10A detects that the cover 20 is closed in the main body 30, it outputs information indicating that the cover 20 is closed.
 図6のステップS119では、検体検査装置10Aの測定機能343は、カバー20が閉じられたことを表す情報に応じて、検体検査装置10Aにより実施される検査を開始する。同時に、検体検査装置10Aの制御機能341は、検査項目「ウイルスA」に色分けされた緑色で、検体検査装置10Aのインジケータ35を点滅させる。 In step S119 of FIG. 6, the measurement function 343 of the sample test device 10A starts the test performed by the sample test device 10A according to the information indicating that the cover 20 is closed. At the same time, the control function 341 of the sample test device 10A blinks the indicator 35 of the sample test device 10A in green color-coded according to the test item “virus A”.
 具体的には、検体検査装置10Aの制御機能341は、検査項目「ウイルスA」の検査の実施中において、緑色で点滅するように、検体検査装置10Aのインジケータ35を制御する。このように、検体検査装置10Aの制御機能341は、検査の実施前と実施中とで異なる発光形態で発光するように、検体検査装置10Aのインジケータ35を制御する。 Specifically, the control function 341 of the sample test device 10A controls the indicator 35 of the sample test device 10A so as to blink in green during the test of the test item "virus A". In this way, the control function 341 of the sample test device 10A controls the indicator 35 of the sample test device 10A so as to emit light in different light emission modes before and during the test.
 図6のステップS119では、検体検査装置10Aの制御機能341は、測定機能343の検査が終了したか否かを監視する。 In step S119 of FIG. 6, the control function 341 of the sample inspection device 10A monitors whether or not the inspection of the measurement function 343 is completed.
 測定機能343の検査が終了していない場合(図6のステップS119;No)、再度、ステップS119の処理が行われる。 If the inspection of the measurement function 343 is not completed (step S119; No in FIG. 6), the process of step S119 is performed again.
 一方、測定機能343の検査が終了した場合(図6のステップS119;Yes)、検体検査装置10Aの測定機能343は、検査項目「ウイルスA」の検査結果を記憶回路33に記憶させ、ステップS120の処理が行われる。 On the other hand, when the test of the measurement function 343 is completed (step S119; Yes in FIG. 6), the measurement function 343 of the sample test device 10A stores the test result of the test item “virus A” in the storage circuit 33, and steps S120. Is processed.
 図6のステップS120では、検体検査装置10Aの制御機能341は、検体検査装置10Aのインジケータ35を消灯する。 In step S120 of FIG. 6, the control function 341 of the sample test device 10A turns off the indicator 35 of the sample test device 10A.
 図6のステップS121では、検体検査装置10Aの制御機能341は、測定機能343により実施された検査項目「ウイルスA」の検査結果を出力装置41に出力させる。例えば、制御機能341は、出力装置41として、ディスプレイ411やプリンタ412を制御し、検査結果をユーザに提示する。具体的には、制御機能341は、検査結果をディスプレイ411に表示したり、プリンタで印刷したりすることにより、ユーザに提示する。 In step S121 of FIG. 6, the control function 341 of the sample test device 10A causes the output device 41 to output the test result of the test item “virus A” carried out by the measurement function 343. For example, the control function 341 controls the display 411 and the printer 412 as the output device 41, and presents the inspection result to the user. Specifically, the control function 341 presents the inspection result to the user by displaying it on the display 411 or printing it with a printer.
 次に、検体検査装置10Bによる検査項目「ウイルスB」の検査について説明する。検体検査装置10Aの制御機能341は、以下のように、スレーブの検体検査装置である検体検査装置10Bの制御に用いられる制御情報を通信機能342から送信させ、かつ、検体検査装置10Bから受信した検出結果を処理する。 Next, the inspection of the inspection item "virus B" by the sample inspection apparatus 10B will be described. The control function 341 of the sample test device 10A causes the communication function 342 to transmit control information used for controlling the sample test device 10B, which is a slave sample test device, and receives the control information from the sample test device 10B as follows. Process the detection result.
 図7のステップS130では、検体検査装置10Aの制御機能341は、検査項目「ウイルスB」に色分けされた青色で、検体検査装置10Bのインジケータ35を点灯させるよう指示する。 In step S130 of FIG. 7, the control function 341 of the sample test device 10A instructs the sample test device 10B to light the indicator 35 in blue color-coded for the test item “virus B”.
 具体的には、検体検査装置10Aの制御機能341は、検査項目「ウイルスB」の検査の実施前において、青色で点灯するように、検体検査装置10Bのインジケータ35を制御する。この場合、検体検査装置10Aの制御機能341は、制御信号として、検査項目「ウイルスB」に応じた青色でインジケータ35を点灯させるための点灯指示を、通信機能342を介して、検体検査装置10Bに送信する。ここで、制御信号または点灯指示は、「制御情報」の一例である。 Specifically, the control function 341 of the sample test device 10A controls the indicator 35 of the sample test device 10B so that it lights up in blue before the test of the test item "virus B" is performed. In this case, the control function 341 of the sample test device 10A gives a lighting instruction for lighting the indicator 35 in blue corresponding to the test item "virus B" as a control signal via the communication function 342 of the sample test device 10B. Send to. Here, the control signal or the lighting instruction is an example of "control information".
 なお、検体検査装置10Aの制御機能341は、検査項目「ウイルスB」を表す色で点灯するように、検体検査装置10Bのインジケータ35を制御しているが、これに限定されない。例えば、インジケータ35が文字列を表示可能である発光部を有する場合、検体検査装置10Aの制御機能341は、検査項目「ウイルスB」を文字列で表示するように、検体検査装置10Bのインジケータ35を制御してもよい。 Note that the control function 341 of the sample test device 10A controls the indicator 35 of the sample test device 10B so as to light up in a color indicating the test item "virus B", but the present invention is not limited to this. For example, when the indicator 35 has a light emitting unit capable of displaying a character string, the control function 341 of the sample test device 10A displays the test item "virus B" as a character string, so that the indicator 35 of the sample test device 10B is displayed. May be controlled.
 図7のステップS131では、検体検査装置10Bの制御機能341は、検体検査装置10Aから送信された点灯指示に応じて、検査項目「ウイルスB」を表す色で、検体検査装置10Bのインジケータ35を点灯させる。 In step S131 of FIG. 7, the control function 341 of the sample test device 10B sets the indicator 35 of the sample test device 10B in a color representing the test item “virus B” in response to the lighting instruction transmitted from the sample test device 10A. Turn it on.
 図7のステップS132では、検体検査装置10Aの制御機能341は、検体検査装置10Bにより実施される検査のガイド情報として、カバー20を開けるためのガイド情報をディスプレイ411に表示させる。 In step S132 of FIG. 7, the control function 341 of the sample test device 10A displays the guide information for opening the cover 20 on the display 411 as the guide information of the test performed by the sample test device 10B.
 具体的には、図8Gに示すように、検体検査装置10Aのディスプレイ411に表示されている領域130のタブは、青色で表記されている。ここで、ユーザは、検体検査装置10Bのインジケータ35に点灯している色と同色である青色で表記された領域130のタブを選択したものとする。この場合、制御機能341は、領域130の全体と、領域110、120、140のタブのみとをディスプレイ411に表示させる。この場合、領域130には、欄131、132、133、134が表示される。欄131には、検査項目「ウイルスB」が表示される。欄132には、検体である患者のID「123456」、氏名「XXXX」が表示される。欄133には、検体検査装置10Bのカバー20を開けるためのガイド情報として、例えば、メッセージ「ランプが点灯している機器のカバーを開けてください。」が表示される。欄134には、欄133のガイド情報がイラストで表示される。 Specifically, as shown in FIG. 8G, the tab of the area 130 displayed on the display 411 of the sample testing device 10A is shown in blue. Here, it is assumed that the user has selected the tab of the area 130 indicated in blue, which is the same color as the color lit on the indicator 35 of the sample testing device 10B. In this case, the control function 341 causes the display 411 to display the entire area 130 and only the tabs of the areas 110, 120, and 140. In this case, columns 131, 132, 133, 134 are displayed in the area 130. The inspection item "virus B" is displayed in the column 131. In column 132, the ID "123456" and the name "XXXX" of the patient as a sample are displayed. In column 133, for example, the message "Please open the cover of the device in which the lamp is lit" is displayed as guide information for opening the cover 20 of the sample testing device 10B. In column 134, the guide information of column 133 is displayed as an illustration.
 また、ステップS132において、検体検査装置10Aの通信機能342は、カバー20を開けるためのガイド情報をディスプレイ411に表示したことを表す通知を、検体検査装置10Bに送信する。 Further, in step S132, the communication function 342 of the sample test device 10A transmits a notification indicating that the guide information for opening the cover 20 is displayed on the display 411 to the sample test device 10B.
 図7のステップS133では、検体検査装置10Bの検知ユニット31は、検体検査装置10Bの本体部30からカバー20が開けられたことを検出したときに、検体検査装置10Bのカバー20が開けられたことを表す情報を出力する。ここで、ステップS132の通知は、「制御情報」の一例である。例えば、検体検査装置10Bの通信機能342は、ステップS132の通知に対する返信として、検体検査装置10Bのカバー20が開けられたことを表す情報を、検体検査装置10Aに送信する。 In step S133 of FIG. 7, when the detection unit 31 of the sample test device 10B detects that the cover 20 has been opened from the main body 30 of the sample test device 10B, the cover 20 of the sample test device 10B is opened. The information indicating that is output. Here, the notification in step S132 is an example of "control information". For example, the communication function 342 of the sample test device 10B transmits information indicating that the cover 20 of the sample test device 10B has been opened to the sample test device 10A as a reply to the notification in step S132.
 図7のステップS134では、検体検査装置10Aの制御機能341は、検体検査装置10Bのカバー20が開けられたことを表す情報に応じて、検体検査装置10Bにより実施される検査のガイド情報として、生体反応デバイス2を検体検査装置10Bに装着させるためのガイド情報をディスプレイ411に表示させる。 In step S134 of FIG. 7, the control function 341 of the sample test device 10A serves as guide information for the test performed by the sample test device 10B according to the information indicating that the cover 20 of the sample test device 10B has been opened. Guide information for mounting the biological reaction device 2 on the sample test device 10B is displayed on the display 411.
 具体的には、検体検査装置10Aのディスプレイ411に表示されている領域130において、欄133には、検体検査装置10Bに生体反応デバイス2を装着させるためのガイド情報として、例えば、メッセージ「検査カートリッジを取り付けてください。」が表示される。欄134には、欄133のガイド情報がイラストで表示される。 Specifically, in the area 130 displayed on the display 411 of the sample test device 10A, column 133 contains, for example, the message "test cartridge" as guide information for mounting the biological reaction device 2 on the sample test device 10B. Please install. ”Is displayed. In column 134, the guide information of column 133 is displayed as an illustration.
 また、ステップS134において、検体検査装置10Aの通信機能342は、検体検査装置10Bに生体反応デバイス2を装着させるためのガイド情報をディスプレイ411に表示したことを表す通知を、検体検査装置10Bに送信する。 Further, in step S134, the communication function 342 of the sample test device 10A transmits to the sample test device 10B a notification indicating that the guide information for mounting the biological reaction device 2 on the sample test device 10B is displayed on the display 411. do.
 図7のステップS135では、検体検査装置10Bの読取装置313は、検体検査装置10Bに装着された生体反応デバイス2の種類を確認する。 In step S135 of FIG. 7, the reading device 313 of the sample testing device 10B confirms the type of the biological reaction device 2 mounted on the sample testing device 10B.
 具体的には、検体検査装置10Bの読取装置313は、検体検査装置10Bに生体反応デバイス2が装着されたときに、生体反応デバイス2の裏面に印刷されたQRコード(登録商標)2aから生体反応デバイス2の種類を読み取り、当該生体反応デバイス2の種類を表す読取情報を出力する。ここで、ステップS134の通知は、「制御情報」の一例である。例えば、検体検査装置10Bの通信機能342は、ステップS134の通知に対する返信として、検体検査装置10Bの読取装置313から出力された読取情報を、検体検査装置10Aに送信する。このとき、検体検査装置10Aの制御機能341は、検体検査装置10Bから出力された読取情報を取得する。 Specifically, the reading device 313 of the sample testing device 10B is a living body from the QR code (registered trademark) 2a printed on the back surface of the biological reaction device 2 when the biological reaction device 2 is attached to the sample testing device 10B. The type of the reaction device 2 is read, and the reading information indicating the type of the biological reaction device 2 is output. Here, the notification in step S134 is an example of "control information". For example, the communication function 342 of the sample testing device 10B transmits the reading information output from the reading device 313 of the sample testing device 10B to the sample testing device 10A as a reply to the notification in step S134. At this time, the control function 341 of the sample testing device 10A acquires the reading information output from the sample testing device 10B.
 図7のステップS136では、検体検査装置10Aの制御機能341は、検体検査装置10Bに割り当てた検査項目「ウイルスB」と、取得した読取情報が表す生体反応デバイス2の種類とを照合し、生体反応デバイス2の種類が検査項目「ウイルスB」に用いられるデバイスであるか否かを表す照合結果をディスプレイ411に表示させる。 In step S136 of FIG. 7, the control function 341 of the sample test device 10A collates the test item “virus B” assigned to the sample test device 10B with the type of the biological reaction device 2 represented by the acquired read information, and the living body. The display 411 displays a collation result indicating whether or not the type of the reaction device 2 is the device used for the inspection item “virus B”.
 例えば、読取情報が表す生体反応デバイス2の種類が、検体検査装置10Bに割り当てた検査項目「ウイルスB」の検査用の生体反応デバイス2ではないものとする。すなわち、ウイルスB検査用の生体反応デバイス2が検体検査装置10Bに正しく装着されていない場合(図7のステップS136;No)、検体検査装置10Aの制御機能341は、検体検査装置10Bの本体部30に装着された生体反応デバイス2の種類が間違えていることを、例えば、ポップアップ画面などでユーザに通知する。その後、再度、ステップS134の処理が行われる。 For example, it is assumed that the type of the biological reaction device 2 represented by the read information is not the biological reaction device 2 for testing the test item "virus B" assigned to the sample test device 10B. That is, when the biological reaction device 2 for virus B test is not correctly attached to the sample test device 10B (step S136; No in FIG. 7), the control function 341 of the sample test device 10A is the main body of the sample test device 10B. The user is notified by, for example, a pop-up screen that the type of the biological reaction device 2 attached to the 30 is wrong. After that, the process of step S134 is performed again.
 例えば、読取情報が表す生体反応デバイス2の種類が、検体検査装置10Bに割り当てた検査項目「ウイルスB」の検査用の生体反応デバイス2であるものとする。すなわち、ウイルスB検査用の生体反応デバイス2が検体検査装置10Bに正しく装着されている場合(図7のステップS136;Yes)、ステップS137の処理が行われる。 For example, it is assumed that the type of the biological reaction device 2 represented by the read information is the biological reaction device 2 for testing the test item "virus B" assigned to the sample testing device 10B. That is, when the biological reaction device 2 for virus B test is correctly attached to the sample test device 10B (step S136; Yes in FIG. 7), the process of step S137 is performed.
 図7のステップS137では、検体検査装置10Aの制御機能341は、検体検査装置10Bにより実施される検査のガイド情報として、検体検査装置10Bに装着された生体反応デバイス2への送液を促すガイド情報をディスプレイ411に表示させる。 In step S137 of FIG. 7, the control function 341 of the sample test device 10A guides the liquid to be sent to the biological reaction device 2 mounted on the sample test device 10B as guide information for the test performed by the sample test device 10B. The information is displayed on the display 411.
 具体的には、検体検査装置10Aのディスプレイ411に表示されている領域130において、欄133には、生体反応デバイス2の孔21aから反応容器201に試料溶液と試薬との混合液202を注入するよう促すガイド情報として、例えば、メッセージ「検査カートリッジに送液してください。」が表示される。欄134には、欄133のガイド情報がイラストで表示される。 Specifically, in the region 130 displayed on the display 411 of the sample testing device 10A, the mixed solution 202 of the sample solution and the reagent is injected into the reaction vessel 201 through the hole 21a of the biological reaction device 2 in the column 133. For example, the message "Please send the liquid to the inspection cartridge" is displayed as the guide information prompting the user. In column 134, the guide information of column 133 is displayed as an illustration.
 また、ステップS137において、検体検査装置10Aの通信機能342は、検体検査装置10Bに装着された生体反応デバイス2への送液を促すガイド情報をディスプレイ411に表示したことを表す通知を、検体検査装置10Bに送信する。 Further, in step S137, the communication function 342 of the sample test device 10A sends a notification indicating that the guide information prompting the liquid to be sent to the biological reaction device 2 mounted on the sample test device 10B is displayed on the display 411 for the sample test. It is transmitted to the device 10B.
 図7のステップS138では、検体検査装置10Aの制御機能341は、検体検査装置10Bに装着された生体反応デバイス2への送液を促すガイド情報をディスプレイ411に表示させてから、所定時間が経過したときに、検体検査装置10Bにより実施される検査のガイド情報として、検体検査装置10Bのカバー20を閉じるためのガイド情報をディスプレイ411に表示させる。 In step S138 of FIG. 7, a predetermined time has elapsed since the control function 341 of the sample test device 10A displays the guide information prompting the liquid delivery to the biological reaction device 2 mounted on the sample test device 10B on the display 411. At that time, as the guide information for the test performed by the sample test device 10B, the guide information for closing the cover 20 of the sample test device 10B is displayed on the display 411.
 具体的には、検体検査装置10Aのディスプレイ411に表示されている領域130において、欄133には、検体検査装置10Bのカバー20を閉じるためのガイド情報として、例えば、メッセージ「カバーを閉じてください。検査を開始します。」が表示される。欄134には、欄133のガイド情報がイラストで表示される。 Specifically, in the area 130 displayed on the display 411 of the sample testing device 10A, column 133 contains, for example, the message "Please close the cover" as guide information for closing the cover 20 of the sample testing device 10B. The inspection will start. ”Is displayed. In column 134, the guide information of column 133 is displayed as an illustration.
 また、ステップS138において、検体検査装置10Aの通信機能342は、検体検査装置10Bのカバー20を閉じるためのガイド情報をディスプレイ411に表示したことを表す通知を、検体検査装置10Bに送信する。 Further, in step S138, the communication function 342 of the sample test device 10A transmits a notification indicating that the guide information for closing the cover 20 of the sample test device 10B is displayed on the display 411 to the sample test device 10B.
 図7のステップS139では、検体検査装置10Bの検知ユニット31は、検体検査装置10Bの本体部30にカバー20が閉じられたことを検出したときに、検体検査装置10Bのカバー20が閉じられたことを表す情報を出力する。ここで、ステップS137、S138の通知は、「制御情報」の一例である。例えば、検体検査装置10Bの通信機能342は、ステップS137、S138の通知に対する返信として、検体検査装置10Bのカバー20が開けられたことを表す情報を、検体検査装置10Aに送信する。 In step S139 of FIG. 7, when the detection unit 31 of the sample test device 10B detects that the cover 20 is closed in the main body 30 of the sample test device 10B, the cover 20 of the sample test device 10B is closed. The information indicating that is output. Here, the notifications in steps S137 and S138 are examples of "control information". For example, the communication function 342 of the sample test device 10B transmits information indicating that the cover 20 of the sample test device 10B has been opened to the sample test device 10A as a reply to the notifications in steps S137 and S138.
 図7のステップS140では、検体検査装置10Aの制御機能341は、検査項目「ウイルスB」に色分けされた青色で、検体検査装置10Bのインジケータ35を点滅させる。 In step S140 of FIG. 7, the control function 341 of the sample test device 10A blinks the indicator 35 of the sample test device 10B in blue color-coded according to the test item “virus B”.
 具体的には、検体検査装置10Aの制御機能341は、検査項目「ウイルスB」の検査の実施中において、青色で点滅するように、検体検査装置10Bのインジケータ35を制御する。このように、検体検査装置10Aの制御機能341は、検査の実施前と実施中とで異なる発光形態で発光するように、検体検査装置10Bのインジケータ35を制御する。この場合、検体検査装置10Aの制御機能341は、制御信号として、検査項目「ウイルスB」に応じた青色でインジケータ35を点滅させるための点滅指示を、通信機能342を介して、検体検査装置10Bに送信する。ここで、制御信号または点滅指示は、「制御情報」の一例である。 Specifically, the control function 341 of the sample test device 10A controls the indicator 35 of the sample test device 10B so as to blink in blue during the test of the test item "virus B". In this way, the control function 341 of the sample test device 10A controls the indicator 35 of the sample test device 10B so as to emit light in different light emission modes before and during the test. In this case, the control function 341 of the sample test device 10A gives a blinking instruction for blinking the indicator 35 in blue corresponding to the test item "virus B" as a control signal via the communication function 342 of the sample test device 10B. Send to. Here, the control signal or the blinking instruction is an example of "control information".
 図7のステップS141では、検体検査装置10Bの制御機能341は、検体検査装置10Aから送信された点滅指示に応じて、検査項目「ウイルスB」を表す色で、検体検査装置10Bのインジケータ35を点滅させる。同時に、検体検査装置10Bの測定機能343は、点滅指示に応じて、検体検査装置10Bにより実施される検査を開始する。 In step S141 of FIG. 7, the control function 341 of the sample test device 10B sets the indicator 35 of the sample test device 10B in a color representing the test item “virus B” in response to the blinking instruction transmitted from the sample test device 10A. Make it blink. At the same time, the measurement function 343 of the sample test device 10B starts the test performed by the sample test device 10B in response to the blinking instruction.
 図7のステップS142では、検体検査装置10Bの制御機能341は、測定機能343の検査が終了したか否かを監視する。 In step S142 of FIG. 7, the control function 341 of the sample inspection device 10B monitors whether or not the inspection of the measurement function 343 is completed.
 測定機能343の検査が終了していない場合(図7のステップS142;No)、再度、ステップS119の処理が行われる。 If the inspection of the measurement function 343 is not completed (step S142; No in FIG. 7), the process of step S119 is performed again.
 一方、測定機能343の検査が終了した場合(図7のステップS142;Yes)、ステップS143の処理が行われる。 On the other hand, when the inspection of the measurement function 343 is completed (step S142; Yes in FIG. 7), the process of step S143 is performed.
 図7のステップS143では、検体検査装置10Bの通信機能342は、検体検査装置10Bにより実施される検査が終了したことを報告するための情報を、検体検査装置10Aに送信する。 In step S143 of FIG. 7, the communication function 342 of the sample test device 10B transmits information for reporting that the test performed by the sample test device 10B has been completed to the sample test device 10A.
 図7のステップS144では、検体検査装置10Aの制御機能341は、検体検査装置10Bにより実施される検査が終了したことを報告するための情報に応じて、検体検査装置10Bのインジケータ35を消灯させる。 In step S144 of FIG. 7, the control function 341 of the sample test device 10A turns off the indicator 35 of the sample test device 10B in response to the information for reporting that the test performed by the sample test device 10B has been completed. ..
 この場合、検体検査装置10Aの制御機能341は、制御信号として、インジケータ35を消灯させるための消灯指示を、通信機能342を介して、検体検査装置10Bに送信する。ここで、制御信号または消灯指示は、「制御情報」の一例である。 In this case, the control function 341 of the sample test device 10A transmits, as a control signal, a turn-off instruction for turning off the indicator 35 to the sample test device 10B via the communication function 342. Here, the control signal or the extinguishing instruction is an example of "control information".
 図7のステップS145では、検体検査装置10Bの制御機能341は、検体検査装置10Aから送信された消灯指示に応じて、検体検査装置10Bのインジケータ35を消灯させる。 In step S145 of FIG. 7, the control function 341 of the sample test device 10B turns off the indicator 35 of the sample test device 10B in response to the turn-off instruction transmitted from the sample test device 10A.
 図7のステップS146では、検体検査装置10Bの通信機能342は、消灯指示に応じて、検体検査装置10Bにより実施された検査項目「ウイルスB」の検査結果を、検体検査装置10Aに送信する。検体検査装置10Aの測定機能343は、検査項目「ウイルスB」の検査結果を記憶回路33に記憶させる。 In step S146 of FIG. 7, the communication function 342 of the sample test device 10B transmits the test result of the test item “virus B” carried out by the sample test device 10B to the sample test device 10A in response to the turn-off instruction. The measurement function 343 of the sample test device 10A stores the test result of the test item “virus B” in the storage circuit 33.
 図7のステップS147では、検体検査装置10Aの制御機能341は、検体検査装置10Bにより実施された検査項目「ウイルスB」の検査結果を出力装置41に出力させる。例えば、制御機能341は、出力装置41として、ディスプレイ411やプリンタ412を制御し、検査結果をユーザに提示する。具体的には、制御機能341は、検査結果をディスプレイ411に表示したり、プリンタで印刷したりすることにより、ユーザに提示する。 In step S147 of FIG. 7, the control function 341 of the sample test device 10A causes the output device 41 to output the test result of the test item “virus B” carried out by the sample test device 10B. For example, the control function 341 controls the display 411 and the printer 412 as the output device 41, and presents the inspection result to the user. Specifically, the control function 341 presents the inspection result to the user by displaying it on the display 411 or printing it with a printer.
 以上の説明により、本実施形態に係る検体検査装置10では、測定機能343は、検体に含まれる検出対象を検出する。入出力装置40は、検査に関する情報を表示するディスプレイ411、検査の検査結果を印刷するプリンタ412、及び、検査に関する情報の入力を受け付ける入力装置42を有する。通信機能342は、スレーブの検体検査装置10と通信を行う。ここで、スレーブの検体検査装置10は、測定機能343を有しているが、スレーブの検体検査装置10には入出力装置40が設けられていない。この場合、制御機能341は、スレーブの検体検査装置10の制御に用いられる制御情報を通信機能342から送信させる。例えば、マスターの検体検査装置10及びスレーブの検体検査装置10は、インジケータ35を更に備え、マスターの検体検査装置10の制御機能341は、制御情報を通信機能342から送信させることにより、検査を実施する装置として選択された検体検査装置10のインジケータ35を、当該検査の検出対象の種類に応じた色で発光するように制御する。また、制御機能341は、スレーブの検体検査装置10から受信した検出結果を処理する。なお、本実施形態では、スレーブの検体検査装置10に入出力装置40が設けられていない場合について説明したが、スレーブの検体検査装置10には、入出力装置40が設けられてもよい、または、マスターの検体検査装置10の入出力装置40とは異なる入出力装置が設けられてもよい。また、スレーブの検体検査装置10に入出力装置40が設けられていない場合について説明したが、スレーブの検体検査装置10には、検査の検査結果を印刷するプリンタ412が設けられてもよい。 According to the above description, in the sample inspection device 10 according to the present embodiment, the measurement function 343 detects the detection target included in the sample. The input / output device 40 includes a display 411 that displays information related to inspection, a printer 412 that prints inspection results of inspection, and an input device 42 that receives input of information related to inspection. The communication function 342 communicates with the slave sample inspection device 10. Here, the slave sample test device 10 has the measurement function 343, but the slave sample test device 10 is not provided with the input / output device 40. In this case, the control function 341 causes the communication function 342 to transmit control information used for controlling the slave sample inspection device 10. For example, the master sample test device 10 and the slave sample test device 10 further include an indicator 35, and the control function 341 of the master sample test device 10 carries out the test by transmitting control information from the communication function 342. The indicator 35 of the sample test device 10 selected as the device to perform the test is controlled so as to emit light in a color corresponding to the type of the detection target of the test. Further, the control function 341 processes the detection result received from the slave sample inspection device 10. In the present embodiment, the case where the slave sample inspection device 10 is not provided with the input / output device 40 has been described, but the slave sample inspection device 10 may be provided with the input / output device 40, or , An input / output device different from the input / output device 40 of the master sample test device 10 may be provided. Further, although the case where the input / output device 40 is not provided in the slave sample test device 10, the slave sample test device 10 may be provided with a printer 412 for printing the test results of the test.
 そこで、本実施形態における検体検査システムでは、マスターの検体検査装置10がスレーブの検体検査装置10を制御することにより、検査効率の向上を図ることができる。 Therefore, in the sample test system of the present embodiment, the test efficiency can be improved by controlling the slave sample test device 10 by the master sample test device 10.
 例えば、マスターの検体検査装置10がスレーブの検体検査装置10を制御することにより、ユーザは、何の検査を予定しているのかを把握することができる。具体的には、スレーブの検体検査装置10である検体検査装置10BによりウイルスBの検査が行われる場合、検体検査装置10Bは、検査項目「ウイルスB」に応じた青色で、インジケータ35を発光させている。このため、ユーザは、検体検査装置10Bのインジケータ35に発光された青色を視認することにより、ウイルスB検査用の生体反応デバイス2を検体検査装置10Bに装着することができる。これにより、本実施形態では、ユーザが見間違えなどにより検体検査装置10Bとは別の検体検査装置を使用するリスクが下がる。このように、本実施形態における検体検査システムでは、ユーザが正しく生体反応デバイス2を検体検査装置10に装着することができるため、検査効率が向上する。 For example, when the master sample test device 10 controls the slave sample test device 10, the user can grasp what test is planned. Specifically, when the virus B is tested by the sample test device 10B, which is the slave sample test device 10, the sample test device 10B causes the indicator 35 to emit light in blue corresponding to the test item "virus B". ing. Therefore, the user can attach the biological reaction device 2 for virus B testing to the sample testing device 10B by visually recognizing the blue light emitted from the indicator 35 of the sample testing device 10B. As a result, in the present embodiment, the risk of the user using a sample testing device different from the sample testing device 10B due to a mistake or the like is reduced. As described above, in the sample test system of the present embodiment, the user can correctly attach the biological reaction device 2 to the sample test device 10, so that the test efficiency is improved.
 また、マスターの検体検査装置10がスレーブの検体検査装置10を制御することにより、ユーザは、何を検査しているのかを把握することができる。具体的には、スレーブの検体検査装置10である検体検査装置10BによりウイルスBの検査が行われている場合、検査時において検体検査装置10Bのカバー20が閉じられているが、検体検査装置10Bは、検査項目「ウイルスB」に応じた青色で、インジケータ35を発光させている。このため、ユーザは、別の作業を行っているときに、画面表示している検体検査装置10Aに近づかなくても、現在、何の検査項目の検査が行われているのかを、検体検査装置10Bのインジケータ35の発光により、一目で確認することができる。このように、本実施形態における検体検査システムでは、ユーザが行っている作業を中断することなく、現在、何の検査項目の検査が行われているのかを確認することができるため、検査効率が向上する。 Further, by controlling the sample inspection device 10 of the master by the sample inspection device 10 of the master, the user can grasp what is being inspected. Specifically, when the virus B is tested by the sample test device 10B, which is the slave sample test device 10, the cover 20 of the sample test device 10B is closed at the time of the test, but the sample test device 10B Is blue according to the inspection item "virus B" and causes the indicator 35 to emit light. Therefore, when the user is performing another work, even if he / she does not approach the sample test device 10A displayed on the screen, the sample test device can determine what test item is currently being tested. It can be confirmed at a glance by the light emission of the indicator 35 of 10B. As described above, in the sample test system of the present embodiment, it is possible to confirm what test item is currently being tested without interrupting the work performed by the user, so that the test efficiency is improved. improves.
 なお、本実施形態における検体検査システムでは、検体検査装置10単体においても、検査効率の向上を図ることができる。 In the sample test system of the present embodiment, the test efficiency can be improved even with the sample test device 10 alone.
 例えば、マスターの検体検査装置10が、生体反応デバイス2を用いて、検体に含まれる検出対象を検出する検査を行う測定機能343と、異なる色を発光可能なインジケータ35と、制御機能341とを備えることにより、ユーザは、何の検査を予定しているのかを把握することができる。具体的には、制御機能341は、検出対象の種類に応じた色であって、生体反応デバイス2に色分けされた色、及び、生体反応デバイス2に反応させる試薬のパッケージに色分けされた色と同色で発光するように、インジケータ35を制御する。例えば、検体検査装置10によりウイルスAの検査が行われている場合、制御機能341は、検査項目「ウイルスA」に応じた緑色であって、ウイルスA検査用の生体反応デバイス2に色分けされた色、及び、ウイルスA検査用の生体反応デバイス2に反応させる試薬のパッケージに色分けされた色と同じ緑色で、インジケータ35を発光させる。このため、ユーザは、検体検査装置10のインジケータ35に発光された緑色を視認することにより、ウイルスA検査用の生体反応デバイス2を検体検査装置10に装着することができる。このように、本実施形態における検体検査システムでは、ユーザが正しく生体反応デバイス2を検体検査装置10に装着することができるため、検査効率が向上する。 For example, the master sample test device 10 uses the biological reaction device 2 to perform a test for detecting a detection target contained in the sample, a measurement function 343, an indicator 35 capable of emitting different colors, and a control function 341. By providing, the user can grasp what kind of inspection is planned. Specifically, the control function 341 is a color according to the type of the detection target, and is a color-coded color for the biological reaction device 2 and a color-coded color for the reagent package to react with the biological reaction device 2. The indicator 35 is controlled so as to emit light in the same color. For example, when the virus A is inspected by the sample inspection apparatus 10, the control function 341 is green according to the inspection item "virus A" and is color-coded into the biological reaction device 2 for the virus A inspection. The indicator 35 is made to emit light in the same green color as the color and the color-coded color in the package of the reagent to react with the biological reaction device 2 for virus A test. Therefore, the user can attach the biological reaction device 2 for virus A test to the sample test device 10 by visually recognizing the green light emitted from the indicator 35 of the sample test device 10. As described above, in the sample test system of the present embodiment, the user can correctly attach the biological reaction device 2 to the sample test device 10, so that the test efficiency is improved.
(その他の実施形態)
 これまで実施形態について説明したが、上述した実施形態以外にも、種々の異なる形態にて実施されてよいものである。
(Other embodiments)
Although the embodiments have been described so far, various different embodiments may be implemented in addition to the above-described embodiments.
 上述した実施形態では、マスターの検体検査装置10である検体検査装置10Aは、例えばHISサーバから検査オーダを受け付けたときの処理について説明したが、実施形態は、これに限定されるものではない。以下、検査オーダを受けずに行う処理について説明する。検査オーダを受けずに行う処理では、例えば、複数の検体検査装置10のうち、検査可能な検体検査装置10であって、ユーザにより選択された検体検査装置10に生体反応デバイス2が装着される。この場合、マスターの検体検査装置10である検体検査装置10Aは、選択された検体検査装置10による検査を受け付ける。 In the above-described embodiment, the sample testing device 10A, which is the master sample testing device 10, has described, for example, the processing when a test order is received from the HIS server, but the embodiment is not limited to this. Hereinafter, the processing performed without receiving the inspection order will be described. In the process performed without receiving the test order, for example, the biological reaction device 2 is attached to the sample test device 10 that can be tested among the plurality of sample test devices 10 and is selected by the user. .. In this case, the sample test device 10A, which is the master sample test device 10, accepts the test by the selected sample test device 10.
 図9、図10は、本実施形態の変形例における検体検査システム1による処理の手順を示すフローチャートである。 9 and 10 are flowcharts showing the procedure of processing by the sample test system 1 in the modified example of this embodiment.
 ここで、ユーザが、検査可能な検体検査装置10として検体検査装置10Aを選択し、検体検査装置10AにウイルスA検査用の生体反応デバイス2を装着した場合について、図9を用いて説明する。 Here, a case where the user selects the sample test device 10A as the testable sample test device 10 and attaches the biological reaction device 2 for virus A test to the sample test device 10A will be described with reference to FIG.
 図9における処理では、図6における処理に対して処理手順が異なり、例えば、ステップS111、S112、S114、S200、S110、S116~S122が実行される。ここで、図9における処理では、図6におけるステップS115に代えて、ステップS200が実行される。 In the process of FIG. 9, the process procedure is different from the process of FIG. 6, and for example, steps S111, S112, S114, S200, S110, and S116 to S122 are executed. Here, in the process of FIG. 9, step S200 is executed instead of step S115 of FIG.
 具体的には、図9に示すように、まず、ステップS111、S112、S114が実行される。例えば、ステップS114において、読取装置313は、検体検査装置10Aに生体反応デバイス2が装着されたときに、生体反応デバイス2の裏面に印刷されたQRコード(登録商標)2aから生体反応デバイス2の種類を読み取り、当該生体反応デバイス2の種類を表す読取情報を出力する。このとき、検体検査装置10Aの制御機能341は、読取装置313から出力された読取情報を取得する。その後、ステップS200の処理が行われる。 Specifically, as shown in FIG. 9, first, steps S111, S112, and S114 are executed. For example, in step S114, when the biological reaction device 2 is attached to the sample test device 10A, the reading device 313 transfers the biological reaction device 2 from the QR code (registered trademark) 2a printed on the back surface of the biological reaction device 2. The type is read, and the reading information indicating the type of the biological reaction device 2 is output. At this time, the control function 341 of the sample inspection device 10A acquires the reading information output from the reading device 313. After that, the process of step S200 is performed.
 図9のステップS200では、制御機能341は、取得した読取情報が表す生体反応デバイス2の種類から検出対象の検査を受け付ける。例えば、読取情報が表す生体反応デバイス2の種類は、ウイルスAの検査用の生体反応デバイス2である。この場合、制御機能341は、読取情報が表す生体反応デバイス2の種類に基づいて、検出対象として検査項目「ウイルスA」の検査を受け付ける。その後、ステップS110の処理が行われる。 In step S200 of FIG. 9, the control function 341 accepts the inspection of the detection target from the type of the biological reaction device 2 represented by the acquired read information. For example, the type of biological reaction device 2 represented by the read information is a biological reaction device 2 for testing virus A. In this case, the control function 341 accepts the inspection of the inspection item "virus A" as the detection target based on the type of the biological reaction device 2 represented by the read information. After that, the process of step S110 is performed.
 例えば、ステップS110において、制御機能341は、検査項目「ウイルスA」の検査の実施前において、緑色で点灯するように、検体検査装置10Aのインジケータ35を制御する。その後、ステップS116~S122が実行される。 For example, in step S110, the control function 341 controls the indicator 35 of the sample inspection device 10A so that it lights up in green before the inspection of the inspection item “virus A” is performed. After that, steps S116 to S122 are executed.
 次に、ユーザが、検査可能な検体検査装置10として検体検査装置10Bを選択し、検体検査装置10BにウイルスB検査用の生体反応デバイス2を装着した場合について、図10を用いて説明する。 Next, a case where the user selects the sample test device 10B as the testable sample test device 10 and attaches the biological reaction device 2 for virus B test to the sample test device 10B will be described with reference to FIG.
 図10における処理では、図7における処理に対して処理手順が異なり、例えば、ステップS132~135、S210、S130、S131、S137~S147が実行される。ここで、図10における処理では、図7におけるステップS136に代えて、ステップS210が実行される。 In the process shown in FIG. 10, the processing procedure is different from the process shown in FIG. 7, and for example, steps S132 to 135, S210, S130, S131, and S137 to S147 are executed. Here, in the process shown in FIG. 10, step S210 is executed instead of step S136 in FIG. 7.
 具体的には、図10に示すように、まず、ステップS132~S135が実行される。例えば、ステップS135において、検体検査装置10Bの読取装置313は、検体検査装置10Bに生体反応デバイス2が装着されたときに、生体反応デバイス2の裏面に印刷されたQRコード(登録商標)2aから生体反応デバイス2の種類を読み取り、当該生体反応デバイス2の種類を表す読取情報を出力する。このとき、検体検査装置10Bの通信機能342は、ステップS134の通知に対する返信として、検体検査装置10Bの読取装置313から出力された読取情報を、検体検査装置10Aに送信する。このとき、検体検査装置10Aの制御機能341は、検体検査装置10Bから出力された読取情報を取得する。その後、ステップS210の処理が行われる。 Specifically, as shown in FIG. 10, first, steps S132 to S135 are executed. For example, in step S135, the reading device 313 of the sample testing device 10B starts with the QR code (registered trademark) 2a printed on the back surface of the biological reaction device 2 when the biological reaction device 2 is attached to the sample testing device 10B. The type of the biological reaction device 2 is read, and the reading information indicating the type of the biological reaction device 2 is output. At this time, the communication function 342 of the sample testing device 10B transmits the reading information output from the reading device 313 of the sample testing device 10B to the sample testing device 10A as a reply to the notification in step S134. At this time, the control function 341 of the sample testing device 10A acquires the reading information output from the sample testing device 10B. After that, the process of step S210 is performed.
 図10のステップS210では、制御機能341は、取得した読取情報が表す生体反応デバイス2の種類から検出対象の検査を受け付ける。例えば、読取情報が表す生体反応デバイス2の種類は、ウイルスB検査用の生体反応デバイス2である。この場合、制御機能341は、読取情報が表す生体反応デバイス2の種類に基づいて、検出対象として検査項目「ウイルスB」の検査を受け付ける。その後、ステップS130、S131の処理が行われる。 In step S210 of FIG. 10, the control function 341 accepts the inspection of the detection target from the type of the biological reaction device 2 represented by the acquired read information. For example, the type of biological reaction device 2 represented by the read information is the biological reaction device 2 for virus B inspection. In this case, the control function 341 accepts the inspection of the inspection item "virus B" as the detection target based on the type of the biological reaction device 2 represented by the read information. After that, the processes of steps S130 and S131 are performed.
 例えば、ステップS130において、検体検査装置10Aの制御機能341は、検査項目「ウイルスB」の検査の実施前において、青色で点灯するように、検体検査装置10Bのインジケータ35を制御する。この場合、検体検査装置10Aの制御機能341は、制御信号として、検査項目「ウイルスB」に応じた青色でインジケータ35を点灯させるための点灯指示を、通信機能342を介して、検体検査装置10Bに送信する。 For example, in step S130, the control function 341 of the sample test device 10A controls the indicator 35 of the sample test device 10B so that it lights up in blue before the test of the test item “virus B” is performed. In this case, the control function 341 of the sample test device 10A gives a lighting instruction for lighting the indicator 35 in blue corresponding to the test item "virus B" as a control signal via the communication function 342 of the sample test device 10B. Send to.
 次に、ステップS131において、検体検査装置10Bの制御機能341は、検体検査装置10Aから送信された点灯指示に応じて、検査項目「ウイルスB」を表す色で、検体検査装置10Bのインジケータ35を点灯させる。その後、ステップS137~S147が実行される。 Next, in step S131, the control function 341 of the sample test device 10B sets the indicator 35 of the sample test device 10B in a color representing the test item “virus B” in response to the lighting instruction transmitted from the sample test device 10A. Turn it on. After that, steps S137 to S147 are executed.
 以上の説明により、本実施形態の変形例に係る検体検査装置10では、上述した効果に加えて、ユーザにより選択された検体検査装置10に生体反応デバイス2が装着された場合をトリガにして、当該選択された検体検査装置10による検査を受け付けることができる。 According to the above description, in the sample testing device 10 according to the modified example of the present embodiment, in addition to the above-mentioned effects, the case where the biological reaction device 2 is attached to the sample testing device 10 selected by the user is used as a trigger. It is possible to accept the inspection by the selected sample inspection apparatus 10.
 ここで、インジケータ35の構造について説明する。 Here, the structure of the indicator 35 will be described.
 図11は、本実施形態に係る検体検査装置10におけるインジケータ35の構造の一例である第1の構造を示す側断面図である。図11に示すように、インジケータ35は、基板351と、基板351に設けられたマルチカラーLED(Light Emitting Diode)352と、マルチカラーLED352を覆うケース353とを備える。 FIG. 11 is a side sectional view showing a first structure which is an example of the structure of the indicator 35 in the sample inspection device 10 according to the present embodiment. As shown in FIG. 11, the indicator 35 includes a substrate 351 and a multi-color LED (Light Emitting Diode) 352 provided on the substrate 351 and a case 353 that covers the multi-color LED 352.
 基板351は、検体検査装置10の本体部30の前面に設けられる。マルチカラーLED352は、基板351に設けられ、複数の色を発光可能な発光部である。例えば、マルチカラーLED352は、光の三原色である赤色(R)、緑色(G)、青色(B)の混合により任意の色を発光する。マルチカラーLED352は、任意の色を発光するために、赤色(R)、緑色(G)、青色(B)の3色のLEDが近接して配置されている。 The substrate 351 is provided on the front surface of the main body 30 of the sample inspection device 10. The multicolor LED 352 is a light emitting unit provided on the substrate 351 and capable of emitting a plurality of colors. For example, the multicolor LED 352 emits an arbitrary color by mixing red (R), green (G), and blue (B), which are the three primary colors of light. In the multicolor LED 352, three color LEDs of red (R), green (G), and blue (B) are arranged in close proximity in order to emit an arbitrary color.
 このようなマルチカラーLED352において、例えば茶色や灰色などの明度の低い色を発光させる際に、次のような場合が考えられる。まず、例えば外部からの光がマルチカラーLED352に入射したときの反射光により、ユーザは、当該LEDが発光しているか否かを区別し難い場合がある。すなわち、当該LEDが発光しない場合に、ユーザには暗く見えない場合がある。次に、マルチカラーLED352は、3色のLEDが近接して配置された構造であるため、光が均一に混合されない場合がある。 In such a multi-color LED 352, the following cases can be considered when emitting a low-brightness color such as brown or gray. First, for example, it may be difficult for the user to distinguish whether or not the LED is emitting light due to the reflected light when the light from the outside is incident on the multicolor LED 352. That is, when the LED does not emit light, it may not appear dark to the user. Next, since the multi-color LED 352 has a structure in which LEDs of three colors are arranged close to each other, the light may not be uniformly mixed.
 そこで、図11に示す例において、ケース353は、光混合部材353aと、遮光部材353bとを有する。 Therefore, in the example shown in FIG. 11, the case 353 has a light mixing member 353a and a light shielding member 353b.
 光混合部材353aは、ドーム形状であり、マルチカラーLED352により発光された複数の色を混合させる。光混合部材353aとしては、例えば、白色半透明樹脂が用いられる。遮光部材353bは、光混合部材353a上に設けられ、外部からの光を遮断する。遮光部材353bとしては、例えば、黒色の遮光塗料が用いられる。また、ドーム形状であるケース353の頂部には、遮光部材353bを貫通して光混合部材353aを露出する開口部353cが形成されている。 The light mixing member 353a has a dome shape and mixes a plurality of colors emitted by the multicolor LED 352. As the light mixing member 353a, for example, a white translucent resin is used. The light-shielding member 353b is provided on the light mixing member 353a and blocks light from the outside. As the light-shielding member 353b, for example, a black light-shielding paint is used. Further, at the top of the dome-shaped case 353, an opening 353c is formed which penetrates the light-shielding member 353b and exposes the light mixing member 353a.
 例えば、マルチカラーLED352により発光された複数の色は、光混合部材353aであるドーム形状の内壁に反射しながら、光混合部材353aにより混合される。光混合部材353aの構造では、開口部353cが形成された部分(露出部分)は肉薄であるため、光混合部材353aにより色が均一に混合された光は、開口部353cから出射される。 For example, a plurality of colors emitted by the multicolor LED 352 are mixed by the light mixing member 353a while being reflected by the dome-shaped inner wall of the light mixing member 353a. In the structure of the light mixing member 353a, the portion (exposed portion) where the opening 353c is formed is thin, so that the light in which the colors are uniformly mixed by the light mixing member 353a is emitted from the opening 353c.
 これにより、図11に示す例では、光混合部材353aにより色が均一に混合された光が開口部353cから出射される。また、図11に示す例では、遮光部材353bにより外部からマルチカラーLED352に入射する光を遮断するため、ユーザは、当該LEDが発光しているか否かを区別することができる。すなわち、当該LEDが発光しない場合に、ユーザには暗く見える。 As a result, in the example shown in FIG. 11, the light in which the colors are uniformly mixed by the light mixing member 353a is emitted from the opening 353c. Further, in the example shown in FIG. 11, since the light shielding member 353b blocks the light incident on the multi-color LED 352 from the outside, the user can distinguish whether or not the LED is emitting light. That is, when the LED does not emit light, it looks dark to the user.
 ここで、図11に示す例では、光混合部材353aにより色が均一に混合された光が、ドーム形状であるケース353の頂部に形成された開口部353cから出射されるため、出射される光の範囲が少ない。このため、視認性を向上させるために、光混合部材353aにより色が均一に混合された光を出射するための出射口を大きくする必要がある。そこで、図12に示す例では、出射口を大きくして、視認性を向上させている。 Here, in the example shown in FIG. 11, the light in which the colors are uniformly mixed by the light mixing member 353a is emitted from the opening 353c formed at the top of the dome-shaped case 353, so that the emitted light is emitted. The range of is small. Therefore, in order to improve the visibility, it is necessary to enlarge the exit port for emitting the light in which the colors are uniformly mixed by the light mixing member 353a. Therefore, in the example shown in FIG. 12, the exit port is enlarged to improve visibility.
 図12は、本実施形態に係る検体検査装置10におけるインジケータ35の構造の一例である第2の構造を示す側断面図である。図12に示すように、インジケータ35は、基板351と、基板351に設けられたマルチカラーLED352と、マルチカラーLED352を覆うケース354とを備えている。すなわち、図12に示す例では、インジケータ35は、図11に示す例におけるケース353に代えて、ケース354を備えている。ケース354は、光混合部材354aと、遮光部材354bと、減光部材354cとを有する。 FIG. 12 is a side sectional view showing a second structure which is an example of the structure of the indicator 35 in the sample inspection device 10 according to the present embodiment. As shown in FIG. 12, the indicator 35 includes a substrate 351 and a multi-color LED 352 provided on the substrate 351 and a case 354 that covers the multi-color LED 352. That is, in the example shown in FIG. 12, the indicator 35 includes a case 354 instead of the case 353 in the example shown in FIG. The case 354 has a light mixing member 354a, a light shielding member 354b, and a dimming member 354c.
 遮光部材354bは、ケース354の側面に設けられ、外部からの光を遮断する。遮光部材354bは、例えば、黒色の遮光塗料が用いられたケースである。光混合部材354aは、遮光部材354bのマルチカラーLED352と対向する位置に設けられ、マルチカラーLED352により発光された複数の色を混合させる。光混合部材354aとしては、例えば、白色半透明フィルムが用いられる。減光部材354cは、遮光部材354bと光混合部材354aとを覆う部材であり、光混合部材354aにより色が均一に混合された光が減光部材354cから出射される。減光部材354cとしては、例えば、ND(Neutral Density)フィルタなどの減光フィルムが用いられる。遮光部材354bと減光部材354cは、明度の低い色の視認性を向上させるために設けられる。 The light-shielding member 354b is provided on the side surface of the case 354 to block light from the outside. The light-shielding member 354b is, for example, a case in which a black light-shielding paint is used. The light mixing member 354a is provided at a position facing the multicolor LED 352 of the light shielding member 354b, and mixes a plurality of colors emitted by the multicolor LED 352. As the light mixing member 354a, for example, a white translucent film is used. The dimming member 354c is a member that covers the light-shielding member 354b and the light mixing member 354a, and the light in which the colors are uniformly mixed by the light mixing member 354a is emitted from the dimming member 354c. As the dimming member 354c, for example, a dimming film such as an ND (Neutral Density) filter is used. The light-shielding member 354b and the dimming member 354c are provided to improve the visibility of low-brightness colors.
 例えば、マルチカラーLED352により発光された複数の色は、光混合部材354aと基板351との間で反射されることで混合される。或いは、例えば、マルチカラーLED352により発光された複数の色は、光混合部材354aの内部で反射することで混合される。図12に示す例では、光混合部材354aが遮光されずに、光混合部材354a上に減光部材354cが設けられているため、光混合部材354aにより色が均一に混合された光は、減光部材354cから出射される。 For example, a plurality of colors emitted by the multicolor LED 352 are mixed by being reflected between the light mixing member 354a and the substrate 351. Alternatively, for example, a plurality of colors emitted by the multicolor LED 352 are mixed by being reflected inside the light mixing member 354a. In the example shown in FIG. 12, since the light mixing member 354a is not shielded from light and the dimming member 354c is provided on the light mixing member 354a, the light in which the colors are uniformly mixed by the light mixing member 354a is reduced. It is emitted from the optical member 354c.
 これにより、図12に示す例では、光混合部材354aにより色が均一に混合された光が減光部材354cから出射される。また、図12に示す例では、遮光部材354bにより外部からマルチカラーLED352に入射する光を遮断するため、ユーザは、当該LEDが発光しているか否かを区別することができる。すなわち、当該LEDが発光しない場合に、ユーザには暗く見える。更に、図12に示す例では、光混合部材354aにより色が均一に混合された光を出射するための出射口を、図11に示す例に比べて大きくすることができるため、視認性を向上させると共に、光混合部材354a上に減光部材354cが設けられていることにより、明度の低い色の視認性を向上させることができる。 As a result, in the example shown in FIG. 12, the light in which the colors are uniformly mixed by the light mixing member 354a is emitted from the dimming member 354c. Further, in the example shown in FIG. 12, since the light shielding member 354b blocks the light incident on the multi-color LED 352 from the outside, the user can distinguish whether or not the LED is emitting light. That is, when the LED does not emit light, it looks dark to the user. Further, in the example shown in FIG. 12, the exit port for emitting the light in which the colors are uniformly mixed by the light mixing member 354a can be made larger than that in the example shown in FIG. 11, so that the visibility is improved. In addition, by providing the dimming member 354c on the light mixing member 354a, the visibility of low-brightness colors can be improved.
 ここで、インジケータ35の調光について説明する。 Here, the dimming of the indicator 35 will be described.
 図13は、本実施形態に係る検体検査装置10におけるインジケータ35の調光の一例を説明するための図である。例えば、マスターの検体検査装置10である検体検査装置10Aにおいて、ユーザが入力装置42を用いてインジケータ35の調光を要求した場合、検体検査装置10Aの制御機能341は、当該要求を受け付けて、図13に示すような画面360をディスプレイ411に表示させる。図13において、画面360上の「LED1」、「LED2」、「LED3」は、インジケータ35を点灯させる色として、ユーザにより設定される。例えば、「LED1」、「LED2」は、それぞれ、検査項目「ウイルスA」、「ウイルスB」に色分けされた色として、ユーザにより設定される。 FIG. 13 is a diagram for explaining an example of dimming of the indicator 35 in the sample inspection device 10 according to the present embodiment. For example, in the sample test device 10A which is the master sample test device 10, when the user requests the dimming of the indicator 35 using the input device 42, the control function 341 of the sample test device 10A accepts the request and receives the request. The screen 360 as shown in FIG. 13 is displayed on the display 411. In FIG. 13, "LED1", "LED2", and "LED3" on the screen 360 are set by the user as colors for lighting the indicator 35. For example, "LED1" and "LED2" are set by the user as color-coded colors for the inspection items "virus A" and "virus B", respectively.
 図13に示す画面360では、検体検査装置10A、10B、10CのマルチカラーLED352において、光の三原色である赤色(R)、緑色(G)、青色(B)のLED(光源)の明るさをそれぞれ調整するための調整部361~363と、設定ボタン364とを有する。調整部361~363の各々は、ユーザが入力装置42を用いて色の値を調整するためのボタンを含み、設定される色の値が大きくなるほど、当該色の光源は明るくなる。図13において、色の値は、初期値として「0」が表示されている。例えば、ユーザが、調整部361~363の操作により、赤色(R)、緑色(G)、青色(B)の値を最大値に設定して、設定ボタン364を操作した場合には、インジケータ35から出射される光は白色になる。 In the screen 360 shown in FIG. 13, the brightness of the red (R), green (G), and blue (B) LEDs (light sources), which are the three primary colors of light, is displayed in the multicolor LEDs 352 of the sample inspection devices 10A, 10B, and 10C. Each has an adjusting unit 361 to 363 for adjusting and a setting button 364. Each of the adjusting units 361 to 363 includes a button for the user to adjust the color value using the input device 42, and the larger the set color value, the brighter the light source of the color. In FIG. 13, “0” is displayed as the initial value of the color value. For example, when the user operates the setting button 364 by setting the red (R), green (G), and blue (B) values to the maximum values by operating the adjustment units 361 to 363, the indicator 35 The light emitted from is white.
 また、ユーザが、調整部361~363の操作により、赤色(R)の値を最大値に設定し、緑色(G)、青色(B)の値を最小値に設定して、設定ボタン364を操作した場合には、インジケータ35から出射される光は赤色になる。同様に、ユーザが、調整部361~363の操作により、緑色(G)の値を最大値に設定し、赤色(R)、青色(B)の値を最小値に設定して、設定ボタン364を操作した場合には、インジケータ35から出射される光は緑色になる。同様に、ユーザが、調整部361~363の操作により、青色(B)の値を最大値に設定し、赤色(R)、緑色(G)の値を最小値に設定して、設定ボタン364を操作した場合には、インジケータ35から出射される光は、青色になる。 Further, the user sets the value of red (R) to the maximum value, sets the values of green (G) and blue (B) to the minimum value by operating the adjustment units 361 to 363, and presses the setting button 364. When operated, the light emitted from the indicator 35 turns red. Similarly, the user sets the green (G) value to the maximum value and the red (R) and blue (B) values to the minimum value by operating the adjustment units 361 to 363, and sets the setting button 364. When is operated, the light emitted from the indicator 35 turns green. Similarly, the user sets the blue (B) value to the maximum value and the red (R) and green (G) values to the minimum value by operating the adjustment units 361 to 363, and sets the setting button 364. When is operated, the light emitted from the indicator 35 becomes blue.
 このように、ユーザが、調整部361~363の操作により、赤色(R)、緑色(G)、青色(B)の値を任意の値に設定して、設定ボタン364を操作することにより、検体検査装置10Aの制御機能341は、インジケータ35から出射される光として、例えば茶色や灰色などの明度の低い色を発光させることができる。 In this way, the user sets the values of red (R), green (G), and blue (B) to arbitrary values by operating the adjustment units 361 to 363, and operates the setting button 364. The control function 341 of the sample test device 10A can emit a low-brightness color such as brown or gray as the light emitted from the indicator 35.
 ここで、インジケータ35の調光は、例えば、検体検査装置10が出荷される直前である出荷時、又は、検体検査装置10が病院等に設置される設置時に行われる。例えば、ユーザは、検査項目「ウイルスB」に色分けされた色として青色を設定する場合、調整部361~363の操作により、青色(B)の値を最大値に設定し、赤色(R)、緑色(G)の値を最小値に設定して、設定ボタン364を操作する。このとき、検体検査装置10Aの制御機能341は、ユーザが画面360上で設定した色を表す情報を、検査項目を表す情報と、当該検査項目の検査に用いられる生体反応デバイス2の種類を識別するQRコード(登録商標)2aを表す情報とを対応付けて、当該検体検査装置10Aの記憶回路33に格納する。 Here, the dimming of the indicator 35 is performed, for example, at the time of shipment immediately before the sample test device 10 is shipped, or at the time of installation when the sample test device 10 is installed in a hospital or the like. For example, when the user sets blue as the color-coded color for the inspection item "virus B", the user sets the value of blue (B) to the maximum value by operating the adjustment units 361 to 363, and red (R), Set the green (G) value to the minimum value and operate the setting button 364. At this time, the control function 341 of the sample inspection device 10A identifies the information representing the color set on the screen 360 by the user, the information representing the inspection item, and the type of the biological reaction device 2 used for the inspection of the inspection item. The information representing the QR code (registered trademark) 2a to be used is associated with the information and stored in the storage circuit 33 of the sample testing device 10A.
 例えば、本実施形態において、検体検査装置10Aの制御機能341は、HISサーバから検査オーダを受け付けたときに、ユーザにより検査項目「ウイルスA」、「ウイルスB」が選択された場合、検査項目「ウイルスA」、「ウイルスB」に色分けされた色として、それぞれ、ユーザが画面360上で設定した緑色、青色で、検査可能な検体検査装置である検体検査装置10A、10Bのインジケータ35を点灯させる。 For example, in the present embodiment, the control function 341 of the sample inspection device 10A receives the inspection item "virus A" or "virus B" when the inspection item "virus A" or "virus B" is selected by the user when the inspection order is received from the HIS server. The indicators 35 of the sample testing devices 10A and 10B, which are testable sample testing devices, are lit in green and blue, respectively, as the colors coded into "virus A" and "virus B" on the screen 360. ..
 また、本実施形態の変形例において、検体検査装置10Aの制御機能341は、当該検体検査装置10Aに装着された生体反応デバイス2のQRコード(登録商標)2aから当該生体反応デバイス2の種類を読取装置313が読み取ったときに、読み取った生体反応デバイス2の種類から検査項目「ウイルスA」の検査を受け付けた場合、検査項目「ウイルスA」に色分けされた色として、ユーザが画面360上で設定した緑色で、検査可能な検体検査装置である検体検査装置10Aのインジケータ35を点灯させる。 Further, in the modified example of the present embodiment, the control function 341 of the sample test device 10A obtains the type of the bioreaction device 2 from the QR code (registered trademark) 2a of the bioreaction device 2 attached to the sample test device 10A. When the reading device 313 receives the inspection of the inspection item "virus A" from the type of the read biological reaction device 2, the user displays the inspection item "virus A" on the screen 360 as a color-coded color. The indicator 35 of the sample testing device 10A, which is a testable sample testing device, is turned on in the set green color.
 このように、検体検査装置10Aの制御機能341は、検査オーダやQRコード(登録商標)2aから検査項目を受け付けた場合、受け付けた検査項目に色分けされた色として、ユーザが画面360上で設定した色で、インジケータ35を点灯させることができる。 In this way, when the test item is received from the test order or the QR code (registered trademark) 2a, the control function 341 of the sample test device 10A is set by the user on the screen 360 as a color-coded color for the received test item. The indicator 35 can be turned on with the specified color.
 以上説明した少なくとも1つの実施形態によれば、検査効率の向上を図ることができる。 According to at least one embodiment described above, the inspection efficiency can be improved.
 いくつかの実施形態を説明したが、これらの実施形態は、例として提示したものであり、発明の範囲を限定することは意図していない。これら実施形態は、その他の様々な形態で実施されることが可能であり、発明の要旨を逸脱しない範囲で、種々の省略、置き換え、変更、実施形態同士の組み合わせを行うことができる。これら実施形態やその変形は、発明の範囲や要旨に含まれると同様に、特許請求の範囲に記載された発明とその均等の範囲に含まれるものである。 Although some embodiments have been described, these embodiments are presented as examples and are not intended to limit the scope of the invention. These embodiments can be implemented in various other embodiments, and various omissions, replacements, changes, and combinations of embodiments can be made without departing from the gist of the invention. These embodiments and modifications thereof are included in the scope and gist of the invention, as well as in the scope of the invention described in the claims and the equivalent scope thereof.

Claims (20)

  1.  検体に含まれる検出対象を検出する検査部と、
     検査に関する情報を表示する表示部、及び、前記検査に関する情報の入力を受け付ける入力部を有する入出力部と、
     前記検査部を有するスレーブの検体検査装置と通信を行う通信部と、
     前記スレーブの検体検査装置の制御に用いられる制御情報を前記通信部から送信させ、かつ、前記スレーブの検体検査装置から受信した検出結果を処理する制御部と、
     を備える検体検査装置。
    An inspection unit that detects the detection target contained in the sample,
    A display unit that displays information related to inspection, an input / output unit that has an input unit that accepts input of information related to the inspection, and an input / output unit.
    A communication unit that communicates with a slave sample inspection device having the inspection unit,
    A control unit that transmits control information used for controlling the slave sample testing device from the communication unit and processes the detection result received from the slave sample testing device.
    Specimen testing device equipped with.
  2.  前記スレーブの検体検査装置は、前記入出力部が設けられていない、または、前記入出力部とは異なる入出力部を備えている、
     請求項1に記載の検体検査装置。
    The slave sample testing device is not provided with the input / output unit, or has an input / output unit different from the input / output unit.
    The sample testing device according to claim 1.
  3.  前記検査の検査結果を印刷する印刷部、
     を更に備え、
     前記スレーブの検体検査装置は、前記印刷部を備えていない、
     請求項1または2に記載の検体検査装置。
    A printing unit that prints the inspection results of the inspection,
    Further prepare
    The slave sample testing device does not include the printing unit.
    The sample testing device according to claim 1 or 2.
  4.  異なる色を発光可能なインジケータ、
     を更に備え、
     前記スレーブの検体検査装置は、前記インジケータを有し、
     前記制御部は、
     前記検査を実施する装置として自装置が選択された際は、当該検査の検出対象の種類に応じた色で発光するように、前記インジケータを制御し、
     前記検査を実施する装置として前記スレーブの検体検査装置が選択された際は、当該検査の検出対象の種類に応じた色で発光するように、前記スレーブの検体検査装置の前記インジケータを制御する、
     請求項1に記載の検体検査装置。
    Indicators that can emit different colors,
    Further prepare
    The slave sample testing device has the indicator.
    The control unit
    When the own device is selected as the device for performing the inspection, the indicator is controlled so as to emit light in a color corresponding to the type of the detection target of the inspection.
    When the slave sample test device is selected as the device for performing the test, the indicator of the slave sample test device is controlled so as to emit light in a color corresponding to the type of the detection target of the test.
    The sample testing device according to claim 1.
  5.  前記検査部は、デバイスを用いて、前記検査を行い、
     前記制御部は、前記検出対象の種類に応じた色であって、前記デバイスに色分けされた色、及び、前記デバイスに反応させる試薬のパッケージに色分けされた色と同色で発光するように、前記選択された検体検査装置の前記インジケータを制御する、
     請求項4に記載の検体検査装置。
    The inspection unit uses the device to perform the inspection.
    The control unit emits light in the same color as the color-coded color for the device and the color-coded color for the reagent package to react with the device, which is a color corresponding to the type of the detection target. Control the indicator of the selected specimen testing device,
    The sample testing device according to claim 4.
  6.  前記表示部は、検査オーダに基づいて実施予定の検査の一覧を表示し、
     前記制御部は、
     実施される検査の選択を、前記入力部を介して受け付け、
     前記選択を受け付けた前記検査を、前記選択された検体検査装置に割り当てる、
     請求項5に記載の検体検査装置。
    The display unit displays a list of inspections scheduled to be carried out based on the inspection order.
    The control unit
    The selection of the inspection to be performed is accepted via the input unit, and the selection is received.
    The test that has accepted the selection is assigned to the selected sample testing device.
    The sample testing device according to claim 5.
  7.  前記制御部は、前記自装置及び前記スレーブの検体検査装置の少なくとも1つを含む検体検査装置の中から、検査可能な検体検査装置を選択する、
     請求項6に記載の検体検査装置。
    The control unit selects a sample testing device that can be tested from among the sample testing devices including at least one of the own device and the slave sample testing device.
    The sample testing device according to claim 6.
  8.  前記表示部は、前記自装置及び前記スレーブの検体検査装置の少なくとも1つを含む検体検査装置の中から、検査可能な検体検査装置の一覧を表示し、
     前記制御部は、前記検査可能な検体検査装置の選択を、前記入力部を介して受け付ける、
     請求項6に記載の検体検査装置。
    The display unit displays a list of sample testing devices that can be tested from among the sample testing devices including at least one of the own device and the slave sample testing device.
    The control unit accepts the selection of the testable sample testing device via the input unit.
    The sample testing device according to claim 6.
  9.  前記制御部は、
     前記選択された検体検査装置に前記デバイスが装着されたとき、前記デバイスに設けられた識別子から前記デバイスの種類を取得し、
     前記選択された検体検査装置に割り当てた前記検査と、前記選択された検体検査装置から出力された前記デバイスの種類とを照合し、当該デバイスの種類が当該検査に用いられるデバイスであるか否かを表す照合結果を前記表示部に表示させる、
     請求項6に記載の検体検査装置。
    The control unit
    When the device is attached to the selected sample testing device, the type of the device is acquired from the identifier provided in the device, and the type of the device is acquired.
    The test assigned to the selected sample testing device is compared with the type of the device output from the selected sample testing device, and whether or not the type of the device is the device used for the test. The collation result representing the above is displayed on the display unit.
    The sample testing device according to claim 6.
  10.  前記制御部は、
     ユーザにより選択された検体検査装置に前記デバイスが装着されたとき、前記デバイスに設けられた識別子から前記デバイスの種類を取得し、
     前記選択された検体検査装置から出力された前記デバイスの種類に基づいて、前記検出対象の前記検査を受け付け、
     前記検査を受け付けた前記検出対象の種類に応じた色で発光するように、前記選択された検体検査装置の前記インジケータを制御する、
     請求項5に記載の検体検査装置。
    The control unit
    When the device is attached to the sample testing device selected by the user, the type of the device is acquired from the identifier provided in the device, and the type of the device is acquired.
    The test to be detected is accepted based on the type of the device output from the selected sample test device.
    The indicator of the selected sample test device is controlled so as to emit light in a color corresponding to the type of the detection target that has received the test.
    The sample testing device according to claim 5.
  11.  前記制御部は、前記検出対象の種類を文字列で表示するように、前記選択された検体検査装置の前記インジケータを制御する、
     請求項4に記載の検体検査装置。
    The control unit controls the indicator of the selected sample testing device so that the type of the detection target is displayed as a character string.
    The sample testing device according to claim 4.
  12.  前記制御部は、前記検査の実施前及び実施中において、前記検出対象の種類に応じた色で発光するように、前記選択された検体検査装置の前記インジケータを制御する、
     請求項4に記載の検体検査装置。
    The control unit controls the indicator of the selected sample test device so as to emit light in a color corresponding to the type of the detection target before and during the test.
    The sample testing device according to claim 4.
  13.  前記制御部は、前記検査の実施前と実施中とで異なる発光形態で発光するように、前記選択された検体検査装置の前記インジケータを制御する、
     請求項12に記載の検体検査装置。
    The control unit controls the indicator of the selected sample test device so that light is emitted in different light emission modes before and during the test.
    The sample testing device according to claim 12.
  14.  前記インジケータは、凸形状に形成された発光部を有する、
     請求項4に記載の検体検査装置。
    The indicator has a light emitting portion formed in a convex shape.
    The sample testing device according to claim 4.
  15.  前記表示部は、前記検査のガイド情報を表示する、
     請求項1に記載の検体検査装置。
    The display unit displays the guide information of the inspection.
    The sample testing device according to claim 1.
  16.  検体に含まれる検出対象を検出する検査部と、
     検査に関する情報を表示する表示部、及び、前記検査に関する情報の入力を受け付ける入力部を有する入出力部が設けられたマスターの検体検査装置と通信を行う通信部と、
     前記マスターの検体検査装置からの制御により動作する制御部と、
     を備える検体検査装置。
    An inspection unit that detects the detection target contained in the sample,
    A communication unit that communicates with a master sample test device provided with a display unit that displays information related to the test and an input / output unit that has an input unit that accepts input of information related to the test.
    A control unit that operates under the control of the master sample testing device,
    Specimen testing device equipped with.
  17.  デバイスを用いて、検体に含まれる検出対象を検出する検査を行う検査部と、
     異なる色を発光可能なインジケータと、
     前記検出対象の種類に応じた色であって、前記デバイスに色分けされた色、及び、前記デバイスに反応させる試薬のパッケージに色分けされた色と同色で発光するように、前記インジケータを制御する制御部と、
     を備える検体検査装置。
    An inspection unit that uses a device to perform an inspection to detect the detection target contained in the sample,
    Indicators that can emit different colors and
    Control that controls the indicator so that the color corresponding to the type of the detection target emits light in the same color as the color-coded color for the device and the color-coded color for the package of the reagent to react with the device. Department and
    Specimen testing device equipped with.
  18.  前記インジケータは、
     複数の色を発光可能な発光部と、
     前記発光部を覆うケースと、
     を備え、
     前記ケースは、
     前記発光部により発光された前記複数の色を混合させる光混合部材と、
     外部からの光を遮断する遮光部材と、
     を有する請求項4又は17に記載の検体検査装置。
    The indicator
    A light emitting part that can emit multiple colors and
    A case that covers the light emitting part and
    With
    The case is
    A light mixing member that mixes the plurality of colors emitted by the light emitting unit, and
    A light-shielding member that blocks light from the outside,
    The sample testing apparatus according to claim 4 or 17.
  19.  前記遮光部材は、前記ケースの側面に設けられ、
     前記光混合部材は、前記遮光部材の前記発光部と対向する位置に設けられ、
     前記ケースは、
     前記遮光部材と前記光混合部材とを覆う減光部材、
     を更に有する請求項18に記載の検体検査装置。
    The light-shielding member is provided on the side surface of the case.
    The light mixing member is provided at a position facing the light emitting portion of the light shielding member.
    The case is
    A dimming member that covers the light-shielding member and the light mixing member,
    The sample testing apparatus according to claim 18, further comprising.
  20.  マスターの検体検査装置及びスレーブの検体検査装置を具備し、
     前記マスターの検体検査装置は、
     検体に含まれる検出対象を検出する検査部と、
     検査に関する情報を表示する表示部、及び、前記検査に関する情報の入力を受け付ける入力部を有する入出力部と、
     前記検査部を有するスレーブの検体検査装置と通信を行う通信部と、
     前記スレーブの検体検査装置の制御に用いられる制御情報を前記通信部から送信させ、かつ、前記スレーブの検体検査装置から受信した検出結果を処理する制御部と、
     を備え、
     前記スレーブの検体検査装置は、
     前記検査を行う検査部と、
     前記マスターの検体検査装置と通信を行う通信部と、
     前記マスターの検体検査装置からの制御により動作する制御部と、
     を備える検体検査システム。
    Equipped with a master sample testing device and a slave sample testing device,
    The master sample testing device
    An inspection unit that detects the detection target contained in the sample,
    A display unit that displays information related to inspection, an input / output unit that has an input unit that accepts input of information related to the inspection, and an input / output unit.
    A communication unit that communicates with a slave sample inspection device having the inspection unit,
    A control unit that transmits control information used for controlling the slave sample testing device from the communication unit and processes the detection result received from the slave sample testing device.
    With
    The slave sample testing device is
    The inspection department that performs the inspection and
    A communication unit that communicates with the master sample testing device,
    A control unit that operates under the control of the master sample testing device,
    Specimen testing system equipped with.
PCT/JP2021/016533 2020-04-28 2021-04-23 Sample inspection device and sample inspection system WO2021220988A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202180002475.2A CN113892028A (en) 2020-04-28 2021-04-23 Subject inspection apparatus and subject inspection system

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020-079321 2020-04-28
JP2020079321 2020-04-28

Publications (1)

Publication Number Publication Date
WO2021220988A1 true WO2021220988A1 (en) 2021-11-04

Family

ID=78300378

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2021/016533 WO2021220988A1 (en) 2020-04-28 2021-04-23 Sample inspection device and sample inspection system

Country Status (3)

Country Link
JP (1) JP2021175975A (en)
CN (1) CN113892028A (en)
WO (1) WO2021220988A1 (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008039556A (en) * 2006-08-04 2008-02-21 Canon Inc Specimen treatment apparatus and specimen treatment method
JP2010195111A (en) * 2009-02-24 2010-09-09 Fujitsu Ten Ltd Onboard computer system
JP2012093326A (en) * 2010-10-29 2012-05-17 Sysmex Corp Specimen processor and computer program
JP2012233710A (en) * 2011-04-28 2012-11-29 Sysmex Corp Specimen analyzer, specimen analyzing system, measurement result management apparatus, and computer program
JP2016050934A (en) * 2014-08-29 2016-04-11 シスメックス株式会社 Inspection system and inspection method
JP2018069768A (en) * 2016-10-24 2018-05-10 日本精機株式会社 Light-emitting device

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008039556A (en) * 2006-08-04 2008-02-21 Canon Inc Specimen treatment apparatus and specimen treatment method
JP2010195111A (en) * 2009-02-24 2010-09-09 Fujitsu Ten Ltd Onboard computer system
JP2012093326A (en) * 2010-10-29 2012-05-17 Sysmex Corp Specimen processor and computer program
JP2012233710A (en) * 2011-04-28 2012-11-29 Sysmex Corp Specimen analyzer, specimen analyzing system, measurement result management apparatus, and computer program
JP2016050934A (en) * 2014-08-29 2016-04-11 シスメックス株式会社 Inspection system and inspection method
JP2018069768A (en) * 2016-10-24 2018-05-10 日本精機株式会社 Light-emitting device

Also Published As

Publication number Publication date
JP2021175975A (en) 2021-11-04
CN113892028A (en) 2022-01-04

Similar Documents

Publication Publication Date Title
JP7068527B2 (en) Automatic analyzer
US20190162670A1 (en) Measurement method and measurement device
WO2021220988A1 (en) Sample inspection device and sample inspection system
WO2016006362A1 (en) Automatic analysis device
US20200182797A1 (en) Method for notifying sample analyzer status and sample analysis system
CN112119339B (en) Method for examining a liquid comprising at least one cell and/or at least one particle
CN110892270B (en) Automatic analyzer
JP6785989B2 (en) Automatic analyzer
JP2021135226A (en) Specimen inspecting device
EP0649524B1 (en) Light measurement apparatus
US20240027353A1 (en) Optical measurement method, optical measurement system, and test kit
JP2018040795A5 (en)
JP2018040795A (en) Specimen measurement device
US20230219093A1 (en) Test kit and test system
JP2021196172A (en) Specimen inspection device
JP2014016261A (en) Inspection cartridge
US10809255B2 (en) Specimen measurement apparatus
JP2021039102A (en) Specimen inspection device
JP6744927B2 (en) Immunoassay device and its operating method
WO2022209396A1 (en) Test device and cartridge
JP2021135236A (en) Specimen inspection device
JP2012202911A (en) Analysis chip
JP2024032509A (en) Analysis equipment
JP2015014496A (en) Detecting device for emission analysis
CN109324031A (en) A method of by the exciting light of specific modulation come resolved Raman signal

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21796647

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21796647

Country of ref document: EP

Kind code of ref document: A1